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Abstract  
Multiple sclerosis (MS) is an inflammatory, demyelinating and neurodegenerative 
disease of the central nervous system (CNS). Conventional whole brain magnetic 
resonance imaging (MRI) measures do not sufficiently explain disability in MS. 
Network science provides a powerful approach to study brain organizational principles 
and in combination with graph theory has revealed fundamental connectivity patterns 
in neurological conditions including MS.  
The overarching aim of this thesis is to investigate structural network disruption 
in MS evaluating the potential of brain networks analyses as novel biomarkers in MS 
pathology.  
The results of this thesis add to the current scientific knowledge. In particular, 
by applying an optimised structural network reconstruction pipeline we demonstrated 
that network metrics explain disability better in MS over and above conventional non-
network metrics. In addition, in the absence of any longitudinal network studies, we 
developed a longitudinal network pipeline which we then applied to our longitudinal 
data. These findings demonstrated for the first time that baseline structural network 
metrics are predictors of future deep grey matter atrophy and increased lesion load. 
Finally, we applied a data-driven network decomposition approach detecting 
progressive weakening of connections that is linked to the severity of MS subtypes 
suggesting that these techniques are sensitive to pathology. 
The results presented here highlight the potential of network-based approaches 
as complementary methods for disease biomarkers to better predict disease course 
and monitor treatment effects. We believe that these findings may provide a framework 
for future studies with the aim to bridge the gap between imaging and symptomatology. 
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Impact Statement 
Conventional magnetic resonance imaging (MRI) measures do not sufficiently explain 
disability in multiple sclerosis (MS). This condition is characterised by focal and 
widespread pathology and it is the leading cause of chronic neurological disability in 
young adults. MRI-derived network-based measures provide an integrative framework 
to gain new insights into pathological processes. However, there is no standard 
pipeline to reconstruct a structural brain network as methods to map the human brain 
are still in their infancy.  
The methodological work presented here can pave the way for future applications 
in academia. We developed and optimised a structural network reconstruction pipeline 
applying the latest methodological techniques that resulted in a robust and biologically 
plausible brain network. These results make the methods section of a currently under 
review revised paper in the Journal of Neurology, Neurosurgery and Psychiatry 
(JNNP). Although this work has focused on MS, the fact that it yields at a network 
which is biologically relevant constitutes this pipeline transferrable across neurological 
diseases including Alzheimer’s, Parkinson’s and Frontotemporal dementia. Moreover, 
there have been hitherto limited longitudinal structural network studies and none in 
MS. Therefore, in collaboration with the Translational Imaging Group (TIG), Centre for 
Medical Image Computing (CMIC) at University College London (UCL), we extended 
our optimised pipeline to accommodate brain structural investigations with more than 
one time-point. This work has been peer reviewed and published as a book chapter in 
Computational Diffusion MRI (2017). With the increasing need for longitudinal studies 
to gain insights into network dynamics and how these are affected in pathology, we 
anticipate that this framework will have a wide range of application not only in MS but 
also in many neurological conditions with longitudinal data. 
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The use of data from people with MS in our studies strengthens the likelihood of 
our findings being translatable into future clinical practice to help understand disease 
neurobiology, inform prognosis and develop imaging biomarkers to monitor therapies. 
We demonstrated distinct network organisation in a cohort with various MS subtypes; 
results to be submitted for publication in the Multiple Sclerosis Journal (MSJ). We also 
showed for the first time that network metrics explain disability better than non-network 
metrics such as lesion load and tissue atrophy. These results are currently under 
review in the Journal of Neurology, Neurosurgery and Psychiatry (JNNP). Additionally, 
network metrics can predict future tissue damage either at the macroscopic level 
(increased lesion volume), or at the microscopic level causing deep grey matter 
volume loss. These findings will be submitted to Human Brain Mapping (HBM) journal 
for publication. Collectively, all of the above results highlight the clinical importance of 
network analysis and the potential of network metrics as outcome measures for 
disease diagnosis, prognosis and for assessing treatment effects in clinical trials.  
To conclude, this multidisciplinary translational research spanned across computer 
and medical sciences and developed techniques that are transferrable across 
neurological disorders. Additionally, our findings extend our current scientific 
knowledge, they will result in four first-author publications and could help to inform 
future clinical practice.  
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Chapter 1 
1. Introduction  
1.1. Problem statement 
Multiple sclerosis (MS) is an inflammatory, demyelinating and neurodegenerative 
disease of the central nervous system (CNS). It is the most common cause of 
neurological disability in young adults, yet its cause and the mechanisms of the 
underlying long-term disability remain uncertain. Magnetic resonance imaging (MRI) 
is now established as a key tool in diagnosing and monitoring MS. Conventional MRI 
techniques such as detection of number and volume of white matter (WM) lesions and 
reduced brain volume (atrophy) are useful outcome measures, but alone do not 
capture the widespread effects of MS pathology, and explain disability only 
moderately. 
1.2. Aims 
The interplay between inflammation, demyelination and neurodegeneration 
necessitates the application of more advanced techniques that could integrate these 
pathological features and better predict disease course and monitor treatment effects. 
One proposed method is network analysis, which provides a framework to study whole 
brain connectivity patterns and their disruptions, incorporating data beyond focal 
pathology. Network analysis has been recently applied to many neurological disorders 
including MS, revealing some common organisational and connectivity patterns. This 
supports the potential that such an approach might hold, which we further sought to 
explore in this thesis. Therefore, the overarching aim of this work was to investigate 
structural network disruption in MS (taking into consideration the different disease 
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subtypes), evaluating the potential of structural brain network analyses as new 
biomarkers in MS pathology. Our specific aims are: 
1. to develop and validate a structural network analysis pipeline 
2. to evaluate whether structural network metrics can explain disability better than 
conventional imaging measures 
3. to propose and validate a longitudinal network analysis pipeline  
4. to assess whether baseline structural network metrics can predict future 
volumetric changes 
5. to investigate the effect of pathology on key subnetworks applying a novel data-
driven network decomposition method 
1.3. Remaining thesis structure  
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Chapter 2 
2. Multiple Sclerosis  
2.1.  Multiple sclerosis overview 
MS is a chronic demyelinating and neurodegenerative disease of the CNS and is the 
most common neurological cause of disability in young adults (Calabrese et al., 2015). 
It is estimated that approximately 2.3 million people have MS worldwide, while women 
are twice as likely to develop the disease (Thompson et al., 2018b). The cause of the 
disease is currently unknown, although it is suggested that multiple susceptibility 
genes and several environmental factors contribute to the disease manifestation 
(Thompson et al., 2018b; Reich et al., 2018). Pathological characterization of MS 
consists of inflammation, demyelination and axonal damage. Modern imaging 
techniques such as MRI have revolutionised our understating of brain phenotypic 
features in vivo and how pathology evolves over time. In this chapter, I provide a brief 
overview of MS, followed by chapter 3 which will introduce MRI fundamentals and its 
usage in the context of MS. The final introductory chapter, chapter 4, will introduce 
network analysis and how its usage in MS has helped us gain further insights into 
pathological processes that relate to disability.   
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2.2. Multiple sclerosis subtypes 
MS is categorized into four main subtypes per its clinical course (Fig 2.1). Since 2013, 
clinically isolated syndrome (CIS) is considered as the first clinical representation of a 
disease that shows characteristics of inflammation and demyelination (loss of myelin) 
suggestive of MS, but still should fulfil the criteria of dissemination in time (for more 
details on diagnostic criteria see chapter 3). Relapsing-remitting MS (RRMS) is the 
most common form of MS, possibly around 85%. It is characterized by clearly defined 
attacks (relapses), followed by partial or complete recovery periods (remission). 
During remission, there is no obvious progression of the disease. Approximately 10% 
of the RRMS patients become secondary-progressive MS (SPMS) within a decade 
after the initial diagnosis and the conversion point is currently very poorly understood. 
After conversion, SPMS is characterized by a steadier progression of disability 
combined with an increase in neurodegeneration. Primary progressive MS (PPMS) is 
characterized by steadily worsening of neurologic function from onset, although the 
rate of progression changes over time. Approximately 10% of patients with MS are 
diagnosed with PPMS (Thompson et al., 2018a) 
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Figure 2.1 Progression of disability in multiple sclerosis over time 
RRMS is marked by relapses (appearance of symptoms) and remission (recovery). 
Initially, disability remains relatively low and it accumulates over time. In PPMS, there 
is a steady increase of disability from disease onset without any relapses. In SPMS, 
the initial relapses disappear, and the physical disability accumulates rapidly. In this 
diagram CIS is not depicted. Relapse and remission are not in temporal scale. 
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2.3. Causes 
The main factors currently thought to play causal roles in MS manifestation can be 
divided into the environmental and the genetic. 
Environmental factors 
Environmental risk factors such as vitamin D deficiency, which is related to reduced 
exposure to sunlight, diet, obesity in early life and cigarette smoking are known to play 
a part in MS development (Marrie, 2004). It is important to state that low vitamin D and 
cigarette smoking are the most critical known causes (Ramanujam et al., 2015; 
Ascherio et al., 2014) and although correction of vitamin D insufficiency could be 
important for disease prevention, there is no evidence of association between 
neonatal vitamin D levels and disease risk (Ueda et al., 2014). In addition, exposure 
to infectious agents in early adulthood might decrease the risk of developing 
autoimmune and allergic diseases (Bach, 2002) while specific infections in young 
adults such as the Epstein-Barr virus increase the risk of developing the disease (Levin 
et al., 2005). 
Genetics  
The fact that MS seems to occur within families provides evidence of the existence of 
genetic causative factors. For example, carriers of specific alleles within the human 
leucocyte antigen (HLA) region are three times more likely to develop MS than non-
carriers. In addition, a genome-wide association study (GWAS) identified some non-
HLA variants such as interleukin 2 receptor alpha (IL2RA) and interleukin 7 receptor 
alpha (IL7RA), that have some minor effects on disease development (for 
comprehensive review see Thompson et al. (2018b)). These results highlight the 
existence of the genetic component in MS and thus invite subsequent studies to 
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identify determinants of disease progression that could result in more personalized 
patient treatment. 
2.4. From causes to pathology  
Currently, there are two main hypotheses that relate to the root of the disease: the 
outside-in and inside-out models (Fig. 2.2). The former takes the view that MS is an 
autoimmune disorder, during which the T-cells from the periphery cross the blood brain 
barrier and together with the B-cells destroy key components of the CNS such as 
myelin and axons (Lassmann et al., 2007). This, in turn, causes additional 
inflammatory reaction such as microglia activation and production of reactive species, 
resulting in demyelination and tissue damage (Haider et al., 2011). The outside-in 
model is challenged by the inside-out model, according to which the problem is 
initiated within the CNS in a manner similar to other neurodegenerative conditions. 
The idea is that primary degeneration, possibly involving the oligodendrocyte-myelin 
complex (Stys et al., 2012), releases antigenic components that in turn trigger the 
immune cascade (Trapp and Nave, 2008). Irrespective of the underlying sequence of 
events that lead to disease manifestation, it is becoming evident that during the 
progressive phases the intensity of the inflammatory response declines over time, 
while demyelination and neurodegeneration remains throughout the disease duration 
(Frischer et al., 2009).  
 The hallmarks of MS pathology are neuroaxonal loss, demyelination and 
astrocytic gliosis (Thompson et al., 2018b). Neuroaxonal loss (also known as 
neurodegeneration) is particularly relevant as it is strongly associated with permanent 
clinical disability. In vivo, the pathogenic events such as inflammation, demyelination, 
axonal loss and gliosis can be studied using both conventional and advanced imaging 
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techniques. For example, neurodegeneration is observed as reduced brain volume (or 
brain atrophy) by volumetric MRI (Thompson et al., 2018b). More detailed role of MRI 
in MS prognosis and diagnosis will be discussed in chapter 3. 
 
 
Figure 2.2. Schematic diagram depicting the two hypothetical models in 
multiple sclerosis 
The “outside-in model” suggests that T-cells from the periphery cross the blood brain 
barrier and along with macrophages and B-cells, destroy components of the Central 
Nervous System (CNS) causing neurodegeneration. To the contrary, the “inside-out 
model” argues that cytodegeneration is the first event in MS similarly to other 
neurodegenerative diseases and the release of several antigenic components causes 
an inflammatory cascade which possibly causes further degeneration. NO: nitric oxide 
(Figure modified from Stys et al. (2012)) 
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2.5. From pathology to clinical features 
Physical symptoms may vary depending on the location of the lesion. For example, a 
common presentation of MS is optic neuritis, in which the affected individual 
experiences loss of vision. Other recognised symptoms in MS are sensory and/or 
motor disturbances (e.g. numbness, tingling, weakness in arm or leg), sphincter or 
brainstem dysfunction (Lublin et al., 2014). Physical disability also varies depending 
on the MS subtype. For example, symptoms tend to resolve after a relapse at earlier 
stages of the disease whereas accumulation of disability and exacerbation of 
symptoms is observed at later stages of the RRMS or in SPMS subtype (Lublin et al., 
2014).  
2.6. Treatment 
Treatments are not curative but can modify the course of the disease. For example, 
immune response modulators such as interferon beta (Bertolotto and Gilli, 2008) or 
glatiramer acetate (Huntley, 2006) are moderately effective and slow the incidence of 
relapses by around 30% (Palace et al., 2015). Newer pharmacological agents such as 
natalizumab (Polman et al., 2006) and fingolimod (Sanford, 2014) aim to reduce 
inflammation completely either by preventing the entrance of immune cells into the 
brain or by blocking departure from the lymph nodes. Even though these treatments 
seem to reduce the relapses by approximately 70%, they can be associated with 
significant side effects (Huntley, 2006), highlighting the importance of close 
monitoring. Interestingly, while disease modifying treatments seem to be effective with 
respect to the inflammatory component of the disease, it is not yet clear what the 
effects are, if any, on the neurodegenerative aspect of the disease. Recently, a phase 
III clinical trial reported that Ocrelizumab was associated with lower rates of clinical 
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progression in patients with PPMS (Montalban et al., 2017) and although the reasons 
that Ocrelizumab slows down disease activity remains uncertain it still signifies a 
positive step towards treatment for the progressive phases.  
2.7. Strategies to study multiple sclerosis in vivo 
The non-invasive study of the brain has given new insights into brain structure and 
function how these are affected in disease conditions. Given the critical importance of 
MRI in monitoring the disease course and in evaluating treatment effects in vivo, 
chapter 3 will introduce MRI and discuss how its application has advanced our 
understanding of MS pathology. 
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Chapter 3 
3. Magnetic resonance imaging and application to multiple 
sclerosis 
3.1. Magnetic resonance imaging overview 
The development of biomarkers for MS has been limited by the slow rate of disease 
progression and the heterogeneous pathological mechanisms (Reich et al., 2018). 
The most important diagnostic and prognostic tool for assessing MS in vivo is MRI. 
Since MRI’s invention, several MRI acquisition methods have been developed aiming 
to improve the quality of the acquired images and therefore provide further insights 
into the pathological processes. For instance, in MS, T1-weighted imaging (Eshaghi 
et al., 2018), fluid attenuated inversion recovery (FLAIR) (Ge, 2006), phase sensitive 
inversion recovery (PSIR) (Sethi et al., 2012), magnetization transfer ratio (MTR) 
(Bodini et al., 2016), diffusion-weighted imaging (DWI) (Bodini et al., 2009) and 
functional MRI (fMRI) (Rocca et al., 2005) are advanced MRI techniques that are 
commonly used either as diagnostic or research tools. This section will provide a very 
brief overview of the basis of MR technology. Since this thesis focuses on diffusion-
based connectivity, a brief introduction of DWI will be given and some common biases 
in MRI processing will be introduced. The final section will discuss how MRI has helped 
advance our understanding in MS pathology. 
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3.2. Electromagnetic basis of magnetic resonance technology  
MRI takes advantage of protons that are highly abundant in the neural tissue.  All 
protons possess a ‘spin’, which generates a local magnetic field. In general, the proton 
spins in a tissue orient in random directions. However, when the tissue is placed in an 
external magnetic field, the protons align along the axis of the main magnetic field, B0. 
Even though, it is likely that some protons will align “antiparallel” to B0, it is 
energetically favourable to orient parallel to B0 so there is a net magnetic field vector, 
M0, in the parallel direction. Additionally, protons in a magnetic field do not stay 
stationary but they precess around their axis at an angular frequency, ω0, that is 
proportional to the gyromagnetic ratio, γ, of the nuclei and the external magnetic field, 
B0 (given in Tesla) and is referred to as the Larmor frequency (Fig. 3.1): !" = $%" 
Eq. 3.1  
 
 
Figure 3.1. Magnetic properties of the hydrogen atom.  
(A) Protons have an angular momentum (“spin”) that generates a local magnetic field. 
(B) The spinning proton precesses around the externally applied magnetic field at a 
very well-defined frequency, the Larmor frequency. 
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To obtain the MR signal for which the images are reconstructed, M0 must be 
disturbed from its equilibrium state and this is achieved by exposing the tissue to 
radiofrequency (RF) pulses, B1. If the RF pulses are oscillating at the Larmor 
frequency and are applied in a direction orthogonal to B0, then there are two main 
outcomes: a) decrease in the net magnetization, M// < M0, as protons will absorb 
energy from the RF and reorient themselves precessing around the direction of B1 and 
b) the generation of a new magnetic field vector, M^, in the transverse plane of the 
main magnetic field. Switching off the RF allows the protons to relax and go back to 
equilibrium, thus the net magnetic field, M//, to reach again its maximum value, M0, and 
the transverse magnetization, M^, to decrease to zero (Fig. 3.2). The time needed for 
protons to realign to the longitudinal direction is measured by T1 while the time 
constant governing the transverse relaxation decay is referred to as T2.  
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Figure 3.2. Radiofrequency pulses and net magnetic field 
(A) A net magnetization, M0, is present along the longitudinal axis. Application of 
radiofrequency (RF) pulse (B) causes a decrease in the net longitudinal magnetization 
M//, (C). Also, a new net magnetization, M^, is generated along the transverse axis 
(C). (D) Switching off the RF pulse causes increase of the net magnetization, M//, along 
the longitudinal axis and decrease in the transverse component, M^, until the net 
magnetic field returns to the original state, M0. (Figure adopted from Carter and Shieh 
(2009)) 
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The MR image contrast can be manipulated using “sequences”, i.e. the programme 
that controls the scanner, including for example when to start and stop the RF pulses. 
The two most important parameters are the repetition time (TR) and echo time (TE). 
The TR is the time between consecutive slice excitation due to RF pulses or excitation 
of the same slice due to refocusing RF pulses. Refocusing RF pulses are needed to 
refocus the spins so that sufficient signal is generated to produce an image (see next 
paragraph). On the other hand, TE is the time between the excitation RF pulse and 
the measured signal (that is called the “echo”).  
In image reconstruction, the classification of each voxel (3-dimensional pixel) 
depends on both the signal intensity and its position within the brain. For instance, in 
a T1-weighted image, cerebrospinal fluid (CSF), WM and grey matter (GM) have the 
lowest, the highest and the intermediate signal intensity respectively due to their 
difference in fat and water composition. For instance, fat has a shorter T1 relaxation 
time than water, which means that fat will recover its longitudinal magnetization. After 
the second RF pulse is given at 90o, fat would have fully recovered in the longitudinal 
plane while water would have not. The higher the transverse magnetization the more 
signal is received (in this case in WM due to the high composition to myelin) (Larvie 
and Fischl, 2016). These differences in signal intensity can be exploited by several 
post-processing algorithms to delineate the various tissue types. Once delineated, the 
volumes of these tissues can be estimated, which allows to assess tissue loss in MS 
pathology for example (Eshaghi et al., 2014).  
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3.3. Diffusion-weighted imaging 
DWI provides image contrast based on the diffusion of water molecules in the brain. 
At the microscopic level, water molecules are in constant motion due to their thermal 
energy, a phenomenon called Brownian motion (Huisman, 2003). In unconstrained 
medium, such as in CSF, water molecules are free to diffuse in any possible direction 
(isotropic diffusion) whereas in the presence of barriers such as neural tracts, the 
diffusion is hindered and the water molecules are more likely to diffuse in the direction 
parallel to the barriers (Fig. 3.3.) (Huisman, 2010; Clayden, 2013).  
 
 
 
 
 
Figure 3.3. Diffusion of water molecules.  
Schematic diagram showing the diffusion of water molecule in a free environment (left) 
and in a restricted environment (right). Water molecules are depicted as orange dots. 
(Figure adapted from García-Martí et al. (2013)) 
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From MR perspective, diffusion-weighed sequences are developed that are 
sensitive to this motion (Fig 3.4.). This is achieved with the application of strong 
magnetic field gradients (variation of the magnetic field with respect to one direction). 
In DWI, equal gradients are applied on either side of a 180o RF in a sequence often 
called Stejskal-Tanner (Stejskal and Tanner, 1965). This is a spin echo type sequence 
that is used to refocus the spin magnetisation by a pulse of resonant electromagnetic 
radiation. These gradient pulses are designed to cancel each other’s effect out if the 
spins do not move. Diffusing spins though move into different positions between the 
first and second diffusion gradient falling out of phase and eventually losing signal 
(signal attenuation). The position change happens along different directions, 
depending on the microstructure. The amount of signal attenuation depends on the 
amplitude and direction of the applied diffusion gradients. Diffusion gradients can be 
applied along any combination of the main Cartesian axis of the scanner, i.e. X, Y, Z 
axes, and combined to produce a single diffusion-weighted image (Alexander et al., 
2011).  
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Figure 3.4. Gradient spin echo technique.  
Stationary spins are not affected by the gradients applied on either side of the 180o 
RF while diffusing spins are dephased. Diffusion gradients are applied along the X, 
Y, Z axes, or any of their combinations, so that the signal can reflect the structure 
presented in each voxel. RF = radiofrequency; DG = diffusion gradients; 
 
The signal loss from the net movement of particles is given by the Stejskal-Tanner 
equation 
 
& = &"'()* 
  Eq. 2.2 
where S is the signal received at any particular gradient value (b value) and S0 is the 
signal without any diffusion-weighting gradients (b0 s/mm2) and D is the apparent 
diffusion coefficient (ADC) (Le Bihan et al., 1991; Stejskal and Tanner, 1965). The b-
value or ‘b’ is given by the equation below: 
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+ = ($-.)0(1 − .3) 
  Eq. 2.3 
where γ is the gyromagnetic ratio (MHz/T), G is the amplitude of the diffusion gradients 
(mT/m), δ is the width of the diffusion gradient pulses (ms) and Δ is the time between 
two diffusion gradients (ms). From the Eq. 2.2 and 2.3 we can see that the signal loss 
depends on the time between the pulses, strength and duration of gradients applied. 
Exploiting thus the signal dependency on particle motion we are able to generate 
image contrast based on the water molecules diffusion properties in tissues (Chilla et 
al., 2015). 
Clinically, several DW images can be obtained by altering the strength and 
magnitude of the applied gradient (b-value). DWI has been particularly useful in cases 
in which conventional MR technique does not show significant changes in images due 
pathological effects. For example, in stroke followed ischaemia (inadequate blood 
supply) DWI changes are detected as early as 30 mins followed the event compared 
to T2-weighted imaging (classically considered as conventional imaging) which 
changes 8 hours after stroke onset (Srinivasan et al., 2006). Further DWI development 
led to the diffusion tensor model (the simplest model that assumes that diffusion 
follows a Gaussian (normal) distribution), allowing quantification of water diffusion in 
each voxel. The most used metric is fractional anisotropy (FA), which quantifies the 
fraction of the diffusion that is anisotropic and takes values between 0 and 1. If, for 
instance, FA close to 1 means that water molecules are mainly diffusing in a single 
direction which is suggestive of underlying structures where no crossing fibres are 
present. Diffusion tensor is rotationally invariant meaning that it defines three 
orthogonal axis and their diffusivities reflecting the underlying tissue independently of 
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the position of the subject in the scanner (Alexander et al., 2011). Additionally, 
diffusion MRI can be used to reconstruct the putative trajectories of the neural tracts 
using various tractography algorithms and this constitutes the basis of structural 
connectivity, which will be discussed in chapter 4 of this thesis. 
3.4. Common MRI acquisition-related artifacts  
MRI artifacts are features that present in the image that are not present in the original 
object. During image acquisition many artifacts can occur which need to be corrected 
so they do not affect diagnostic and research quality. Some of the common artifacts 
that we corrected in this thesis are introduced below. 
Bias field  
Bias field is also known as intensity inhomogeneity occurring within tissue of the same 
physical properties mainly due to sensitivity of the receiver coil (Despotovic et al., 
2015). Mapping out and removing intensity variation is most commonly performed in 
structural scans as subsequent algorithms to delineate various tissue types rely on 
intensity homogeneity within tissue of the same properties.  
Motion artefact 
Motion artefacts are caused by voluntary or involuntary subject movements e.g. from 
physiological sources like respiration, cardiac motion and blood flow, as well as from 
macroscopic motion such as swallowing or change in position of the head that can 
happen despite stabilisation in the coil with padding. These result in image blurring or 
shading. Techniques such as cardiac gating aim to synchronise the involuntary 
movements with image acquisition minimising thus motion artefacts (Barrett and Keat, 
2004). 
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Eddy currents  
For diffusion weighting, additional strong magnetic field gradients are added, and 
acquisition is very fast (usually the entire image for a certain slice is acquired in a 
single shot using echo planar imaging (EPI). This means that rapidly changing 
magnetic field gradients are applied during the acquisition. These gradients are 
inducing additional currents that are known as eddy currents.  Eddy currents cause 
unwanted time-varying gradients and shifts in the main magnetic field which ultimately 
cause image shearing, shading and blurring (Spees et al., 2011). Image post-
processing techniques have been developed that aim to minimise the effects of the 
eddy currents (Andersson and Sotiropoulos, 2015).  
Echo planar imaging distortions  
As mentioned above, EPI is an MR acquisition method that allows fast image 
acquisition that significantly shortens MR imaging times and can thus reduce motion 
artefacts. However, EPI is sensitive to magnetic field inhomogeneities and in particular 
in anatomic structures at the interface between air, tissue and fluid due to the 
differences in their magnetic susceptibility (the extent to which a substance become 
magnetised when placed in an external magnetic field) (Poustchi-Amin et al., 2001). 
This can cause image geometric distortion at areas between CSF, brain tissue and 
skull.  
3.5. Image registration 
One particular concept in image analysis is image registration. It is defined as the 
process of overlaying (spatially aligning) two or more images that are taken at different 
time points or using different modalities (pulse sequences). Briefly, image registration 
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relies on the finding of common image features so that corresponding images can be 
spatially aligned. There are two types of spatial alignment: 
Rigid transformation 
It is considered a 6-parameter transformation because it includes translation along the 
X, Y, Z dimensions and rotation along the X, Y, Z axis. These preserve the shape of 
the object but they move it around in space. In neuroimaging, rigid body 
transformations are typically used to align scans belonging to the same person but 
acquired at different times or using different pulse sequences.  
Affine transformation 
It is considered a 12-parameter transformation as it includes 6 more parameters i.e. 
stretching along the X, Y, Z axes and shearing or skewing along the XY, YZ, XZ, 
planes. It is most commonly used for inter-subject registration (different subjects) or 
the same subjects but for different stages of their development (Despotovic et al., 
2015). 
Specific to MS inter-subject registration problems are due to brain lesions that 
make it difficult to match the same structures between healthy and diseased brains in 
a common coordinate space (Chard et al., 2010). Therefore, some techniques have 
been proposed to overcome this issue by filling WM lesions with intensities similar to 
those of WM before any post-processing steps (Magon et al., 2014; Valverde et al., 
2015). Such approach is most commonly applied in T1-weighted scans but not for DWI 
scans as changing the intensity in DWI data will significantly alter the underlying 
derived diffusivity impacting subsequent analysis. 
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3.6. Application of magnetic resonance imaging in multiple 
sclerosis 
MRI is now firmly established as a key tool in the diagnosis of MS due to its ability to 
identify mainly WM lesion distribution. According to the 2017 revised McDonald’s 
criteria: dissemination in space requires the presence of two or more lesions in specific 
locations: periventricular, juxta-cortical, infra-tentorial and spinal cord. Dissemination 
in time can be established by the a) presence of a lesion when compared with a 
previous scan and b) simultaneous presence of gadolinium (pharmacological agent 
used in MRI to improve image contrast) enhancing and non-enhancing lesion 
(Thompson et al., 2018a).  
MRI is also an important research tool to assess further mechanisms of MS as 
well as prediction of disease progression. This is particularly important because the 
number and volume of WM lesions alone can only explain a fraction of the diverse 
clinical outcomes. This mismatch has been termed as clinico-radiological paradox 
(Barkhof, 2002). This led to the usage of more advanced techniques including 
diffusion-weighted methods to investigate normal appearing brain tissue. These 
techniques have been successful in detecting changes outside visible WM pathology 
such as reduced tissue integrity, suggesting disconnection as a potential mechanism 
of cognitive dysfunction (Dineen et al., 2009). In addition to WM pathology, studies 
have also investigated grey matter (GM) revealing a relationship between GM atrophy 
and cognitive deficits (Fisniku et al., 2008b; Fisher et al., 2008; Steenwijk et al., 2016) 
in an attempt to study disease mechanisms. In addition, in a large multicentre study 
Eshaghi et al. (2018) demonstrated that deep grey matter (DGM) volume loss drives 
disability accumulation in MS highlighting the importance of quantitative MRI 
measures for disease progression, too.  
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3.7. Motivation for the methods used in this thesis 
The interplay between inflammation, demyelination and neurodegeneration 
throughout the brain, and even more generally in the CNS, points towards the 
necessity of more advanced techniques that would be able to integrate across space 
pathological features, forecast the disease course and monitor treatment effects. One 
possible way is the use of network analysis which can incorporate data from the 
interconnecting regions beyond focal pathology aiming to provide a more holistic 
characterization between localised damage and diffused pathology. Chapter 4 will 
introduce network analysis and discuss current application to MS.  
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“In biology, if seeking to understand function, it is usually a good idea to study 
structure” (Crick and Koch). 
-------- 
Chapter 4 
4. Brain network analysis and application to multiple 
sclerosis 
4.1. Brain network overview 
As discussed in chapter 3, the sensitivity of MRI to acute and chronic WM lesions has 
made this tool essential for diagnosis (Thompson et al., 2018b). However, 
conventional MRI techniques do not necessarily represent processes of brain 
reorganisation in pathology and poorly reflect the long-term course of the disease 
(Filippi and Agosta, 2010; Fisniku et al., 2008a). Besides, current techniques that 
follow anatomical region-of-interest approaches (Bodini et al., 2009) can capture 
localized pathological mechanisms but not widespread pathology, thus it is quite 
difficult to predict the effect of localized damage to the broader functional domain 
(Barkhof, 2002).  
Network analysis offers an alternative approach to study the brain. The human 
brain is essentially a network of neurons or brain regions and knowledge about their 
interconnections is limited. The interest in human brain mapping goes back to 
Santiago Ramón y Cajal, over a century ago (Ramón y Cajal, 1892), who for many is 
considered the father of modern neuroscience, and whose drawings of the neuronal 
cells shed light on the fundamental components of the CNS.  Subsequent research 
focused on studying the neurons as a system to understand higher order functions 
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(Hebb, 1949). Disruption of the system gave rise to the “disconnection syndrome” 
concept (Catani and Mesulam, 2008). For example, a lesion in the corpus callosum, 
the brain region which connects the left and right hemispheres, could interrupt inter-
hemispheric connections, i.e. disconnect the two hemispheres; an anomaly that at the 
beginning of the century would have been found surgically (i.e. craniotomy) 
(Geschwind and Kaplan, 1962). In the late 1970s, the first human being was MRI 
examined signifying a new era in diagnostic medicine. With the use of MRI and its 
specialised methods i.e. tractography, to visualise the connection pathways (Jones, 
2008) in combination with fMRI (Rocca et al., 2005) we could non-surgically identify 
function-specific pathways providing practical evidence of the disconnection 
syndrome. Using MRI as a tool, Sporns proposed a conceptual framework where the 
entire brain connectivity was modelled as a network, also known as a connectome 
(Sporns et al., 2005). This integrative approach aims to provide a map of the brain 
connections so that we can better appreciate how these are affected in pathology. 
Brain connectivity can be sub-divided into three scales and in three modes. The 
scales include microscale connectivity, looking at the synaptic connections of 
individual neurons (Lichtman et al., 2014), mesoscale connectivity, studying the 
connectivity between neuronal populations or cellular assemblies (Oh et al., 2014), 
and macroscale connectivity, where large populations of neurons forming distinct brain 
regions are studied (Hagmann et al., 2008). The modes or patterns of connectivity 
refer to several interrelated facets of brain organization. For example, structural 
connectivity refers to the physical links between brain regions, functional connectivity 
studies the statistical dependencies between the activity of different brain regions 
whereas effective connectivity investigates the causal interactions between distinct 
units in the CNS (Park and Friston, 2013). The main method used in this thesis from 
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an analysis perspective is macroscale structural connectivity and hence this chapter 
will focus on this type of connectivity, which will also be referred to as a structural brain 
network. 
 
4.2. Structural network reconstruction 
The brain network comprises nodes (brain regions) connected by edges and it can be 
represented as a matrix known as a connectivity matrix. Nodes, edges and the 
connectivity matrix are the main topics discussed in this section. 
Network nodes 
For a brain network, nodes are the different brain regions. Typically, a high resolution 
(1x1x1 mm3) structural T1-weighed scan is used to parcellate the brain into 
anatomically distinct subregions (parcellations). There are many ways that such 
parcellation can be performed and there is no consensus as to what the criteria should 
be when parcellating the brain (Fig. 4.1) (Arslan et al., 2018). Ideally, both brain 
structure-function information should be taken into account (Craddock et al., 2013). 
Some of the popular atlases (reference image with a prior defined anatomical 
information (Evans et al., 2012)) are Automated Anatomical Labelling (AAL) and 
Harvard-Oxford which are based on anatomical landmarks, while Talairarch is based 
on cytoarchitecture as derived from post-mortem studies (Sotiropoulos and Zalesky, 
2017). The subsequent connectome is built through two approaches a) tractography-
based connectivity or b) cortical thickness-based correlation. Tractography is a 
method that allows us to reconstruct the neural pathways (see nodes subsection 
below). Cortical thickness correlation networks are based on the assumption that 
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connected brain areas share similar characteristics: neuronal and synaptic density, 
myelination and architecture (He et al., 2007).  
 Geodesic Information Flows (GIF) software was recently developed for brain 
segmentation and parcellation. According to Cardoso et al. (2015), GIF calculates the 
voxel probabilities of  GM, WM and CSF using an atlas propagation and label fusion 
strategy and showed statistically improved segmentation of the different tissue types 
when compared to other techniques (Cardoso et al., 2015). The parcellation was in 
accordance to the Desikan-Killiany-Tourville atlas protocol  that it the largest manually 
labelled human brain images based on anatomical characteristics 
(http://neuromorphometrics.org:8080/seg/) (Klein and Tourville, 2012). In this thesis, 
GIF was used to define the network nodes (chapter 5).  
 
 
 
Figure 4.1. Examples of brain parcellations 
Basic brain parcellation strategies include (A) prior anatomical templates (B) random 
division (C) functionally defined regions of interest (Figure adopted from Filippi et al. 
(2013)).  
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Network edges 
Comparable to nodes, there are alternative ways to define the network edges. If the 
method that is chosen to build the network is cortical thickness connectivity, then 
edges represent the correlation coefficient between each pair of nodes. On the other 
hand, if the tractography-based connectivity was chosen from diffusion-weighted 
imaging, then tractography algorithm is performed which estimates the WM 
trajectories in vivo (Kaiser, 2011).  
 As discussed in chapter 3, DWI is capable of characterising tissue 
microstructure in vivo. This is achieved by acquiring several images to measure the 
magnitude of water diffusion in different directions oriented around the sphere. The 
magnitude and direction of water diffusion within each voxel is inferred through the 
measured signal. For example, diffusion tensor imaging (DTI) measurements acquired 
along the different directions are fitted to the three-dimensional ellipsoid represented 
mathematically by 3x3 matrix, known as a tensor. Then the diffusion in this tensor can 
be fully characterised by three orthogonal eigenvalues that represent the magnitude 
of diffusion along the longest, middle and shortest axes of the ellipsoid and the 
eigenvectors that represent the orientation of these axes (Alexander et al., 2011) (Fig. 
4.2 B). 
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Figure 4.2. Diffusion tensor model 
(A) Schematic representation of a neuron. (B) Ellipsoid corresponding to a magnetic 
resonance voxel. The red arrows correspond to the three orthogonal eigenvectors on 
the major, medium and minor axis. (C) Fibres may be traced using the principal 
direction in each voxel. A single ellipsoid representing the principal direction is 
demonstrated in one of the voxels (voxels are shown here as a grid). 
 
 
As each voxel contains thousands of neurons, diffusion MRI can infer the 
underlying fibre orientation indirectly by estimating the diffusion of water molecules in 
each voxel (Herculano-Houzel, 2009; Lent et al., 2012). When axons are 
homogeneously aligned within each voxel, then the DTI model offers a good 
approximation of the principal direction of the diffusion of water molecules and 
consequently the fibre orientation (Alexander et al., 2011). However, fibres are known 
to disperse, cross or merge, known as “crossing fibres”. The proportion of the WM 
voxels that contains multiple fibre orientations approaches 90% (Jeurissen et al., 
2013). Hence more advanced algorithms have been developed that aim to better 
estimate fibre trajectories. One such method is constrained spherical deconvolution 
(CSD) that can estimate fibre orientation from diffusion data directly. With this method, 
the response function could be estimated which basically represents the signal of a 
single coherently oriented fibre bundle (Tournier et al., 2007; Tournier et al., 2004). 
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This method can robustly determine the fibre orientation distribution within acceptable 
clinical time (under 10 minutes) (Farquharson et al., 2013). Recent studies have 
demonstrated the superiority of this technique over DTI in corticospinal tracks 
(Farquharson et al., 2013; Mormina et al., 2015). 
After the voxel-wise estimation of axonal fibres, tractography approaches are 
used to estimate the putative connections based on the estimated principal directions 
(Fig. 4.2C). There are two main approaches: a) deterministic in which only one 
streamline emanates from each voxel and b) probabilistic tractography which 
estimates a probability for any given streamline (Fig. 4.3). A number of studies have 
assessed the test-retest reliability of tractography methods for connectome 
reconstruction. In general, probabilistic tractography shows greater connectome 
reproducibility while reducing the effect of potential misalignment errors (Zalesky et 
al., 2016). However, it could result to more spurious connections due to the greater 
spatial dispersion of the streamline trajectories (Cote et al., 2013). On the other hand, 
deterministic tractography results in lower connections but it shows greater variation 
both within and across subjects (Sotiropoulos and Zalesky, 2017). In general, there is 
a paradigm shift from deterministic to probabilistic tractography methods owing to the 
development of advanced models for streamline reconstruction.  
 
 
 
  58 
 
 
Figure 4.3. Examples of tractography  
(A) Deterministic and (B) probabilistic tractography of the pyramidal tract overlaid on 
fractional anisotropy image. Colour bar represents the probability for the presence of 
the tract (Figure adopted from Craddock et al. (2013)). 
 
 
Once the tractogram is generated between all pairs of nodes, several measures 
of connectivity strength are then derived. The simplest measure is the number of 
streamlines between two regions. However, streamlines are not really axons but rather 
a mathematical representation of the putative tracts thus do not really relate to 
connectivity strength (Jones et al., 2013). Other connectivity measures based on water 
diffusion in each voxel such as fractional anisotropy (FA) and apparent diffusion 
coefficient (ADC) are used to weight the edges of the network. FA and ADC are 
measures extensively used in medical research and reflect different microstructural 
changes. However, the use of those measures in network analysis has some intrinsic 
limitations including lack of sensitivity as localized disruption in one part of the tract 
might be masked when values are averaged across the whole tract (Jones et al., 2013; 
Colby et al., 2012). Fig. 4.4 shows an example of a weighted graph in which the edges 
have different thickness reflecting differences in the weights.  
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The development of methods that improve the interpretability of streamline 
count as reliable measure for connectivity strength is an active research area. Such 
methods include anatomically constrained tractography (ACT) which provides 
anatomical priors that are shown to reduce known false positives (Smith et al., 2012) 
and spherical-deconvolution informed filtering of tractograms (SIFT2) that reweights 
the generated streamlines so that streamline count correlates to WM density (Smith 
et al., 2015b; Smith et al., 2015a). Other methods include unsupervised tractogram 
reconstruction using reference tracts (Clayden et al., 2009) while more recently a 
hierarchical clustering of streamline tractography algorithm has been proposed so that 
streamlines are clustered based on their anatomical neighbourhood, thus minimising 
random variability between subjects (Siless et al., 2018).  
 
 
 
 
 
 
 
 
Figure 4.4. Example of a graph 
A model graph demonstrating the nodes and the edges. The thickness of the 
connections corresponds to the weight of the connection i.e. thicker lines mean higher 
weights. 
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Connectivity matrix 
Finally, irrespective of the choice of edges, the brain network is usually visualized as 
a connectivity matrix whose links between each pair of nodes can be shown as a 
binary number considering only the presence (1) or absence (0) of a connection, or as 
a weighted number taking a range of values (Rubinov and Sporns, 2010). In addition, 
there are several weighting strategies that are used to reflect the type of the pairwise 
connection, the most common being FA and the number of streamlines, to represent 
connection integrity or connection density respectively. Fig. 4.5. shows an example of 
a weighted connectivity matrix. Fig. 4.6. summarises the connectome reconstruction 
pipeline. 
 
 
Figure 4.5. Example of a weighted connectivity matrix 
The numbers on the rows and columns correspond to the nodes and the element in 
the matrix correspond to the number of streamlines between a pair of nodes.  
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Figure 4.6. Network reconstruction pipeline 
(A) Basic workflow showing the different steps for brain network (also termed as 
connectome) reconstruction. The anatomical and diffusion images are processed as 
different streams and are finally compiled into a brain connectome. (B) For 
visualization purposes the brain connectome is represented as a matrix encoding the 
strength and the type of connection between two brain region pairs. These pairwise 
connections can either be weighted (taking a range of values), unthresholded (left) 
or thresholded (middle) to remove spurious connections and then binarised (right) 
taking values between 0 and 1. 
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4.3. Graph theory in brain networks 
Following brain network reconstruction, metrics from the well-established field of 
mathematics, graph theory, are usually derived to quantitatively summarise brain 
organization. Graph theory is the study of mathematical objects used to model 
pairwise relations between objects. It is a very broad theme with several applications 
in biological, physical and social systems (Rubinov and Sporns, 2010). This 
subsection aims to briefly introduce some popular concepts of graph theory when 
studying brain networks. Since in this thesis, we used weighted networks (compared 
to binary; see chapter 5) the equations for the weighted forms are provided. 
The human brain is structurally and functionally organised into a complex 
network to facilitate integration and segregation of information processing. An 
integrated network is one in which each node is easily accessible by any other node. 
Global efficiency and characteristic path length are measures used to quantify network 
integration (Rubinov and Sporns, 2010). More specifically, global efficiency is defined 
as the average of inverse shortest path lengths and it is inversely related to the 
characteristic path length – that is the minimum number of steps required to travel 
from one node to another (Rubinov and Sporns, 2010). It corresponds to the structural 
capacity of information transfer between parts of the network and it is mainly 
associated with the long-range connections. The equation is as follows: 
567 = 19: ∑ <=>?7@?∈B,?D>	9 − 1 (F>∈B  
Eq. 4.1 
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where n is the number of nodes and i,j are the nodes of the graph. (=>?7)(F corresponds 
to the distance of the weighted shortest path length between i,j. This equation is a 
generalization from the definition of the binary unweighted networks as proposed by 
Latora and Marchiori (2001).  
 By contrast, segregation is the propensity of the network to form highly 
interconnected local cliques which are sparsely connected with the rest of the network 
and can be measured in terms of local efficiency and clustering coefficient. Local 
efficiency, similar to global efficiency, is defined as the average of the inverse distance 
matrix but in a sub-cluster of the network (Latora and Marchiori, 2001). It is considered 
a measure of the local information flow. As this is a node-specific measure we average 
over all the nodes to get the mean local efficiency metric. In this study, we used the 
following generalization algorithm,  
 
5G7 = 19: 1H>	(H>	 − 1): I>?I>JK=?J7(L>)M(F>∈B>∈B  
Eq. 4.2 
 
where [=?J7 	(L>)](F is the inverse weight of the shortest path between nodes j and h 
which are immediate neighbours of node i and I>? is the connection status between i 
and j: I>?=1 when a link (i,j) exists and I>?=0 otherwise. 	H> is the strength of the node 
i (the sum of the weight of the edges connected to it) 
In addition, the clustering coefficient is a measure of local organization reflecting how 
well the neighbour’s nodes are connected (Rubinov and Sporns, 2010).  
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P7 = 19: 2R>7H>	(H>	 − 1)>∈B  
Eq. 4.3 
where  
H> = ∑ I>??∈B ,    R>7 = F0∑ ST>?T>JT?JU?,J∈B  
Eq. 4.4 
N is the overall number nodes (for which there are n). 	H> is the strength of the node i 
(the sum of the weight of the edges connected to it) and R>7 is the sum of the geometric 
mean of the weights in each triangle1.  
Another concept that is used in this thesis is edge density and it is known as the 
connectivity of the network. It is defined as the percentage of the connections that 
exist relative to the potential number of connections. The equation is: 
 
V = 25L(L − 1) 
Eq. 4.5 
 
                                            
1 In the unweighted form, number of triangles around node i correspond to the number of pairs of 
neighbours of that node that are connected to it. 
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where E is the number of edges and N is the overall number of nodes. Since the 
derived network is undirected we divide the denominator by 2 so that any potential 
pairwise edge is counted once and not twice.  
Further graph theory concepts have also received a lot of interest. For example, 
so-called “hubs” are brain regions that have higher degree (binary graph) or strength 
(weighted graph) (van den Heuvel and Sporns, 2013). Brain regions that are 
consistently identified as network hubs are the precuneus, anterior and posterior 
cingulate cortex, insular cortex, superior frontal cortex, temporal and lateral parietal 
cortex (van den Heuvel et al., 2010). Further studies have also demonstrated that 
brain networks can be decomposed into different modules (Meunier et al., 2009) while 
van den Heuvel and Sporns (2011) showed that hubs have the tendency to be more 
closely connected among themselves rather than nodes of lower connectivity, known 
as “rich-club” (Fig. 4.5).  
Another interesting framework for brain network decomposition was introduced by 
Clayden et al. (2013), who showed that the network can be decomposed into stable, 
meaningful and reproducible “principal networks”. This data-driven approach identifies 
subnetworks with strong internal connectivity, allowing multiple layers of connectivity 
to be considered separately. Thus, principal network analysis provides a framework to 
study the effects of pathology on key subnetworks. This technique has been used in 
chapter 9 to investigate topological organisation in MS. 
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Figure 4.7. Summary of the main measures derived with graph analysis 
(A) A graph is composed of nodes and edges (connections). (B) A weighted graph 
provides information regarding the strength of the connection. Higher connection 
weights are represented by thicker lines (C) The clustering coefficient describes the 
tendency of the nodes to form local triangles and it is a measure of local connectivity. 
(D) The shortest path length describes the minimum number of steps required to 
communicate between two nodes and it provides insights into the communication 
efficiency between those nodes. (E) The degree of the node describes the number of 
existing connections of that node. A node with many connections will have a more 
central role in the network and it may suggest the existence of hub nodes. (F) The 
“rich-club” organization describes the tendency of hub nodes to be more closely 
connected among themselves. (For each metric the node and edge of interest is 
always highlighted (Figure adopted from Filippi et al. (2013)). 
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4.4. Application of network analysis in multiple sclerosis 
The preceding sections introduced the concept of the structural brain network, its 
reconstruction and graph theory analysis. In this section, we discuss the main findings 
emerging from the application of network analysis in MS. Even though several imaging 
modalities and methods have been used, such as cortical thickness (He et al., 2009) 
and electroencephalography (Van Schependom et al., 2014), here we focus on DWI-
based networks. 
One of the first studies looking at networks constructed with DWI data was 
conducted by Shu et al. (2011). The authors constructed FA-weighted and number of 
streamlines-weighted brain networks and showed decreased global and local network 
efficiencies in 39 RRMS patients compared to healthy volunteers. These differences 
were correlated with WM LL, EDSS scores (disability score) and disease duration (Shu 
et al., 2011). Going a step further, Li and colleagues introduced a new metric, namely 
“communicability”, that accounts for “both direct and indirect connections” in an 
attempt to quantify network differences that are not “lesion-related”. They showed 
decreased communicability in several brain areas, whereas increases in this metric 
were observed in DGM structures suggestive of “compensatory mechanisms” in early 
RRMS (Li et al., 2013). 
Recent studies have further investigated network changes in MS and subtypes. 
Pardini and colleagues showed that global efficiency of the motor network, derived 
from composite measures (FA, MTR and tract volume), correlates better than 
conventional imaging metrics with EDSS score in RRMS and SPMS patients (Pardini 
et al., 2015). Other studies showed further network alterations that highlight the 
possibility of structural adaptations at early stages of the disease in order to preserve 
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cognitive function (Muthuraman et al., 2016; Fleischer et al., 2016; Llufriu et al., 2016). 
Finally, two independent studies developed a method that allowed the automatic 
classification of MS patients into different clinical profiles (Muthuraman et al., 2016; 
Kocevar et al., 2016), highlighting the fact that MS subtypes share different underlying 
network properties. 
Longitudinal studies are imperative to investigate disease progression. For 
instance, Bodini et al. (2016) have reported evidence that cortical damage is the 
sequence of normal appearing WM pathology, which in turn is predicted by 
abnormalities within WM lesions, while a study by Tur et al. (2016) provided 
longitudinal evidence of anterograde trans-synaptic degeneration in optic neuritis 
patients. Both studies used diffusion-weighted imaging for their investigation. 
Currently, there are no longitudinal studies from a network perspective. Longitudinal 
network approaches hold the potential to study dynamics of network function over 
time, evaluate network alterations in disease and investigate whether these constitute 
processes that partially or fully compensate for tissue loss in the absence of any 
clinical decline.  
 To conclude this chapter, we can appreciate the variability of the techniques 
that lead to network reconstruction in the absence of any standardised pipelines: from 
node selection to modelling crossing fibres, and from the various tractography 
algorithms to the various weighting schemes (i.e. FA or number of streamlines) of the 
network. And finally, the resulting matrix can be thresholded and/or binarised in a 
subjective way. Each of these steps/techniques has been developed and used with 
the goal of improving the biological basis of the resulting network. Despite the plethora 
of choices, which might be paradoxically considered as caveats as the results are not 
easily generalisable, some interesting patterns have emerged. With the ongoing, 
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active research in the field, acknowledging the current limitations, it will not be long 
until we see some further developments that could lead to more widespread usage of 
network analysis, especially in clinical practise. 
 
4.5. Remaining questions and research aims of this thesis 
The brain connectome is a conceptual framework that allows a holistic rather than 
reductionist study of the brain. This is particularly important in diseases such as MS 
where diffused pathogenic processes cannot be captured by conventional imaging 
techniques. As discussed, network analysis is a multistep procedure with no 
consensus on optimal network construction, and several decisions should be made 
during the process which can influence subsequent analysis. In chapter 5, we are 
going to present the various steps taken during the network reconstruction pipeline 
that was optimised and used in this thesis, using advanced techniques that aimed to 
minimise tracking biases thus making the resulting network more biologically 
plausible. Using this pipeline, we then investigated whether network metrics can 
explain disability over and above brain atrophy and lesional metrics in chapter 6. In 
the absence of any longitudinal network studies, in chapter 7, we developed and 
validated a longitudinal network framework which we then applied in chapter 8 to 
investigate whether baseline network metrics can predict future brain damage. Up to 
this stage, network metrics were derived from the whole brain and thus in chapter 9 
we used a novel data-driven brain decomposition method to study whether brain 
different topological organisation exists in MS subtypes.  
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Chapter 5 
5. Optimization of the structural network pipeline for 
baseline analysis 
Summary 
In this chapter, we present the work performed to optimise the network reconstruction 
pipeline to be used in subsequent clinical studies (presented in chapters 6-9). We 
employed the latest advances in the field of connectomics, which include anatomically 
constrained tractography and spherical-deconvolution informed filtering of 
tractograms for diffusion processing in order to minimise structural connectivity biases. 
This chapter presents the main output steps during the reconstruction process in a 
small cohort that constitutes healthy subjects and multiple sclerosis patients. 
Additionally, it demonstrates that the optimised pipeline is highly reproducible and 
remains stable across subjects. The yielded network shares features with previous 
studies that employed techniques similar to the ones applied here. This chapters 
concludes that the proposed pipeline minimises the reconstruction biases and 
constitutes the derived network biologically plausible, suitable for structural 
connectivity studies. 
Scientific contribution 
The contents of this chapter are included in the methods section in a manuscript that 
is currently under review in Journal of Neurology, Neurosurgery and Psychiatry: 
“Structural network disruption markers explain disability in multiple sclerosis”.  
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5.1. Introduction  
As discussed in chapter 4, brain networks derived from DWI can be reconstructed by 
compiling pre-processed diffusion MRI images with pre-processed structural MRI 
images. DWI and tractography techniques can be used to indirectly reconstruct the 
trajectories and estimate microstructural properties of WM fibre bundles. Despite 
promising applications in many neurological disorders including MS, many problems 
are associated with structural connectome quantification (Jones et al., 2013; 
Sotiropoulos and Zalesky, 2017) some of which are associated with the processing 
steps themselves. Network reconstruction is a multistep process and each step needs 
to be carefully examined otherwise it could become a potential source of error (bias) 
that might have negative effects in the final analysis (Griffa et al., 2013).  
Additionally, for the brain network reconstructions to provide biologically 
meaningful information, the derived network should provide metrics that are 
biologically relevant such as density of WM connection between brain regions (Sporns 
et al., 2005). However, due to the fact that raw streamline counts provide an unreliable 
quantitative marker of fibre connectivity (Jones et al., 2013), diffusion metrics such as 
FA are usually employed. However, such metrics are rather indirect (Jones et al., 
2013) or they become unreliable in regions where fibre distribution is complex, i.e. 
‘crossing fibres’ which represent up to 90% of WM voxels (Jeurissen et al., 2013). 
Therefore, the focus of recent studies was to eliminate abnormal streamline 
termination in WM and CSF, which is not biologically plausible (Smith et al., 2012), 
and to make streamline density a reliable measure of WM density (Smith et al., 2015a). 
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With these in mind, the aims of work presented in this chapter were: 
1. to use the recently developed state-of-art techniques that minimise tracking 
biases to optimize a connectome pipeline  
2.  to quality assess the output of each processing step in healthy controls (HC) 
and MS patients and  
3.  to validate the generated network.  
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5.2. Methods 
5.2.1. Participants  
For this study, we chose five healthy controls and five MS patients from an existing 
database. Subjects were selected randomly, although for the five chosen MS patients 
one was RRMS, one was PPMS and three were SPMS to ensure a representative 
range of the disease spectrum. Each optimization step was evaluated by visual 
inspection for the subjects. After this, 12 HC were analysed in order to validate the 
generated pipeline. This work has been approved by the local institutional ethics 
committee and written consent was obtained from all the patients. 
5.2.2. MRI data acquisition  
Brain MRI data were acquired using a Philips Achieva 3T MR scanner (Philips 
Healthcare, Best, Netherlands) using a 32-channel coil. The high angular resolution 
diffusion imaging (HARDI) scan consisted of a cardiac-gated spin-echo (SE) sequence 
with echo planar imaging (EPI) readout (resolution = 2x2x2 mm3, repetition time (TR) 
= 24000 ms; echo time (TE) = 68 ms; 61 isotropically distributed diffusion-weighted 
directions, b-value = 1200 s/mm2, 7 b = 0 volumes, matrix size 112 x 112, number of 
slices 72). In each subject, the following data was also acquired: (1) T1-weighted 
scans were also acquired using a 3D fast-field echo scan (resolution = 1x1x1 mm3, TR 
= 6.9 ms, TE = 3.1 ms, inversion time (TI) = 824.5 ms) and (2) dual-echo proton 
density/T2-weighted axial oblique scans (resolution = 1x1x1 mm3, TR = 3500 ms, TE 
= 19/85 ms, field of view 240x180, number of slices 50). All data were acquired with 
slices aligned with the anterior commissure (AC) – posterior commissure (PC) line to 
minimise the effect of head positioning on data analysis. 
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5.2.3. Structural imaging processing  
Bias field correction of structural imaging 
To correct for magnetic field inhomogeneity, structural images were bias field 
corrected using the N4 algorithm (Tustison et al., 2010). 
Lesion filling  
For WM lesion detection, T2-hyper intense lesions were manually delineated from the 
proton density (PD)-weighted scans using JIM (v6.0, Xinapse Systems, Aldwincle, 
UK). The PD-weighted lesion masks were registered to T1-weighted scans using 
pseudo-T1 image as previously described (Hickman et al., 2002).  
Registration between T1-weighted and diffusion-weighted image 
A rigid-body transformation was performed to register the subject’s T1-weighted image 
to the corresponding DWI image using BrainSuite (Bhushan et al., 2012), where the 
target volume was the first b0 image after DWI pre-processing, resulting in a structural 
image of resolution = 2x2x2 mm3 (Smith et al., 2012). The purpose of registering the 
structural images to the diffusion images at this stage is two-fold: a) matching the voxel 
dimensions and positions of the T1-scan to that of DWI means that any subsequent 
image derived from the anatomical scan will be inherently aligned to the DWI and b) 
aligning the anatomical image to the DWI and not the other way around ensures that 
re-orientation of the gradient directions is not required.  
Tissue segmentation and parcellation  
We non-rigidly transformed the lesions to DWI space and then filled the T1-weighted 
images in this space using a modality-agnostic patch-based method (Prados et al., 
2016b). The reason that we registered the T1-image in DWI space before lesion filling 
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is so that we matched all the anatomical features between the two modalities including 
lesions. Hence, we ensured that the non-rigid registration was not affected by the 
lesion filling technique. The filled T1-weighted images in low resolution were then 
segmented into cortical grey matter (CGM), WM, DGM, brainstem and CSF and 
parcellated into anatomically distinct regions according to Desikan–Killiany–Tourville 
atlas protocol using the GIF framework (Cardoso et al., 2015). This method has been 
previously used in different neurological diseases such as MS (Eshaghi et al., 2018), 
dementia (Premi et al., 2017) and epilepsy (Taylor et al., 2017). GIF is freely available 
as web-service at http://cmictig.cs.ucl.ac.uk/niftyweb (Prados et al., 2016a). The full 
list of brain regions generated with GIF are shown in Table 5.1. The generated WM 
and brainstem tissues were joined together to form the appropriate tissue used for 
ACT algorithm. ACT provides the anatomical prior to improve the accuracy of the 
reconstructed streamlines (Smith et al., 2012).  
5.2.4. Diffusion-weighting imaging processing  
Diffusion-weighted imaging pre-processing  
The mean b0 image was rigid registered to the first b0 image. Then, the same rigid 
transformation was applied to the 61 DWI volumes. FSL v5.0.9 was used on the DWI 
data to correct for eddy current and head motion using affine registration to the first 
b0 (Andersson and Sotiropoulos, 2016). We also corrected the geometric distortions 
caused by EPI sequences using BrainSuite v15b (Bhushan et al., 2012). As discussed 
in chapter 4, EPI sequences are quite sensitive to inhomogeneities of the magnetic 
field resulting in localised distortions particularly at the interface between tissue, bone 
and air.  
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Model response function and perform constrained spherical 
deconvolution 
For estimation of the response function, that is the signal expected from a voxel that 
contains a single coherent fibre bundle, we used the Tax algorithm (Tax et al., 2014). 
Then, CSD was performed to estimate the voxel-wise fibre orientation distribution 
functions (fODFs) (Tournier et al., 2007; Tournier et al., 2004).  
 
Whole-brain streamline tractography  
For each subject, 107 streamlines were generated using the “dynamic seeding 
mechanism” (Smith et al., 2015b). For probabilistic tractography, the 2nd-order 
Integration over Fibre Orientation Distributions (iFOD2) algorithm (Tournier et al., 
2010) was employed, implementing the ACT framework (Smith et al., 2012). As a test, 
we also generated a tractogram containing 108 streamlines for two subjects. Moreover, 
in MS, tractography algorithms are known to be hampered by the presence of lesions 
(Sotiropoulos and Zalesky, 2017). Thus, in our approach, during tractogram 
reconstruction we provided anatomical prior of the WM as part of the ACT algorithm 
ensuring that no streamlines are incorrectly terminated in the WM due to the lesions. 
To validate this, we also ran the tractography in a subject for which lesion masks were 
not provided during the tractography step and tested the effects on the derived 
tractogram (Fig. 5.8). We chose the 107 streamline tractogram as the default and 
SIFT2 was applied to modulate the contribution of each streamline to the relevant 
edge (Smith et al., 2015b).  
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5.4.5. Connectome reconstruction  
Brain GM parcellations were selected from whole brain parcellation derived from GIF 
(Cardoso et al., 2015) and constituted the GM nodes of the network. A symmetric 
matrix consisting of 120 nodes was constructed. Each network edge was defined as 
the sum of weights of streamlines connecting a pair of nodes (Smith et al., 2015b).  
5.4.6. Reproducibility   
To test the reproducibility of our findings, we used a split-half method. Briefly, we 
divided the control group into 2 subgroups according to the distributions of age and 
gender; controls1: 6 participants, 3 females; controls2: 6 participants, 3 females. To 
determine whether there was a consistent topological organisation in the population 
we used Student’s t-test to compare the edge density between the two subgroups.   
 
As, discussed in chapter 4, edge density, is defined as    
V = 25L(L − 1) 
Eq. 5.1. 
where E is the number of edges and N is the number of nodes. The definition is the 
same for weighted and binary matrices. Edge density was derived from TractoR 
(http://www.tractor-mri.org.uk; (Clayden et al., 2011)). 
We also identified network hubs. Hubs are nodes with central role in the 
network and there are several ways with which they can be identified (van den Heuvel 
and Sporns, 2013). Here, hubs were defined as regions that exhibited high strength 
(Kw; ≥ mean + standard deviation (SD)) (Shu et al., 2011; Yeh et al., 2016) resulting 
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in 18 regions. In brain terms, hubs are generally considered as brain areas that are 
important for enabling efficient neuronal signalling and communication.  
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5.3. Results  
The output files for each step were visually inspected. In this section, we shall 
demonstrate images of the main processing steps. 
Quality assessment of the structural images  
Firstly, the anatomical images were bias field corrected (Fig. 5.1.B). This step is 
necessary as the segmentation and parcellation algorithms rely on intensity 
homogeneity to accurately delineate CSF, GM and WM. The anatomical images were 
subsequently lesion filled (Fig. 5.1.D,F), as lesions in the brain can affect the 
estimation of the segmentation parameters (Chard et al., 2010) and then processed 
using GIF (Cardoso et al., 2015) to generate brain tissue parcellation and 
segmentation. Fig. 5.3 and Fig. 5.4 show an example of brain parcellation and 
segmentation respectively. 
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Figure 5.1. Anatomical images pre-processing  
(A) Raw T1-weighted image, (B) T1-weighted was bias field corrected i.e. the intensity 
inhomogeneity (the increased brightness) that it is observed in the centre of the scan 
in (A) is removed in (B). (C) The lesion probability masks (red-yellow masks) overlaid 
on T1-weighted image. (D) Lesion filled T1-weighted image. Red arrow in (E) point at 
a lesion (voxels with lower intensity than expected) which was subsequently filled in 
(F) using a modality-agnostic patch-based approach (Prados et al., 2016b). Red boxes 
in (B) and (D) show the area that is magnified in (E) and (F), respectively. 
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Figure 5.2. Brain parcellation 
The brain tissue is divided into non-overlapping, distinct regions as depicted by the 
different colours. (A) sagittal, (B) coronal, (C) transverse plane.  
 
 
Figure 5.3. Brain tissue segmentation 
The brain tissue is segmented into 5 tissue types, (A) CSF, (B) CGM, (C) WM, (D) 
DGM and brainstem. Note that the brainstem is not depicted in the above figures as 
the image was captured at a level where brainstem was not visible.  
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Brain regions 
1 Right Accumbens Area 61 Right middle occipital gyrus 
2 Left Accumbens Area 62 Left middle occipital gyrus 
3 Right Amygdala 63 Right medial orbital gyrus 
4 Left Amygdala 64 Left medial orbital gyrus 
5 Brain Stem And Pons 65 Right postcentral gyrus medial segment 
6 Right Caudate 66 Left postcentral gyrus medial segment 
7 Left Caudate 67 Right precentral gyrus medial segment 
8 Right Cerebellum Exterior 68 Left precentral gyrus medial segment 
9 Left Cerebellum Exterior 69 Right superior frontal gyrus medial segment 
10 Right Hippocampus 70 Left superior frontal gyrus medial segment 
11 Left Hippocampus 71 Right middle temporal gyrus 
12 Right Pallidum 72 Left middle temporal gyrus 
13 Left Pallidum 73 Right occipital pole 
14 Right Putamen 74 Left occipital pole 
15 Left Putamen 75 Right occipital fusiform gyrus 
16 Right Thalamus Proper 76 Left occipital fusiform gyrus 
17 Left Thalamus Proper 77 Right opercular part of the inferior frontal gyrus 
18 Cerebellar Vermal Lobules I-V 78 Left opercular part of the inferior frontal gyrus 
19 Cerebellar Vermal Lobules VI-VII 79 Right orbital part of the inferior frontal gyrus 
20 Cerebellar Vermal Lobules VIII-X 80 Left orbital part of the inferior frontal gyrus 
21 Left Basal Forebrain 81 Right posterior cingulate gyrus 
22 Right Basal Forebrain 82 Left posterior cingulate gyrus 
23 Right anterior cingulate gyrus 83 Right precuneus 
24 Left anterior cingulate gyrus 84 Left precuneus 
25 Right anterior insula 85 Right parahippocampal gyrus 
26 Left anterior insula 86 Left parahippocampal gyrus 
27 Right anterior orbital gyrus 87 Right posterior insula 
28 Left anterior orbital gyrus 88 Left posterior insula 
29 Right angular gyrus 89 Right parietal operculum 
30 Left angular gyrus 90 Left parietal operculum 
31 Right calcarine cortex 91 Right postcentral gyrus 
32 Left calcarine cortex 92 Left postcentral gyrus 
33 Right central operculum 93 Right posterior orbital gyrus 
34 Left central operculum 94 Left posterior orbital gyrus 
35 Right cuneus 95 Right planum polare 
36 Left cuneus 96 Left planum polare 
37 Right entorhinal area 97 Right precentral gyrus 
38 Left entorhinal area 98 Left precentral gyrus 
39 Right frontal operculum 99 Right planum temporale 
40 Left frontal operculum 100 Left planum temporale 
41 Right frontal pole 101 Right subcallosal area 
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42 Left frontal pole 102 Left subcallosal area 
43 Right fusiform gyrus 103 Right superior frontal gyrus 
44 Left fusiform gyrus 104 Left superior frontal gyrus 
45 Right gyrus rectus 105 Right supplementary motor cortex 
46 Left gyrus rectus 106 Left supplementary motor cortex 
47 Right inferior occipital gyrus 107 Right supramarginal gyrus 
48 Left inferior occipital gyrus 108 Left supramarginal gyrus 
49 Right inferior temporal gyrus 109 Right superior occipital gyrus 
50 Left inferior temporal gyrus 110 Left superior occipital gyrus 
51 Right lingual gyrus 111 Right superior parietal lobule 
52 Left lingual gyrus 112 Left superior parietal lobule 
53 Right lateral orbital gyrus 113 Right superior temporal gyrus 
54 Left lateral orbital gyrus 114 Left superior temporal gyrus 
55 Right middle cingulate gyrus 115 Right temporal pole 
56 Left middle cingulate gyrus 116 Left temporal pole 
57 Right medial frontal cortex 117 Right triangular part of the inferior frontal gyrus 
58 Left medial frontal cortex 118 Left triangular part of the inferior frontal gyrus 
59 Right middle frontal gyrus 119 Right transverse temporal gyrus 
60 Left middle frontal gyrus 120 Left transverse temporal gyrus 
 
Table 5.1. List of generated grey matter regions  
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Quality assessment of the diffusion-weighted images  
After we corrected for eddy-currents and geometric distortions (Fig. 5.4), we estimated 
the fODF and tested its performance in voxels that are known to have crossing fibres 
and no crossing fibres (Fig. 5.5). Then, a whole brain probabilistic tractography was 
performed using the ACT framework. Fig. 5.6 shows that the generated tractogram 
was confined to WM as expected. Fig. 5.7 demonstrates an example of misregistration 
between b0 and DWI that can have detrimental effects on subsequent steps. Fig. 5.8 
shows that no streamlines are abnormally terminated in WM due to WM lesions. 
 
 
 
Figure 5.4. Geometric distortion correction 
Uncorrected (A) and corrected (B) for geometric distortion b0 image without diffusion 
weighting overlaid on anatomical T1-weighted image. The arrows point are regions 
where the corrections are more prominent.  
  
A B
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Figure 5.5. Voxel-wise fibre orientation distribution  
Fibre orientation distributions (FOD) overlaid on T1-weighted image. The data were 
visually inspected at two places as the arrows point. Right: corpus callosum where 
we expect no crossing fibres, and this is validated by the magnified FOD which has 
only two lobes and Left: at an area where we expect crossing fibres i.e. at the 
intersection between callosal fibres and corticospinal tracts. The crossing fibres are 
modelled by FOD by having 4 lobes. CC; corpus callosum 
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Figure 5.6. Whole brain probabilistic tractography  
T1-weighted anatomical image (A) was segmented into CGM, WM and DGM (B). In 
(C) and (D) the generated tractogram was overlaid on the segmented and anatomical 
image respectively for visual inspection. The generated streamlines were restricted 
only in WM as expected.  
 
Figure 5.7. Example of the effect of misalignment between diffusion image with 
and without weighting  
Fibre Orientation Distribution (FODs) is overlaid on (A) diffusion image without 
weighting (B0) and (B) diffusion weighted images (DWI). Due to the misalignment, the 
estimated FODs in (A, C) do not reflect the “true” underlying biological structure such 
as the corpus callosum as compared to (B, D). The red boxes in (A) and (B) represent 
the magnified images in (C) and (D) respectively. CC; corpus callosum. 
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Figure 5.8. Effect of lesions on tractography 
Color-coded line at the GM-WM interface overlaid on diffusion weighted image without 
directional weighting (B0) corresponds to the streamline termination points in (A), (B), 
(C), (D) and (E). In (B) there are streamlines terminated in a lesion compared to (A) 
as shown by the red arrow. The red arrow points to a lesion (C), to a lesion overlaid 
with lesion mask (orange; D) and to lesion overlaid with lesion mask and streamline 
termination points (E). In our study, we made sure that no streamlines are terminated 
in lesions. The effect of streamline termination and network measures is beyond the 
scope of this chapter.  
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Quality assessment of the connectome  
The Fig. 5.9. shows the brain modelled as a graph and the connectivity matrix, also 
known as adjacency matrix, corresponding to only one individual. The two-
dimensional connectivity matrix shows the pairwise connectivity between the 120 
nodes of the network. Each column and its corresponding row corresponds to a unique 
node. In this study, we used the SIFT2 algorithm (Smith et al., 2015b) which reweights 
the contribution of streamline to the relevant edge. This means that the values in the 
matrix correspond to the pairwise sum of the cross-sectional area of the streamlines. 
Additionally, the matrix has zero values in the main diagonal (zero-diagonal) which 
means that we did not consider self-connections.  
For the network validation we classified 12 control participants into 2 subgroups 
based on the age and gender and estimated the edge density. Controls1: 6 
participants, 3 females, age (mean ± standard deviation (SD)) 36.5±11.7 years and 
controls2: 6 participants, 3 females (mean ± SD) 34.7 ± 14.5 years. There were no 
significant differences in the age and gender between the two groups (p = 0.81). When 
edge density as a network metric was compared between the two groups we found no 
significant difference (p = 0.40) 
We also ranked brain regions based on the strength (KW) metric and defined as 
hubs the nodes that had high Kw (≥ mean + one SD) (Table 5.2). We identified the 
following hubs: the left and right precentral gyrus, left and right postcentral gyrus, left 
and right superior frontal gyrus, left and right middle frontal gyrus, and the subcortical 
brain structures, left and right thalamus proper and left and right putamen. These 
network hubs agree with previous work (Yeh et al., 2016) 
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Figure 5.9. Example of a brain graph and connectivity matrix 
On the left, the brain is modelled as a graph and on the right two-dimensional 
connectivity (adjacency) matrix is shown. In this zero-diagonal matrix, each row and 
column correspond to a different node (120 in total) and the element inside the matrix 
encodes information about the sum of the cross-sectional area of each streamline 
(Smith et al., 2015b). The matrix is organized in a way that the top left half quadrant 
corresponds to the left hemisphere and the bottom half right to the right hemisphere 
and they both contain intra-hemispheric connections.  
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Table 5.2. Structural network hubs 
Network hubs defined based on the nodal strength (Kw; ≥ mean + one standard 
deviation (SD)). The defined regions are in accordance with the hubs published in the 
literature (Yeh et al., 2016).  
  
BRAIN REGION KW (X105) 
RIGHT PRECENTRAL GYRUS 3.48 (0.22) 
LEFT PRECENTRAL GYRUS 3.62 (0.23) 
RIGHT SUPERIOR FRONTAL GYRUS 3.44 (0.18) 
LEFT SUPERIOR FRONTAL GYRUS 3.35 (0.17) 
RIGHT MIDDLE FRONTAL GYRUS 2.90 (0.19) 
LEFT MIDDLE FRONTAL GYRUS 3.07 (0.18) 
RIGHT THALAMUS  2.69 (0.16) 
LEFT THALAMUS  2.50 (0.15) 
RIGHT POSTCENTRAL GYRUS 2.26 (0.11) 
LEFT POSTCENTRAL GYRUS 2.31 (0.13) 
RIGHT SUPERIOR PARIETAL LOBULE 2.29 (0.09) 
LEFT SUPERIOR PARIETAL LOBULE 2.04 (0.11) 
RIGHT PUTAMEN 2.34 (0.12) 
LEFT PUTAMEN 2.20 (0.09) 
RIGHT PRECUNEUS 2.21 (0.10) 
LEFT PRECUNEUS 2.03 (0.10) 
RIGHT MIDDLE TEMPORAL GYRUS 2.06 (0.10) 
LEFT MIDDLE TEMPORAL GYRUS 1.89 (0.09) 
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5.4. Discussion  
Recent advancements in neuroimaging, especially in diffusion MRI, provide powerful 
tools for the analysis of the brain as a complex network. However, creating a 
connectome is challenging in the sense that it is a multistep process and each step is 
a potential source of variance that can seriously bias the analysis, and advanced 
methods should be used that address some of the tracking biases. Therefore, careful 
quality assessment of each step is essential to ensure that the derived network reflects 
the underlying anatomical characteristics. The main steps and the usage of the 
advanced methods were shown in the results section above. 
Beyond the quality assessment of the chosen algorithms, one must always 
consider the feasibility of connectome quantification. Weighting the connectomes with 
diffusion metrics such as FA or with number of streamlines suffers from intrinsic 
limitations as discussed in Jones et al. (2013) and in Sotiropoulos and Zalesky (2017). 
Therefore, several connectome studies represent the brain as a binary network 
meaning that existing connections irrespective of weight get the value “1” whereas no 
connections get the value “0”. To eliminate any spurious connections – usually 
represented with very low weight in the matrix – several arbitrary thresholding steps 
are performed. However, trace studies in macaques showed that the brain is a 
heterogeneous and complex network (Markov et al., 2011) and thus this binary 
formation fails to capture brain’s true complexity. Therefore, a weighted connectome 
could potentially be more relevant for connectivity analysis, if the reconstructed 
tractogram can reflect the underlying biological connectivity. In this study, the state-of-
art CSD approach (Tournier et al., 2004; Tournier et al., 2007), the ACT framework 
(Smith et al., 2012) and SIFT2 technique (Smith et al., 2015b) were employed: CSD 
models intra-voxel crossing fibres, ACT improves the connection accuracy by 
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providing anatomical priors and SIFT2 improves the streamline density under the 
assumption that the FOD amplitude corresponds to the underlying fibre density 
(Raffelt et al., 2012). Recently, it has been demonstrated that streamline density 
derived after the application of SIFT method correlates better with WM connection 
estimates as derived from post-mortem tissues (Smith et al., 2015a). Hence, we 
believe that the use of these advanced methods should render the reconstructed 
network more biologically plausible, since they capture the continuous biological fibre 
connection density. Therefore, any detected changes are most likely to be relevant to 
pathology.  
There is an additional point in favour of using of weighted connectivity matrix. 
The use of SIFT2 which reweights the streamlines so that false positives receive 
relatively weak weight (Smith et al., 2015b; Yeh et al., 2016). Hence keeping these 
low weights is unlikely to have a detrimental impact on the connectomic metrics and 
at the same time there is no need to arbitrarily threshold the matrix which might 
unfavourably alter the connectivity. 
The proposed method is highly reproducible. For example, we showed that the 
estimated edge density is highly stable across age and gender matched subjects. 
Moreover, the network hubs, brain areas with high strength, identified in this study are 
in accordance with the previously reported study (Yeh et al., 2016) despite the fact 
that the parcellation scheme used is different (https://surfer.nmr.mgh.harvard.edu vs 
http://cmictig.cs.ucl.ac.uk/niftyweb/program.php?p=GIF) i.e. FreeSurfer vs GIF. This 
suggests that the hubs are relatively stable features of the network. Ideally, the brain 
network reconstructions and lesion effects should be validated histologically but 
because of the absence of appropriate ground-truth biological information further 
validation of our network cannot be performed. 
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The limitations associated with mapping the human brain and as a result with 
network reconstruction have been discussed in chapter 4. In this chapter, we used 
the latest techniques developed that are shown to reduce some of the known biases 
during the reconstruction process. Here, we do not claim that our structural network is 
a true representation of the actual human brain. We argue though that application of 
these state-of-art techniques improves significantly the reconstructed network such 
that it reflects better the underlying biology. To our knowledge this tis the first time that 
these techniques have been used in MS. 
 
5.5. Conclusions 
In conclusion, structural brain network reconstruction is a multistep process and each 
step is a potential source of bias. Here, we used state-of-the-art techniques, we quality 
assessed the output of each processing step and we validated the generated 
connectome with previously reported ones. The use of techniques such as ACT and 
SIFT2 are able to address a range of tractogram biases resulting in the reconstruction 
of a biologically plausible network. This pipeline will be used in chapter 6 to investigate 
whether network metrics could explain disability in MS better than non-network 
metrics. 
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Chapter 6 
6. Structural network disruption markers explain disability 
above non-network metrics in multiple sclerosis 
Summary 
In this chapter, we evaluated whether brain network metrics can improve the prediction 
of clinical and cognitive dysfunction in multiple sclerosis beyond brain atrophy 
measures and white matter lesions. We applied the pipeline developed in chapter 5 
in 51 healthy controls and 122 MS patients consisting of 58 relapsing-remitting, 28 
primary progressive and 36 secondary progressive. Structural brain networks were 
reconstructed from diffusion-weighted magnetic resonance images. Standard metrics 
reflecting network density, efficiency and clustering coefficient were derived and 
compared between subjects’ groups. Stepwise linear regression analyses were used 
to investigate the contribution of network measures that explain clinical disability 
(Expanded Disability Status Scale) and information processing speed (Symbol Digit 
Modalities Test) compared with conventional imaging metrics alone and to determine 
the best statistical model that explains better Expanded Disability Status Scale and 
Symbol Digit Modalities Test. This chapter shows compared to controls, network 
efficiency and clustering coefficient were reduced in multiple sclerosis whilst these 
measures are also reduced in secondary progressive relative to relapsing-remitting 
patients. Structural network metrics increase the variance explained by the statistical 
models for clinical and information processing dysfunction. The best model for 
Expanded Disability Status Scale score showed that reduced network density and 
global efficiency and increased age were associated with increased clinical disability. 
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The best model for Symbol Digit Modalities Test score showed that lower deep grey 
matter volume, reduced global efficiency and male gender were associated with worse 
cognitive performance. This chapter concludes that network metrics were able to 
explain disability better than conventional imaging measures suggesting that network 
metrics can provide additional clinically relevant information about multiple sclerosis 
pathology. 
 
Scientific contribution 
The results presented in this chapter are currently under review (revised version) in 
Journal of Neurology, Neurosurgery and Psychiatry: “Structural network disruption 
markers explain disability in multiple sclerosis”.   
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6.1. Introduction 
As discussed in chapter 4, diffusion-derived networks in MS have shown reduced 
network efficiency correlating with physical disability (Shu et al., 2011) or cognitive 
performance (Llufriu et al., 2017). A very common cognitive domain affected is 
information processing speed and is assessed by Symbol Digit Modalities Test 
(SDMT) (Rocca et al., 2015). Neurologic impairment with particular emphasis on 
ambulation status is evaluated by another widely used measure, Expanded Disability 
Status Scale (EDSS) (Kurtzke, 1983). 
Whether network metrics improve the correlation with disability beyond routine 
imaging metrics is unknown. In addition, previous investigations included only RRMS 
or SPMS and did not examine all MS subtypes. In this study, using the pipeline that 
we developed in chapter 5, we aimed: 
1. to study the structural network differences between subjects’ groups in a cohort 
that includes the main MS subtypes (RRMS, PPMS, SPMS) 
2. to investigate whether network measures can explain disability over and above 
conventional imaging metrics  
3. to determine the best statistical model for predicting change in EDSS and 
SDMT.  
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6.2. Methods 
This section will summarise the pipeline that we introduced in chapter 5 
6.2.1. Participants  
We recruited 122 MS patients (58 RRMS, 28 PPMS and 36 SPMS) who had not 
experienced relapses within the preceding 4 weeks and classified as per Lublin and 
Reingold criteria (Lublin and Reingold, 1996). Fifty-one HC were also examined. 
Participants underwent MRI and neurological assessment using EDSS (Kurtzke, 
1983). A verbal SDMT test was performed in a subset of MS participants (n=60) 
(eTable 6.1 supplemental) to screen for information processing speed. Fatigue 
(visual analogue scale), depression and anxiety (Hospital Anxiety and Depression 
Scale [HADS]) were also assessed in some patients (eTable 6.2 supplemental). This 
work has been approved by the local institutional ethics committee and written consent 
was obtained from all the patients. 
6.2.2. MRI data acquisition  
MRI data acquisition parameters were introduced in section 5.2.2. Briefly, MRI data 
were acquired on a Philips Achieva 3T MR scanner (Philips Healthcare, Best, 
Netherlands) with a 32-channel head coil using: (1) 3D sagittal T1-weighted scans with 
a fast-field echo scan, (2) whole brain High Angular Resolution Diffusion Imaging 
(HARDI) scan with echo planar imaging consisted of a cardiac-gated spin-echo (SE) 
sequence and (3) dual-echo proton density/T2-weighted axial oblique-scans.  
6.2.3. Structural network reconstruction pipeline 
For network reconstruction, we used the optimised pipeline discussed in chapter 5 
and illustrated in Fig. 6.1. The main steps are summarised below:  
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Structural images processing  
Briefly, an affine transformation was performed to register the subject’s non-filled T1-
weighted bias-field corrected image to the corresponding DWI using BrainSuite v.15b 
(Bhushan et al., 2012). The target volume was the first b0 image after DWI pre-
processing, resulting in a structural image of resolution 2x2x2 mm3. T2-hyperintense 
lesions were affine transformed to DWI space and then filled the T1-weighted images 
using a modality-agnostic patch-based method (Prados et al., 2016b). The filled T1-
weighted images were then segmented into different tissue types and parcellated 
according to Desikan–Killiany–Tourville atlas protocol using GIF (Cardoso et al., 
2015). We then estimated the volumes of the various tissue types (NABV (normal 
appearing brain volume (BV)), GM, CGM, DGM and reduction of these volumes reflect 
atrophy measures. We also estimated LL (lesion load) as a measure of WM focal 
damage.  
Diffusion-weighted imaging processing and tractography 
The mean b0 image was rigid registered to the first b0 image. Then, the same rigid 
transformation was applied to the 61 DWI volumes. FSL v5.0.9 was used on the DWI 
data to correct for eddy current and head motion (Andersson and Sotiropoulos, 2016) 
and BrainSuite v.15b to correct for EPI distortions (Bhushan et al., 2012). For the 
whole brain probabilistic tractography, we used MRtrix3 v0.3.14 to generate 107 
streamlines implementing the ACT framework (Smith et al., 2012) followed by SIFT2 
algorithm (Smith et al., 2015b).  
Network reconstruction and metrics 
GM parcellations constituted the network nodes, 120 in total and each network edge 
was defined as the sum of weights of streamlines connecting a pair of nodes (Smith 
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et al., 2015b). We extracted a range of standard network measures using TractoR 
(Clayden et al., 2011). We focused on the following network topological measures: 
Edge density, also known as connectivity, is the ratio of the connections exist relative 
to the number of potential connections. Global efficiency is a network integration metric 
that describes the information flow over the entire network while local efficiency is 
considered a local homolog of global efficiency quantifying information transfer within 
local networks. Finally, clustering coefficient reflects the number of connections 
between neighbouring nodes and is related to network segregation (Rubinov and 
Sporns, 2010). We used the weighted forms of the graph-derived metrics, except edge 
density, which is derived from a binary network. 
6.2.4. Statistical analysis 
Statistical analysis was performed using R software (https://www.r-project.org/ v3.3.0). 
For all the models, we explored whether there was a violation of normality assumption 
of the residuals. Data are reported as mean ± standard deviation (SD), unless 
otherwise stated. P-values<0.05 were considered statistically significant. 
Preliminary analysis  
To assess network differences between subjects’ groups ANOVA analysis was used 
adjusting for age, gender, LL and total intracranial volume (TIV) to correct for head 
size. To explore possible associations of all the variables in MS patients, we used 
bivariate Pearson’s correlations. The variables include network metrics (edge density, 
global efficiency, mean local efficiency and mean clustering coefficient), atrophy 
measures (volumes of NABV, GM, CGM, DGM), WM damage metrics (LL), clinical 
scores (EDSS and SDMT) and patient age and gender (Fig. 6.2). In this study, atrophy 
measures and WM lesions are also referred to as MRI metrics. Volumetric differences 
  106 
between HC and MS patients were also assessed (eTable 6.3 supplemental 
results). 
Network measures and volumetric parameters in explaining EDSS and 
SDMT  
We performed stepwise linear regression analyses using each of the volume metrics 
(in turn) as independent variables and age, gender and LL as covariates to explain 
clinical scores (dependent variable). We also controlled for the presence of disease 
modifying treatments (DMTs). We selected the best model as assessed with the 
adjusted R2 and then added each network metric, in turn, as an independent variable. 
For SDMT, we performed a post-hoc analysis controlling for education level as a 
categorical and afterwards as continuous variable to investigate possible linear 
relationship between education level and SDMT. To assess whether the effect for each 
network metric in explaining disability is group-dependent, we stratified the MS 
population based on their clinical profile by creating an interaction term e.g. the product 
between the network metric and a categorical variable for MS subgroup (RRMS, 
PPMS, SPMS), ‘network metrics x MS subgroup’, that was then included in the model 
as an explanatory variable. For SDMT we explored possible associations between 
network metrics and MRI variables in HC. 
Final models to explain EDSS and SDMT  
To find the best model that explains disability, a stepwise forward selection linear 
regression strategy was employed. All variables of interest were sequentially added to 
the model and kept only if significant, culminating in two final models, one per each 
clinical score.  
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6.3. Results 
Demographic, clinical, MRI and network data from MS patients and HC are 
summarised in Table 6.1. 
Differences in network metrics in MS population and subtypes 
There was a significant decrease in global efficiency (regression coefficient (RC) = -
71.23, p = 0.016), mean local efficiency (RC = -72.53, p = 0.31) and mean clustering 
coefficient (RC = -14.84, p < 0.0001) in the whole MS group when compared with HC. 
For the subtypes, there was reduced global efficiency in PPMS (RC = -85.82, p = 
0.027) and in SPMS (RC = -145.34, p = 0.0002) relative to HC and also decrease in 
this metric in SPMS relative to RRMS (RC = -111.90, p = 0.0008). Mean local 
efficiency was reduced in SPMS compared to HC (RC = -158.42, p = 0.0002) and to 
RRMS (RC = -128.21, p = 0.0007). Relative to HC, mean clustering coefficient was 
reduced in RRMS (RC = -14.84, p < 0.0001), PPMS (RC = -13.42, p < 0.0001) and 
SPMS (RC = -20.30, p < 0.0001) while relative to RRMS it was reduced in SPMS (RC 
= -8.30, p = 0.0033). There was also a significant decrease in SPMS compared to 
PPMS (RC = -6.88, p = 0.037). All models were adjusted for age, gender, LL and TIV 
(Table 6.2; Fig. 6.2). 
Descriptive associations among study variables in patients 
Pairwise associations among clinical, volume and network metrics, LL and age study 
variables are shown in Fig. 6.3. Higher LL was associated with lower connectivity (r = 
-0.3), lower values of global (r = -0.3) or local (r = -0.2) efficiency and reduced 
clustering (r = -0.6). Also, lower connectivity and lower clustering coefficient were 
associated with reduced volumes of NABV, GM, CGM, DGM and NAWM (r = between 
0.2 and 0.5). Moreover, we found associations between clinical scores and network 
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measures, e.g. higher EDSS and lower SDMT scores were associated with lower 
connectivity values, global and local efficiency and clustering coefficient (r = between 
0.2 and 0.5). Additionally, correlation analyses between clinical scores and volume 
metrics demonstrated that higher EDSS scores and lower SDMT were associated with 
reduced volumes of NABV, GM, CGM, DGM and NAWM (r = between 0.2 and 0.5). 
Higher LL was also associated with decreased SDMT (r = -0.5) but showed very little 
correlation with EDSS score (r = -0.1). We also found that higher EDSS score is 
associated with lower SDMT score (r = 0.5). Gender showed weak associations with 
network metrics (r= between -0.1 and 0.2). For age, we found that older participants 
show lower values of network metrics (r = between -01 and 0.2) except edge density 
that shows weak linear relationship (r < 0.05).  
Statistical modelling of EDSS score 
We found that NABV was the only significant predictor of EDSS after adjusting for age, 
gender and LL. For each mL decrease in NABV there was an increase in the EDSS 
score of 4.06x10-3 (95% confidence interval (95%CI): -7.68x10-3 to -4.3x10-3) p = 
0.029, adjusted R2 = 0.185; Table 6.3). We did not find any significant adjusted 
associations between the other volume metrics and EDSS.  
When network metrics were added to the model reported above as predictors, in 
turn, we found that they were each associated with EDSS independently of NABV. 
Specifically, we found that for each percentage point decrease in edge density there 
was an increase in the EDSS score of 0.13 (95% CI: -0.27 to -1.49x10-3, p = 0.047, 
adjusted R2 = 0.205) and for each unit decease in global efficiency there was an 
increase in the EDSS score of 2.67x10-3 (95% CI: -4.75x10-3 to -5.81x10-4, p = 0.013, 
adjusted R2 = 0.221). In addition, we found that for each unit decease in mean local 
efficiency there was an increase in the EDSS score of 1.90x10-3 (95% CI: -3.76x10-3 
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to -4.40x10-5, p = 0.045, adjusted R2 = 0.206) and finally for each unit decease in mean 
clustering coefficient there was an increase in the EDSS score of 3.98x10-2 (95% CI: 
-6.34x10-2 to -1.61x10-2, p = 0.011, adjusted R2=0.235) (Table 6.3). We did not find 
any significant difference in the effect of any of the network measures in any of the MS 
subgroups examined. All the above models were adjusted for age, gender, LL and 
DMTs. 
The best model to explain EDSS using the stepwise forward selection linear 
regression analysis showed that lower edge density, lower global efficiency and 
increased age of the participants were significantly associated with EDSS (Table 6.3). 
This model explained 26% of the variance in EDSS compared with 18.5% for the 
NABV alone or with 20% for global efficiency (-0.02, 95% CI: -0.0049 to -0.00063, p = 
0.012) or with 20% for edge density (-0.16, 95% CI: -0.28 to -0.035, p = 0.012), after 
adjusting for age, gender and LL. 
Statistical modelling of SDMT score 
We repeated the multiple linear regression analyses to predict SDMT score. When 
only volume metrics were included, the best model fit was achieved by DGM as 
predictor, showing that for each 1 cm3 decrease in the volume of DGM there was a 
decrease in the SDMT score of 1.61 (95% CI: 0.79 to 2.43, p < 0.001, adjusted R2 = 
0.361; Table 6.4), i.e. smaller DGM volumes were associated with worse information 
processing speed in the whole MS group. 
When we added network metrics, in turn, in our multiple regression analysis that 
included DGM as one of the predictors, we found that global efficiency, mean local 
efficiency and mean clustering coefficient were able to significantly explain additional 
variance in SDMT. For each unit increase in global efficiency there was an increase 
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in the SDMT score of 0.02 (95% CI: 0.01 to 0.04, p = 0.008, adjusted R2=0.396). For 
each unit increase in mean local efficiency there was an increase in the SDMT score 
of 0.02 (95% CI: 0.002 to 0.03, p = 0.018, adjusted R2 = 0.380) and finally for each 
unit increase in mean clustering coefficient there was an increase in the SDMT score 
of 0.21 (95% CI: 0.05 to 0.38, p = 0.013, adjusted R2 = 0.387). There was no evidence 
of change of SDMT score per percentage increase in edge density (0.44, 95% CI: -
0.56 to 1.44, p = 0.38, adjusted R2 = 0.374; Table 6.4). Additionally, there was no 
significant difference in the effect of any of the network metrics in any of the subgroups 
examined. 
The best model to explain SDMT using the stepwise forward selection linear 
regression analysis showed that greater DGM volume, greater global efficiency and 
female gender were all associated with better information processing speed (Table 
6.4). This model explained 39.6% of the variance in SDMT scores compared with 36% 
for the DGM alone (1.61, 95 % CI: 0.79 to 2.43, p < 0.001). 
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6.5. Discussion  
This study detected differential topological organisation of WM networks in MS 
patients and subtypes. We also demonstrated that markers of network disruption 
explain EDSS and SDMT performance over and above metrics of tissue atrophy and 
WM lesions.  
Structural network differences between subjects’ groups 
We detected network topological changes in MS. Relative to HC, SPMS had reduced 
global and local efficiency, PPMS reduced global efficiency while there was no 
efficiency change in RRMS. These changes reflect network alterations due to diffuse 
WM pathology including impaired long and short distance connections characteristics 
that are more prominent in the progressive types. Previous studies focused mainly on 
RRMS reporting decreases in this metric in structural (Kocevar et al., 2016; Shu et al., 
2016; Shu et al., 2011) and functional (Rocca et al., 2016; Shu et al., 2016; Liu et al., 
2017) networks whilst others, in accordance with this work, found no differences 
(Llufriu et al., 2017). Intriguingly, increased efficiency in RRMS in the first year from 
onset in the absence of clinical impairment is suggestive of structural adaptations to 
maintain normal function (Fleischer et al., 2017). Our RRMS cohort has a relatively 
long disease duration with high EDSS with accrual of baseline disability as a result of 
incomplete recovery from relapses explaining partly the absence of this effect. To date, 
only one study considered SPMS and PPMS groups reporting reduced global 
efficiency, in accordance with our findings (Kocevar et al., 2016). Moreover, we 
demonstrate reduced global and local efficiency in SPMS relative to RRMS, a result 
likely to reflect the neurodegenerative component in this progressive subtype. 
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Clustering coefficient is a “small-world” metric and reduction suggests a more 
random architecture (Bullmore and Sporns, 2012) related to increased disability as 
shown in our study and elsewhere (Douw et al., 2011). Previous structural studies 
reported increased clustering coefficient in RRMS compared to HC (Muthuraman et 
al., 2016; Fleischer et al., 2017; Tewarie et al., 2014) and is thought to reflect transient 
compensatory changes. No change was reported in functional networks (Rocca et al., 
2016; Schoonheim et al., 2012). Here, we report a decrease in clustering coefficient 
in RRMS compared to HC, in agreement with a study that investigated both structural 
and functional networks (Shu et al., 2016). We also extend these findings, 
demonstrating reduction of this metric in the progressive phases. Clustering coefficient 
was further reduced in SPMS relative to RRMS and PPMS indicating that impaired 
local information flow is linked to the disease severity. Nonetheless, further 
investigations with bigger sample sizes and longitudinal study design should confirm 
the study findings.  
Network measures explain additional variance of disability 
Whole brain atrophy is a relatively strong predictor of EDSS. Our study shows that the 
addition of network metrics into the model, singly and together, explains more EDSS 
variance, leading to our final model (Table 6.3), according to which edge density and 
global efficiency explain 26% of the variance, that is 7% more compared to NABV 
alone (18.5%). Loss of connectivity could reflect neurodegeneration due to continuous 
inflammation (Friese et al., 2014) while reduced global efficiency could indicate 
impaired structural long-range connections probably due to inflammatory activity and 
neuroaxonal loss (Mangeat et al., 2018). The fact that these measures integrate 
information beyond local tissue damage atrophy measures may account for the 
increased explained variance. 
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 SDMT was most strongly associated with DGM atrophy and WM damage 
(Tewarie et al., 2015). Previous structural and functional studies demonstrated the 
relationship between network disruption and cognitive impairment (Tewarie et al., 
2015; Schoonheim et al., 2015; Dineen et al., 2009). Our study findings showed that 
global efficiency is not only associated with SDMT as previously shown but it also 
explained additional variance (Table 6.4) highlighting that intact network integration is 
important for efficient information processing beyond participant’s education level and 
treatment. These findings are also consistent across WM diseases (Tuladhar et al., 
2016) signifying the relevance of network efficiency as potential marker of cognitive 
disability. 
MS is a heterogeneous disease. This study included MS patients with the main 
disease phenotypes in order to provide a representative snapshot of structural 
networks throughout the entire disease course. Our regression analyses show that the 
behaviour of the network metrics was similar in all MS subtypes suggesting that these 
measures could be useful across the whole MS disease spectrum. The same 
statistical models did not explain SDMT in HC. This negative result is not surprising 
given the narrow distribution of the SDMT variable in HC compared to patients (see 
Table 6.1 for mean and SD). Furthermore, due the small number of HC for which we 
have SDMT (n=12) these results should be interpreted with caution. Future studies 
could assess whether the findings presented here are replicated in other cohorts. 
Descriptive associations among study variables in patients 
Our univariate associations in patients revealed some interesting patterns. Low values 
of network metrics were associated with clinical impairment and worse information 
processing speed in accordance with previous studies (Shu et al., 2011; Llufriu et al., 
2017; Shu et al., 2016). Interestingly, reduced clustering showed the strongest 
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association out of network metrics with worse SDMT indicating that network 
randomization impairs information processing speed as shown previously (Douw et 
al., 2011). Our multivariate analysis though, demonstrated that reduced network 
integration and tissue atrophy can more strongly affect SDMT performance. In line 
with previous work (Shu et al., 2011), WM lesions impair the communication between 
brain regions at the global and local level as demonstrated by the reduced network 
efficiencies. As shown in the exact same cohort, we did not find any association 
between WM lesions and EDSS (Pardini et al., 2015) and only weak association 
between WM lesions and SDMT and this highlights the need to explore non-
conventional MRI metrics to explain disability. Also, there was no association between 
edge density and any of the network efficiencies. Although this could be the result of 
wiring cost and efficiency (Bullmore and Sporns, 2012), we argue that direct 
comparison between binary and weighted network is not valid. 
In our approach we used CSD to model intra-voxel crossing fibres (Tournier et 
al., 2007), ACT and SIFT2 to improve connection accuracy and streamline density 
(Smith et al., 2015b; Smith et al., 2012) respectively with the assumption that the FOD 
amplitude corresponds to the underlying fibre density (Raffelt et al., 2012). These 
advanced methods improve tractogram reconstruction without the need of various 
scaling techniques (Yeh et al., 2016). We also provided anatomical prior of the WM 
ensuring that no streamlines are incorrectly terminated in the WM due to lesions as 
showed in chapter 5 (Fig. 5.8). In fact, we identified an association between LL and 
connectivity, but this is a moderate correlation (r = -0.3) highlighting that our current 
approach is not overly influenced by lesions. 
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Limitations and future directions  
This study has several limitations. In our approach, we applied techniques to address 
some of the reconstruction biases and to ensure that no streamlines were abnormally 
terminated in WM (Smith et al., 2012; Smith et al., 2015b; Yeh et al., 2016). However, 
histological validation studies are required to make direct links between imaging 
measures and underlying pathology. Additionally, the cross-sectional design of the 
study does not allow to determine the clinical relevance of network measures over 
time. Moreover, we used SDMT scores for approximately half of MS cohort (n=60 vs 
n=122) but this subcohort had similar proportions of MS subgroups to the whole cohort 
(eTable 6.1 supplemental). Also, the effects of fatigue, depression and anxiety can 
be investigated in future studies with larger cohorts. A post-hoc analysis revealed 
depression and anxiety scores showed mild correlations with SDMT whereas fatigue 
did not. It is difficult to investigate their influences in our cohort as the HADS and 
fatigue scores were not collected in all subjects with SDMT. Additionally, medication 
that are commonly used in MS including antidepressants, benzodiazepines and 
antimuscarinics for bladder dysfunction (Panicker et al., 2015) can all affect cognitive 
functions and processing speed influencing thus the study findings. Due to the 
retrospective nature of the study, medication use could not be quantified here but this 
should be tested in future studies. Finally, although the effect of cortical lesions in 
clinical scores is limited (van de Pavert et al., 2016), it is possible that they may 
influence our study outcomes.  
The study findings could provide the basis for future work. There are different 
scales that we could study MS from, including micro, meso and macro scales 
(Cercignani and Gandini Wheeler-Kingshott, 2018). Network analysis offers a 
framework at the macroscale to study whole brain connectivity patterns beyond focal 
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pathology while TBSS, for example, is currently considered a leading technique for 
the voxel-wise DTI analysis (Dineen et al., 2009). Future investigations could focus in 
the comparison between scales and their link with clinical outcome. Additionally, 
further studies could follow a subnetwork or nodal rather than global network analysis 
and perhaps derive integrative measures of structural and functional networks and 
investigate if these parameters explain additional variance 
6.6. Conclusion   
In conclusion, we found distinct structural network organisation in the various groups. 
In addition, network metrics and in particular global efficiency explains disability over 
and above non-network metrics supporting the relevance of intact long-distance 
connections mainly, to maintain normal function. These results highlight the fact that 
network metrics can provide additional clinical information regarding MS pathology. 
To gain further insights into network dynamics, longitudinal studies are required 
which can elucidate how network changes over time. Longitudinal structural network 
studies have not yet performed in MS, while from an image analysis perspective they 
require specific processing techniques which will be discussed in chapter 7. 
  
  117 
 
 
 
Figure 6.1. Flowchart of structural brain network reconstruction 
For each subject, (A) T1-weighted image is segmented into grey matter (B) and white 
matter (C). The grey matter segmentation is parcellated into cortical and deep grey 
matter regions (B) which serve as network nodes (D) in the subsequent network-based 
analysis. From a diffusion-weighted image (DWI) (E), voxel-wise fibre orientation 
distribution (FOD) (F) is estimated and whole brain tractography undertaken (G), with 
the white matter segmentation (C) used to prevent this from spilling into grey matter 
(see main text for details). Finally, nodes and tractogram are modelled into a network 
(H). Connections are weighted by the sum of the pairwise streamline weights. 
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Table 6.1. Demographics, clinical, MRI and network metrics  
  HC  
(n = 51) 
MS patients  
(n = 122) 
RRMS  
(n = 58) 
PPMS  
(n = 28) 
SPMS  
(n = 36) 
  Demographics 
Age, years 41 ± 13 48 ± 11 42 ± 10 52 ± 9 53 ± 7 
Gender (M/F) 25/26 36/86 18/40 10/18 8/28 
Disease duration, years - 15 ± 10 11 ± 8 14 ± 7 22 ± 10 
% (no) patients of DMTs - 58 (67) 84 (48) 13 (3) 47 (16) 
% (no) patients who 
relapsed in the previous 
two years  
- 51 (38) 68 (32) 0 (0) 24 (6) 
 Clinical scores 
EDSS, median - 5.5 (0-8.5) 2 (0-7) 6 (3-8) 6.5 (4-8.5) 
SDMT 65.08 ± 8.31 45.50 ± 13.27 51.04 ± 14.28 42.86 ± 9.46 39.00 ± 10.88 
  MRI metrics 
NABV (cm3) 1158 ± 102 1042 ± 120 1070 ± 123 1060 ± 122 984 ± 93 
GM (cm3) 679 ± 57 625 ± 65 641 ± 64 632 ± 67 593 ± 52 
CGM (cm3) 640 ± 54 591 ± 61 606 ± 61 597 ± 65 561 ± 50 
DGM (cm3) 39.00 ± 3.39 34.18 ± 4.02 34.86 ± 4.09 35.41 ± 3.50 32.12 ± 3.54 
NAWM (cm3) 480 ± 49 418 ± 59 429 ± 62 429 ± 60 391 ± 45 
LL (mL) - 14.37 ± 15.92 12.78 ± 15.72 16.56 ± 19.83 15.23 ± 12.73 
  Network metrics 
Edge Density (%) 92.6 ± 2.7 90.6 ± 3.2 90.8 ± 3.3 90.5 ± 3.0 90.3 ± 3.0 
Global efficiency 3881 ± 121 3783 ± 175 3827 ± 137 3763 ± 196 3729 ± 199 
Mean local efficiency 3975 ± 139 3889 ± 200 3934 ± 160 3868 ± 220 3831 ± 229 
Mean clustering coefficient  247 ± 9.2 223 ± 18.3 227 ± 17.2 224 ± 20.5 217 ± 16.8 
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Values listed are mean ± standard deviation (SD) 
Abbreviations: HC = healthy controls; MS = multiple sclerosis; RRMS = relapsing-
remitting MS; PPMS = primary progressive MS; SPMS = secondary progressive MS; 
EDSS = Expanded Disability Status Scale; SDMT = Symbol Digit Modalities Test; 
NABV = normal appearing brain volume; GM = grey matter; CGM = cortical grey 
matter; DGM = deep grey matter; NAWM = normal appearing white matter; LL = 
Lesion load 
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Table 6.2. Network differences between different groups 
EDGE DENSITY 
 HC RRMS PPMS 
 RC 95% CI p-value RC 95% CI p-value RC 95% CI p-value 
MS -0.65 -1.69 0.38 0.210       
RRMS -0.71 -1.84 0.42 0.219       
PPMS -0.72 -2.11 0.67 0.310 -0.011 -1.27 1.25 0.987    
SPMS -0.45 -1.78 0.88 0.507 0.258 -0.93 1.43 0.670 0.27 -1.12 1.66 0.707 
GLOBAL EFFICIENCY 
MS -71.23 -129.47 -13.00 0.016       
RRMS -33.44 -95.11 28.25 0.287       
PPMS -85.82 -161.65 -9.96 0.027 -52.38 -121.08 16.34 0.135    
SPMS -145.34 -218.38 -72.28 0.0001 -111.90 -176.47 -47.31 0.0008 -59.52 -135.72 16.67 0.126 
MEAN LOCAL EFFICIENCY 
MS -72.53 -138.60 -6.46 0.031       
RRMS -30.21 -100.16 39.74 0.396       
PPMS -85.68 -171.68 0.34 0.051 -55.46 -133.39 22.47 0.162    
SPMS -158.42 - 241.26 -75.58 0.0002 -128.21 -201.44 -54.96 0.0007 -72.74 -159.16 13.68 0.099 
MEAN CLUSTERING COEFFICIENT 
MS -14.84 -19.89 -9.79 <0.0001       
RRMS -12.00 -17.51 -6.48 <0.0001       
PPMS -13.42 -20.19 -6.64 0.0001 -1.42 -7.55 4.73 0.650    
SPMS -20.30 -26.84 -13.76 <0.0001 -8.30 -14.07 -2.52 0.0033 -6.88 -13.69 -0.06 0.037 
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Abbreviations: HC = healthy controls; MS = multiple sclerosis; RRMS = relapsing-
remitting MS; PPMS = primary progressive MS; SPMS = secondary progressive MS; 
RC = regression coefficient; CI = confidence intervals 
P-values in bold denote statistical significance at P < 0.05 when the groups on the 
left were compared to the groups on the top row and adjusted for age, gender, lesion 
load and total intracranial volume.  
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Figure 6.2. Boxplots of network metrics between the various groups 
Boxplots show the unadjusted results. The bottom and the top of each box is the first 
and the third quantile, and the band inside is the median. The ends of the whiskers 
represent the lowest and the highest datum within 1.5 interquartile range. The 
statistical significance is denoted as * and this is after adjusting for age, gender, lesion 
load and total intracranial volume. 
*p<0.05, **p<0.01, ***p<0.001  
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Figure 6.3. Descriptive pairwise univariable associations in patients 
The reported value in each entry of the matrix corresponds to the pairwise Pearson 
correlation coefficient (r). 
Abbreviations:  
ED = Edge density; GE = global efficiency; mLE = mean local efficiency; mCC = mean 
clustering coefficient; NABV = normal appearing brain volume; GM = grey matter; 
CGM = cortical grey matter; DGM = deep grey matter; NAWM = normal appearing 
white matter; LL = lesion load; EDSS = Expanded Disability Status Scale; SDMT = 
Symbol Digit Modalities Test
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Table 6.3. Stepwise linear regression for prediction of EDSS in multiple 
sclerosis 
 
Abbreviations: EDSS = Expanded Disability Status Scale; NABV = normal 
appearing brain volume; mLE = mean local efficiency; mCC = mean clustering 
coefficient; CI = confidence intervals 
p – values in bold denote statistical significance at p < 0.05
 
Model summary +  
predictors 
Regression  
Coefficient 95% CI p-value 
 MRI metrics 
EDSS score Adj. R2 = 0.185       
 NABV, cm3 -0.0041 (-0.0077 to -0.00043) 0.029 
 Age, years 0.081 (0.044 to 0.12) <0.001 
 Female -0.73 (-1.66 to 0.20) 0.125 
     
 MRI metrics + network measures 
EDSS score Adj. R2 = 0.205     
 NABV, cm3 -0.0021 (-0.0061 to 0.0019) 0.297 
 Edge density, % -0.13 (-0.26 to -0.0014) 0.047 
 Age, years 0.087 (0.051 to 0.12) <0.001 
 Female -0.60 (-1.53 to 0.33) 0.202 
     
 Adj. R2 = 0.221     
 NABV, cm3 -0.0037 (-0.0073 to -0.00016) 0.041 
 Global efficiency -0.0026 (-0.0048 to -0.00058) 0.013 
 Age, years 0.072 (0.036 to 0.11) <0.001 
 Female -0.52 (-1.44 to 0.40) 0.266 
     
 Adj. R2 = 0.206     
 NABV, cm3 -0.0041 (-0.076 to -0.00049) 0.026 
 mLE -0.0019 (-0.0038 to -0.000044) 0.045 
 Age, years 0.073 (0.036 to 0.11) <0.001 
 Female -0.57 (-1.50 to 0.37) 0.231 
     
 Adj. R2 = 0.229     
 NABV, cm3 -0.0016 (-0.005 to 0.007) 0.551 
 mCC -0.029 (-0.051 to -0.0075) 0.008 
 Age, years 0.078 (-0.0042 to 0.0022) <0.001 
 Female -0.30 (-1.26 to 0.66) 0.534 
     
 Final model 
EDSS score Adj. R2 = 0.259    
 Edge density, % -0.17 (-0.28 to -0.060) 0.003 
 Global efficiency -0.0031 (-0.0051 to -0.0011) 0.003 
 Age, years 0.081 (0.047 to 0.12) <0.001 
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Table 6.4. Stepwise linear regression for prediction of SDMT in multiple 
sclerosis 
 
Abbreviations: SDMT = Symbol Digit Modalities Test; DGM = deep grey matter; 
mLE = mean local efficiency; mCC = mean clustering coefficient; CI = confidence 
intervals 
p – values in bold denote statistical significance at p < 0.05
 
Model summary +  
predictors 
Regression  
Coefficient 95% CI p-value  
MRI metrics 
SDMT score Adj. R2 = 0.361 
   
 
DGM, cm3 1.61 (0.79 to 2.43) <0.001  
Lesion load, mL -0.17 (-0.34 to -0.0014) 0.048  
Female 12.16 (5.51 to 18.82) <0.001      
 
MRI metrics + network measures 
SDMT score Adj. R2 = 0.352 
   
 
DGM, cm3 1.52 (0.61 to 2.43) 0.001  
Lesion load, mL -0.17 (-0.34 to 0.0069) 0.059  
Edge density, (%) 0.24 (-0.75 to 1.23) 0.624  
Female 11.94 (5.18 to 18.70) <0.001      
 
Adj. R2 = 0.396 
   
 
DGM, cm3 1.93 (1.21 to 2.65) <0.001  
Global efficiency 0.021 (0.0055 to 0.035) 0.008  
Female 10.97 (4.37 to 17.56) 0.002      
 
Adj. R2 = 0.380 
   
 
DGM, cm3 2.01 (1.28 to 2.75) <0.001  
mLE 0.015 (0.0028 to 0.028) 0.018  
Female 11.43 (4.79 to 18.06) 0.001      
 
Adj. R2 = 0.387 
   
 
DGM, cm3 1.45 (0.63 to 2.28) <0.001  
mCC 0.21 (0.047 to 0.38) 0.013  
Female 9.92 (2.98 to 16.85) 0.006 
     
 Final model 
SDMT score Adj. R2 = 0.396    
 DGM, cm3 1.93 (1.21 to 2.65) <0.001 
 Global efficiency 0.021 (0.0055 to 0.035) 0.008 
 Female 10.97 (4.36 to 17.56) 0.002 
  126 
Appendix A Supplemental results 
eTable 6.1: Characteristics of the participants with and without SDMT score 
  Whole MS 
population 
 (n = 122) 
MS 
Population  
with SDMT 
(n = 60) 
MS 
Population  
without SDMT 
(n = 62) 
p-
value 
Subtypes 
RRMS = 58 
PPMS = 28 
SPMS = 36 
RRMS = 28 
PPMS = 14 
SPMS = 18 
RRMS = 29 
PPMS = 15 
SPMS = 18 
0.98a 
Age, years 48 ± 11 47 ± 11 49 ± 10 0.48b 
Gender (M/F) 36/86 18/42 18/44 0.99a 
Disease 
duration, years 15 ± 10 16 ± 11 14 ± 8 0.29
b 
EDSS, median 5.5 (0-8.5) 4.5 (1.0-8.5) 6 (0 - 8.5) 0.07b 
 
 
Values listed are mean ± standard deviation (SD) 
Comparison was performed between the MS population with and without SDMT 
a chi Square test 
b Student t-test for independent samples 
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive MS; SPMS = secondary progressive MS; EDSS = Expanded 
Disability Scale Status; SDMT = Symbol Digit Modality Test;  
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eTable 6.2: Depression and fatigue levels of the participants with SDMT 
scores 
 
Values listed are mean ± standard deviation (SD).  
Fatigue was measured using a 10cm Visual Analogue Scale. Depression and 
Anxiety scores were recorded using the Hospital Anxiety and Depression Scale. 
Abbreviations: HC = healthy controls; MS = multiple sclerosis; RRMS = 
relapsing-remitting MS; PPMS = primary progressive MS; SPMS = secondary 
progressive MS;  
 
  
 
HC MS patients RRMS PPMS SPMS 
Anxiety       
    Mean ± SD 4.72 ± 3.90 6.31 ± 3.68 6.28 ± 3.72 5.54 ± 4.03 7.08 ± 3.42 
    % (no) 
subjects 92 (11) 78 (47) 93 (26) 73 (11) 67 (12) 
Depression       
    Mean ± SD 2.74 ± 2.46 5.92 ± 3.46 5.43 ± 3.56 6.25 ± 3.88 6.83 ± 2.79 
    % (no) 
subjects 92 (11) 78 (47) 93 (26) 73 (11) 67 (12) 
Fatigue       
    Mean ± SD 3.05 ± 2.75 4.36 ± 2.51 4.03 ± 2.18 4.40 ± 2.67 4.97 ± 3.06 
    % (no) 
subjects 92 (11) 78 (47) 93 (26) 73 (11) 67 (12) 
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A. Volumetric differences between HC and MS patients and subtypes  
There was a significant decrease in the volumes of BV, GM, CGM, DGM and WM (all 
p < 0.05) in patients compared with HC after adjusting age, gender and LL. Examining 
the MS subtypes, RRMS and SPMS had lower volumes (BV, GM, WM, CGM, DGM) 
adjusted for age, gender and LL (all p < 0.05) when compared with HCs. PPMS group 
also had lower BV, DGM and WM (all p < 0.05) whereas the decrease in CGM volume 
vs HCs showed borderline significance (p = 0.063 adjusted for age, gender and LL). 
See eTable 6.3 (supplemental). 
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eTable 6.3: Between group differences in MRI metrics 
 
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = primary progressive MS; SPMS = secondary 
progressive MS; LL = Lesion load; BV = brain volume; GM = grey matter; CGM = cortical grey matter; DGM = deep grey matter; 
WM = white matter; RC = regression coefficient; CI = confidence intervals  
p -values in bold denote statistical significance at p < 0.05 when compared to controls and adjusted for age, gender and lesion load  
a Lesion load was compared against relapsing-remitting group 
Volume metrics 
 
MS patients (n = 122) RRMS (n = 58) PPMS (n = 28)  SPMS (n = 36) 
 
RC 95% CI p-value RC 95% CI p-value RC 95% CI p-value RC 95% CI p-value 
BV (cm3) -79.51 (-112.40 to -46.62) <0.001 -64.86 (-100.57 to -29.15) <0.001 -69.33 (-115.35 to 23.31) 0.034 -126.86 (-170.95 to 82.77) <0.001 
GM (cm3) -30.67 (-47.68 to -13.65) <0.001 -24.80 (-43.40 to -6.19) 0.0093 -24.21 (-48.19 to -0.23) 0.048 -51.77 (-74.74 to -28.80) <0.001 
CGM (cm3) -26.97 (-43.08 to 10.85) 0.0012 -21.36 (-39.01 to 3.72) 0.018 -21.59 (-44.32 to 1.15) 0.063 -46.42 (-68.20 to -24.64) <0.001 
DGM (cm3) -3.70 (-4.84 to -2.55) <0.001 -3.43 (-4.67 to 2.20 <0.001 -2.62 (-4.21 to -1.03) 0.0014 -5.35 (-6.87 to -3.83) <0.001 
WM (cm3) -26.97 (-43.08 to -10.85) 0.0012 -27.26 (-43.72 to -10.81) 0.0013 -28.60 (-49.80 to -7.39) 0.0085 -59.88 (-80.20 to -39.56) <0.001 
LLa (mL)  -   -  3.78 (-3.50 to 11.06) 0.306 2.46 (-4.26 to 9.17) 0.470 
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Chapter 7 
7. Longitudinal analysis framework for structural brain 
networks with application to multiple sclerosis 
Summary 
In this chapter, we considered the problem of reconstructing brain networks, where 
diffusion-weighted and T1-weighted magnetic resonance images have been acquired 
at multiple time-points for the same subject. We introduced a method for registering 
diffusion-weighted and structural scans in a subject-specific half-way space and we 
demonstrated that half-way space-derived network metrics are strongly correlated with 
native space-derived network metrics. We also reported sufficient agreement between 
the two techniques in a cohort comprising of 12 healthy controls and 12 multiple 
sclerosis patients. The results remained unaffected when the analyses were evaluated 
in controls and patients separately. The findings of this chapter might be of particular 
interest in longitudinal structural network studies assessing network changes over time 
in normal and disease conditions.  
 
Scientific contribution 
The results presented in this chapter have been published in peer-review book chapter 
as: Longitudinal analysis framework of DWI data for reconstructing structural 
brain networks with application to multiple sclerosis. Computational Diffusion 
MRI. 
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7.1. Introduction  
As discussed in previous sections diffusion MRI allows the non-invasive investigation 
of tissue microstructure and it is an increasingly popular technique for reconstructing 
structural brain networks. Network-based analyses have provided valuable insights 
into the mechanisms underlying brain function and how pathology may affect them. 
However, to date this has been limited to cross-sectional (single time-point) analyses. 
Longitudinal studies have the potential to provide valuable insights into the dynamics 
of network function, their decline and collapse due to pathology, and would establish 
whether or not network-based outcome measures are sufficiently sensitive to change 
to be viable measures of treatment efficacy.  
From an imaging analysis perspective, specialised techniques are required in 
order to take advantage of the longitudinal study designs without introducing any 
potential biases. For instance, a possible bias could arise by not treating all time-points 
the same way i.e. when follow-up images are resampled (the process of 
transforming/rotating a sampled image from one coordinate system to another) to the 
baseline scans. This can cause a noticeable reduction in image quality (smoothing) in 
the follow-up scan leaving the baseline scan intact which means that longitudinal 
changes would be overestimated (Reuter and Fischl, 2011). To avoid this, structural 
scans from all available time-points have been proposed to be transformed into an 
unbiased within-subject template ensuring equal treatment of all images (hereinafter 
referred to as half-way space) (Reuter et al., 2012). Recently, the half-way space 
approach has been extended to longitudinal diffusion-weighted data and it was 
combined with tensor-based registration to achieve images alignment within and 
across subjects (Keihaninejad et al., 2013). Moreover, the application of the 
longitudinal tractography framework improved the reliability and sensitivity of the 
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reconstructed tractogram when compared to data reconstructed at each time point 
independently (Yendiki et al., 2016). Collectively, these studies provide evidence that 
the use of half-way template may be an effective approach in assessing structural or 
diffusion metrics’ changes due to disease progression.  
To date, there are limited number of diffusion-derived networks (Tuladhar et al., 
2016; Nir et al., 2015) with more than one time-point and none of these studies used 
a longitudinal framework in their analyses. Considering the given advantages of the 
longitudinal approach (half-way registration) in imaging processing, it is likely that such 
an approach could be used when assessing network analysis over time. However, the 
effects of such registration on networks has not been examined yet. This is particularly 
important as resampling of diffusion-weighted scans requires both registration of the 
spatial information and the correct reorientation of the corresponding diffusion-
weighting gradient directions, a step that could be a potential source of bias. With 
these in mind, we aimed to: 
1. to propose a longitudinal network pipeline combining the best practices for 
unbiased processing of structural data with diffusion data 
2. to demonstrate that tractogram reconstruction in half-way space is feasible  
3. to evaluate the effects of the pipeline on the network metrics by comparing 
them against the network metrics derived from native space.  
4. to stress test our method testing whether these effects were different 
between HC and MS patients.   
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7.2. Methods 
7.2.1. Participants  
Twelve HC (6 males; mean age 36 ± 13 years) and 61 MS (21 males; mean age 47 ± 
11 years), were scanned at two time-points, approximately two years apart (1.84 ± 
0.55 years). For this study, we selected, MS patients who were ranked above the 20th 
centile for whole brain LL (n=12). This is because we wanted to investigate whether 
the degree of the visible inflammation will affect differently our network metrics when 
compared with the control group. This work has been approved by the local 
institutional ethics committee and written consent was obtained from all the patients. 
7.2.2. MRI data acquisition  
This is the same as in previous experimental chapters. Briefly, MRI data were acquired 
on a Philips Achieva 3T MR scanner (Philips Healthcare, Best, Netherlands) with a 
32-channel head coil using: (1) 3D sagittal T1-weighted scans with a fast-field echo 
scan, (2) whole brain HARDI scan with EPI consisted of a cardiac-gated SE sequence 
and (3) dual-echo proton density/T2-weighted axial oblique-scans.  
7.2.3. Overview of the longitudinal pipeline  
Structural images pre-processing  
As discussed in previous chapters, affine transformation was performed to register the 
subject’s non-filled T1-weighted bias-field corrected image to the corresponding DWI 
using BrainSuite v.15b (Bhushan et al., 2012) of the appropriate time point. The target 
volume was the first b0 image after DWI pre-processing, resulting in a structural image 
of resolution 2x2x2 mm3. T2-hyperintense lesions were affine transformed to DWI 
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space and then filled on the T1-weighted images using a modality-agnostic patch-
based method (Prados et al., 2016b).  
Diffusion-weighted imaging pre-processing  
The mean b0 image was rigid registered to the first b0 image. Then, the same rigid 
transformation was applied to the 61 DWI volumes. FSL v5.0.9 was used on the DWI 
data to correct for eddy current and head motion (Andersson and Sotiropoulos, 2016) 
and BrainSuite v.15b to correct for EPI distortions (Bhushan et al., 2012).  
Within-subject registration for diffusion-weighted and structural images  
We performed pairwise symmetric rigid registrations of the mean b0 image to obtain 
transformation matrices between each pair of images using NiftyReg 
(http://niftyreg.sf.net) (Leung et al., 2012). For each image, we computed the 
geometric log mean of pairwise affine transformations (Alexa, 2002)  
Following this step, both diffusion-weighted and anatomical images from all 
time-points were transformed into a common unbiased half-way space. In addition, we 
rotated the diffusion gradient vectors applying their corresponding transformation 
between native and half-way space. Subsequent processing of the diffusion-weighted 
and structural images was performed in this subject-specific space.  
Tissue segmentation and parcellation  
Brain tissue was segmented and parcellated as discussed in section 5.2.3 (chapter 
5). Briefly, the T1-weighted images were segmented into CGM, WM, DGM, brainstem 
and CSF and parcellated into anatomically distinct subregions using the GIF 
framework v2.0 (Cardoso et al., 2015). GIF is free available as webservice at 
http://cmictig.cs.ucl.ac.uk/niftyweb (Prados et al., 2016a). The generated WM and 
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brain- stem tissues were joined together to form the appropriate tissue as required for 
ACT algorithm (Smith et al., 2012).  
Tractogram reconstruction  
As discussed in section 5.2.3 (chapter 5) for diffusion-weighted post-processing, we 
used algorithms from the MRtrix3 v0.3.14 package (http://www.mrtrix.org). We 
estimated the response function (Tax et al., 2014) and followed by CSD to model fibre 
orientation distributions (Tournier et al., 2007; Tournier et al., 2004). Then, we used 
iFOD2 algorithm (Tournier et al., 2010) to generate one tractogram per subject with 
107 streamlines in combination with ACT (Smith et al., 2012) followed by SIFT2 (Smith 
et al., 2015b).  
To visualise the reconstructed tractogram we performed whole-brain 
directionally-encoded colour track-density mapping (TDI) (Calamante et al., 2010).  
Structural brain network reconstruction  
The SIFT2 re-weighted streamlines from the previous step were then assigned to the 
closest node as defined by the GIF parcellation framework (Cardoso et al., 2015). A 
range of network metrics including edge density, global efficiency, mean local 
efficiency and mean clustering coefficient were computed using the TractoR package 
(Clayden et al., 2011). Summary of the longitudinal pipeline is illustrated in Fig. 7.1.  
7.2.4. Overview of the baseline pipeline  
This is the same pipeline that was discussed in chapter 5. Briefly, we used the first 
time-point and followed the exact same pipeline as described above. By default, there 
were no subject-specific half-way registrations. The same network metrics were 
extracted that allowed us to perform the correlations. Here after the metrics derived 
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with this pipeline will be referred to as native metrics as opposed to the half-way 
metrics. Fig. 7.2 summarises the baseline pipeline. 
7.2.5. Statistical analysis  
Statistical analysis was performed using R software (https://www.r-project.org) v3.3.0. 
We used Pearson correlation analysis to investigate the level of correlation between 
baseline native and baseline half-way space network metrics. To further investigate 
the agreement between the two methods we used Bland-Altman plots (Bland and 
Altman, 1986). The plots display the difference between the metrics against their 
mean. We computed each point on the Bland-Altman plot for each subject using the 
following equation  	"#(%,') = (0.5("- +	"/	,"- −	"/)) 
 Eq. 7.1 
where M1 and M2 are the metric values (native and half-way network metrics) for the 
subject i.  
For all the models, we explored whether there was a violation of normality 
assumption of the residuals. Data are reported as mean (± SD), unless otherwise 
stated. P-values < 0.05 were considered statistically significant.  
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7.3. Results 
Visual inspection of track-density map  
Fig. 7.3 demonstrates the track-density maps generated in native and half-way space. 
Visual inspection of these demonstrated that: a) the tractograms appeared to be 
normal without any obvious abnormalities, b) tractography in half-way space was 
feasible and c) the half-way space tractograms were similar as the ones in native 
space.  
Correlation of the network metrics at native and half-way space  
We derived a range of commonly used network metrics from native and half-way 
space. We firstly assessed the Pearson correlations of the whole brain network- 
derived measures combining the MS and HC groups as shown in Table 7.1. As can 
be seen there was a significant positive correlation (r ≥ 0.94, p < 0.001) of all the 
network measures examined. To examine whether the effect of registration in half-
way space was different in the control group compared to MS group, we estimated the 
correlation coefficient of the network metrics for each group separately. We observed 
strong positive correlation between the network metrics derived in native and half-way 
space for both HC and MS subjects (r ≥ 0.80, p < 0.001) (Table 7.1; Fig. 7.4).  
Bland-Altman analysis of the network metrics at native and half-way 
space  
Finally, we used Bland-Altman analysis to evaluate the degree of agreement between 
the two pipelines. Fig. 7.5 showed Bland-Altman plots for edge density, global 
efficiency, mean local efficiency and mean clustering coefficient computed from native 
and half-way space. The mean bias (% ± SD) for edge density computation is +1.08 ± 
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1.55%, for global efficiency is -2.05 ± 2.07%, for mean local efficiency is -2.33 ± 1.95% 
and for mean clustering coefficient is -1.39 ± 2.14% in the half-way against the native 
space. The mean bias estimation was consistent when different groups were 
examined (Table 7.2; Fig. 7.5)  
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7.4. Discussion  
In this chapter, we introduced a novel method that extends the longitudinal registration 
framework beyond the anatomical and diffusion-weighted data. Using registration best 
practices, we have successfully derived network metrics from networks that have been 
previously registered in the half-way space.  
Firstly, we demonstrated a strong correlation between native and half-way 
space-derived network metrics. Importantly, these results were further confirmed 
when data from HC and MS patients were analysed separately. Especially for the latter 
group, we chose to apply our method on participants who had very high LL (top 20%) 
in order to stress test our methods mainly because it is known that diffusion metrics 
are affected in lesional brains (Werring et al., 1999). The results demonstrated that 
the correlation was maintained when both controls and patients were examined 
separately. Of note, edge density showed slightly lower correlation between native 
and half-way metrics in MS compared to the other metrics. Edge density was derived 
from a binary network, by definition, meaning that for this metric only the presence or 
absence of a connection is considered. The lower correlation in the multiple sclerosis 
group only, might suggest that slightly misregistered lesions may interrupt the 
underlying FODs and ultimately causing disruption of connections. The rest of the 
network measures were derived from a weighted network and hence did not suffer 
from this issue. This is because a zero weight and a small weight have a similar effect 
on the total variance. Nonetheless, by demonstrating a strong correlation between 
structural network metrics derived in native and half-way space in a group with very 
high structural brain abnormalities suggests that the pipeline is likely to perform at 
least as well across the whole spectrum of the disease.  
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To further evaluate our approach, we used Bland-Altman plots to examine the 
similarity between the two methods. These results supported the correlation 
observations demonstrating a sufficient agreement with the mean bias limited to less 
than 2.5 % between the two pipelines. Importantly, this agreement was independent 
of pathology providing further evidence that supports the applicability of this technique 
in disease state and more specifically in disorders with substantial WM damage.  
Moreover, we have demonstrated that registration of diffusion-weighted data in 
half-way space was successful as evaluated by the reconstructed directionally-
encoded colour TDI maps (Fig. 7.3). In traditional scalar image registration, there is a 
lot of focus on spatial alignment. This is not the case in diffusion-weighted data as they 
require both spatial image registration and re-orientation of the gradient directions 
constituting diffusion-weighted image registration much more complex and 
challenging (Alexander et al., 2001; Zhang et al., 2006). Here, indeed, we 
demonstrated correct data registration and reorientation of the voxel-wise signal 
profile into a half-way space suggesting the feasibility of such an approach.  
Some limitations apply to this work. In the proposed method, the same steps 
were followed to both time-points during network reconstruction avoiding thus any 
interpolation asymmetry induced bias (Keihaninejad et al., 2013). However, our 
analyses did not examine whether the technique presented here reduced the network 
metrics variability when compared to the native metrics. Such results could be 
suggestive of the advantages that our method might hold. One way to examine this, 
was to assess the specificity and sensitivity of each pipeline using a test-retest de- 
sign. However, due to the absence of such a dataset we could not perform this 
analysis. Nonetheless, the use of the multiple time-point technique allows the 
investigator to extract structural, diffusion or network metrics while all the scans are 
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registered in a common space, extending the technique beyond the already 
established frameworks (Reuter et al., 2012; Keihaninejad et al., 2013).  
 
7.5. Conclusion 
In conclusion, we have shown for the first time a pipeline for structural brain network 
reconstruction from longitudinally acquired diffusion-weighted data. Our approach 
takes advantage of the already established within-subject registration techniques that 
have been successfully used in anatomical and diffusion data. In general, there was 
good agreement between network measures derived from scans processed in native 
and half-way space, indicating that our pipeline does not substantially degrade 
measures while bringing longitudinally acquired data into alignment. This pipeline 
enables longitudinal studies on structural network characteristics and appears 
sufficiently robust to allow this even in the presence of substantial brain abnormalities. 
Chapter 8 will use the proposed pipeline to investigate the predictive value, if any, of 
the baseline network metrics in follow-up volumetric changes. 
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Figure 7.1. Overview of the longitudinal brain network reconstruction pipeline 
Abbreviations: T1-w = T1 weighted image; DWI = diffusion-weighted image 
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Figure 7.2. Overview of the baseline brain network reconstruction pipeline 
Abbreviations: T1-w = T1 weighted image; DWI = diffusion-weighted image 
 
Figure 7.3. Quality check of track-density imaging 
Super-resolution directionally-encoded color track-density imaging (TDI) map 
reconstructed in native (A) and half-way space (B).  
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Network metrics Whole group Healthy controls MS patients 
Edge density r = 0.94*** r = 0.93*** r = 0.80*** 
Global efficiency r = 0.95*** r = 0.94*** r = 0.94*** 
Mean local efficiency r = 0.98*** r = 0.98*** r = 0.96*** 
Mean clustering coefficient r = 0.98*** r = 0.94*** r = 0.92*** 
Table 7.1. Pearson correlation coefficients between native and half-way space 
network metrics 
*P < 0.05, **P < 0,001, ***P < 0.001 
Abbreviations: MS = multiple sclerosis; r = Pearson correlation coefficient 
 
Figure 7.4. Scatterplots of networks metrics  
Scatterplots of edge density, global efficiency, mean local efficiency and mean 
clustering coefficient derived from native and half-way space.  
Abbreviations: HC = healthy controls; MS = multiple sclerosis  
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Network metrics Whole group Healthy controls MS patients 
Edge density 1.08 ± 1.55% 1.45 ± 1.12% 0.70 ± 1.87% 
Global efficiency -2.05 ± 2.07% -2.17 ± 1.04% -1.92 ± 2.85% 
Mean local efficiency -2.33 ± 1.95% -2.55 ± 0.70% -2.10 ± 2.75% 
Mean clustering coefficient -1.39 ± 2.14% -0.84 ± 1.50% -2.06 ±2.78% 
Table 7.2. Bland-Altman analysis for network metrics derived from network 
and half-way space 
In this table, the difference between native and half-way metrics divided by the mean 
of each metric is expressed as a percentage 
Abbreviations: MS = multiple sclerosis 
 
Figure 7.5. Bland-Altman plots of network metrics  
Bland-Altman plots of edge density, global efficiency and mean local efficiency, mean 
clustering coefficient derived from native and half-way space. Blue line corresponds 
to the mean of the whole group and red lines indicate 1.96xSD.  
Abbreviations: ED = edge density; GE = global efficiency; mLE = mean local 
efficiency; mCC = mean clustering coefficient   
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Chapter 8 
8. Baseline whole brain network measures predict future 
volumetric changes in multiple sclerosis 
Summary 
In this chapter, we evaluated the relationship between baseline diffusion-based 
network metrics and follow-up (interval from baseline 1.84 ± 0.55 years) brain damage, 
expressed either as brain atrophy or as visible inflammation hypothesising that 
baseline network parameters are harbingers of future brain changes. We applied the 
pipeline developed in chapter 7 in 61 patients (41 females; age 47 ± 11 years; disease 
duration 17 ± 11 years) consisting of 27 relapsing-remitting (22 females; age 41 ± 11 
years; disease duration 12 ± 9 years), 14 primary progressive (6 females; age 50 ± 10 
years; disease duration 13 ± 8 years) and 20 secondary progressive (12 females; age 
54 ± 7 years; disease duration 26 ± 10 years) and in 12 healthy controls (6 females; 
age 36 ± 13 years). Baseline and follow-up structural brain networks were 
reconstructed from diffusion-weighted magnetic resonance images and baseline 
network metrics including edge density, network efficiency and clustering coefficient 
were computed. Using multiple linear regression analysis, we demonstrated that 
higher baseline edge density predicted higher follow-up LL in relapsing-remitting (p = 
0.033) whereas higher global (p = 0.0019) or local (p = 0.0017) efficiency predicted 
lower follow-up LL in primary progressive independently. The findings suggest that 
diffusion-based network metrics can be novel predictors of progression in multiple 
sclerosis. 
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Scientific contribution 
The manuscript derived from this chapter has been reviewed internally and is going to 
be submitted in Human Brain Mapping peer-review journal.: The predictive value of 
network metrics in multiple sclerosis: a longitudinal study.   
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8.1. Introduction  
Network measures are not only correlated with disability (Shu et al., 2011; Llufriu et 
al., 2017) but they can also explain disability better than conventional imaging metrics 
as discussed in chapter 6 highlighting the clinical relevance of network-based 
approaches in MS. However, little is known about network metrics’ predictive value for 
tissue damage. In fact, there is great interest in identifying predictors of brain damage 
in MS as not all patients have either the same rate of progression or they do not 
convert into more progressive phases at the same time. The limited longitudinal 
studies have provided evidence that higher baseline lesion volume predicts SPMS 
conversion from RRMS (Fisniku et al., 2008a) while more recently it was reported that 
cortical damage is a consequence of NAWM pathology as measured by MTR (Bodini 
et al., 2016). In this longitudinal study, using a novel longitudinal network pipeline 
presented in chapter 7 we aimed for the first time: 
1.  to evaluate whether baseline network measures could predict future brain 
tissue abnormalities, either at the macroscopic level, i.e. greater lesion volume, 
or at the microscopic level, i.e. GM damage, ultimately causing tissue loss, i.e. 
atrophy.  
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8.2. Methods 
8.2.1. Participants  
Twelve HC (6 females; mean age 36 ± 13 years), 27 RRMS (22 females; mean age 
41 ± 11 years), 14 PPMS (6 females, mean age 50 ± 10 years) and 20 SPMS (12 
females; mean age 54 ± 7 years), were scanned at two time-points, approximately two 
years apart (1.84 ± 0.55 years). This work has been approved by the local institutional 
ethics committee and written consent was obtained from all the patients. 
8.2.2. MRI data acquisition  
MRI acquisition parameters were reported in chapter 5. Briefly, MRI data were 
acquired on a Philips Achieva 3T MR scanner (Philips Healthcare, Best, Netherlands) 
with a 32-channel head coil using: (1) 3D sagittal T1-weighted scans with a fast-field 
echo scan, (2) whole brain HARDI scan with EPI consisted of a cardiac-gated SE 
sequence and (3) dual-echo proton density/T2-weighted axial oblique-scans.  
8.2.3. Longitudinal network pipeline 
We presented in chapter 7 a longitudinal pipeline to reconstruct structural brain 
networks (Charalambous et al., 2017) and illustrated in Fig. 7.1. The main steps are 
summarised below. 
Structural image pre-processing  
Bias field corrected structural images were rigid-body transformed to the 
corresponding DWI image of the appropriate time point using BrainSuite v15b. This 
resulted in a structural scan of resolution 2x2x2 mm3. T2-hyperintense lesions non-
rigidly transformed to DWI space and then filled the T1-weighted images using a 
modality-agnostic patch-based method (Prados et al., 2016b). 
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Diffusion-weighted imaging pre-processing  
The mean b0 image was rigid registered to the first b0 image. Then, the same rigid 
transformation was applied to the 61 DWI volumes. FSL v5.0.9 was used on the DWI 
data to correct for eddy current and head motion (Andersson and Sotiropoulos, 2016) 
and BrainSuite v.15b to correct for EPI distortions (Bhushan et al., 2012).  
Within-subject registration for diffusion-weighted and structural images  
We performed pair-wise symmetric rigid registrations to the mean b0 image to obtain 
the transformation matrices between each pair of images using NiftyReg 
(http://niftyreg.sf.net). After this, both diffusion-weighted and anatomical images from 
both time-points were transformed into a common half-way space. Moreover, we 
rotated the diffusion gradients applying the corresponding transformation matrix. 
Subsequent analyses were performed in this subject-specific space 
Tractogram and structural brain network reconstruction  
As discussed in section 5.2.3. (chapter 5) for diffusion-weighted post-processing, we 
used algorithms from the MRtrix3 v0.3.14 package (http://www.mrtrix.org). We used 
CSD to model fibre orientation distributions (Tournier et al., 2007; Tournier et al., 2004) 
followed by the iFOD2 algorithm (Tournier et al., 2010) to generate one tractogram per 
subject with 107 streamlines in combination with ACT framework (Smith et al., 2012) 
followed by SIFT2 (Smith et al., 2015b). The SIFT2 re-weighted streamlines were then 
assigned to the closest node as defined by GIF (Cardoso et al., 2015).GM 
parcellations were the network nodes whereas the networks edges were the sum of 
the weight of the streamlines.  
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Study metrics 
Structural brain network metrics included edge density, global efficiency, mean local 
efficiency and mean clustering coefficient. These were computed from the TractoR 
package (Clayden et al., 2011). NABV and GM volume were computed from their 
corresponding time-point (baseline and follow-up) after registered in the half-way 
space. To perform a more regional analysis, GM volume was further divided into CGM 
and DGM volume. Reduction of these measures is considered as tissue atrophy. We 
also estimated LL as a measure of WM focal damage at baseline and follow-up. 
8.2.3. Statistical analysis  
This cohort is a subset of the one used in chapter 6 for which we had longitudinal data 
and we followed the longitudinal pipeline as described in chapter 7. For these 
reasons, we recalculated the metrics and we reassessed the associations between 
network and MRI metrics at baseline. To explore possible longitudinal associations 
between network and MRI metrics, multiple linear regression analyses were computed 
in which baseline network measures were used as independent variables (one in each 
regression), and follow-up volumes, i.e. NABV, GM, CGM, DGM and LL were included 
in the model as the dependent variable (one in each regression). These models were 
adjusted for the baseline value of the follow-up volume being predicted. To study the 
ability of each baseline network metric to predict follow-up volumes in each of the MS 
subtypes, a categorical variable indicating MS phenotype (i.e. ‘subgroup’) and an 
interaction term ‘subgroup x network metric’ were added as covariates to the analyses. 
For all the regression models in this study, baseline age, gender, baseline disease 
duration and baseline LL were entered as covariates. Finally, we evaluated differences 
in network parameter changes over time between controls and patients.  
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Statistical analysis was performed using R software (https://www.r-project.org/ 
v3.3.0.). Data are reported as mean ± SD (two significant figures), unless otherwise 
stated. P-values < 0.05 were considered statistically significant. 
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8.3. Results 
Demographic, clinical, MRI and network data from MS patients and healthy controls 
are summarised in Table 8.1. 
Baseline associations between network metrics with lesion load and MRI 
volumes 
At baseline, there was strong evidence of an association between lower edge density, 
global efficiency and clustering coefficient and greater LL. For each 1% decrease in 
edge density there was a higher LL of 2.13 ml (95% CI: 3.30 to 0.97, p < 0.001). In 
addition, for each unit decrease in global efficiency there was a higher LL of 0.025 ml 
(95% CI: 0.047 to 0.0040, p = 0.037) and finally for each unit decrease in mean 
clustering coefficient there was a higher LL of 0.51 ml (95% CI: 0.70 to 0.33, p < 0.001). 
We did not find any association between mean local efficiency and LL at baseline 
(eTable 8.1 supplemental).  
There was also an association between edge density, mean local efficiency and 
mean clustering coefficient and MRI volumes. For each 1% reduction in edge density 
there were lower volumes of NABV by 10.84 cm3 (95% CI: 3.49 to 18.18, p = 0.005), 
GM by 5.64 cm3 (95% CI: 1.65 to 9.63, p = 0.006), CGM by 5.19 cm3 (95% CI: 1.39 to 
8.98, p = 0.008) and DGM by 0.45 cm3 (95% CI: 0.21 to 0.70, p < 0.001). In addition, 
for each unit increase in mean local efficiency there was an adjusted decrease in the 
DGM volume of 0.0038cm3 (95% CI: -0.0073 to -0.00024, p = 0.036) (eTable 8.6 
supplemental). Moreover, for each unit decrease in mean clustering coefficient there 
was lower NABV of 2.35 cm3 (95% CI: 1.09 to 3.62, p < 0.001), GM volume of 0.81 
cm3 (95% CI: 0.12 to 1.50, p = 0.023), CGM volume of 0.73 cm3 (95% CI: 0.082 to 
1.39, p = 0.028) and DGM volume of 0.072 cm3 (95% CI: 0.027 to 0.12, p = 0.002) 
  158 
(eTable 1-5 supplemental). The associations between mean clustering coefficient 
and MRI metrics were no longer significant after adjusting for LL.  
 
Prediction of follow-up lesion load and MRI volumes from baseline 
network metrics 
For the whole group, we found that higher baseline edge density predicted higher 
follow-up LL (0.18 ml, (95% CI: 0.021 to 0.35), p = 0.033) (Table 8.2). In addition, we 
detected that higher baseline global efficiency predicts lower follow-up DGM volume 
(0.52x10-3 cm3 (95% CI: -0.99x10-3 to -0.57x10-5), p = 0.048) after adjusting for its 
baseline value (Table 8.3). Both models were adjusted for the baseline value of the 
variable being predicted  
We also detected different effects of baseline network metric for each of MS 
subtypes. We found that higher edge density at baseline predicted higher follow-up LL 
in RRMS subtype (0.40, 95% CI: 0.035 to 0.76, p = 0.03) only (Table 8.2; Fig. 8.2A). 
Moreover, lower baseline global efficiency (-0.0076, 95%: -0.012 to -0.0029, p = 
0.0019) or mean local efficiency (-0.0068, 95% CI: -0.011 to -0.0027, p = 0.0017) 
predicted higher follow-up LL only in PPMS after adjusting for the baseline LL value 
(Table 8.2; Fig. 8.2B, C). Finally, in PPMS, higher baseline edge density predicts 
greater DGM volume at follow-up (0.075, 95% CI: 0.0019 to 0.15, p = 0.044) (Table 
8.3; Fig 8.3.). 
Network changes and differences over time in patients and controls  
Network metrics did not change in patients or controls (eTable 8.9 supplemental). 
There was evidence of greater decrease in edge density over time in SPMS compared 
to HC (-0.78%, 95% CI: -1.63 to 0.08, p = 0.075). We also report evidence of less 
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decrease in mean clustering coefficient over time in PPMS compared to controls (3.01, 
95% CI -0.21 to 6.23, p = 0.066). We did not find any changes over time in global or 
local efficiency, nor in any metrics in RRMS. 
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8.4. Discussion  
We have evaluated the relationship between baseline network metrics and follow-up 
structural volumes and demonstrated that network metrics can predict reduced DGM 
volume and increased WM lesions. 
Baseline network measures predict macroscopic visible inflammation 
Firstly, we demonstrated that higher baseline edge density predicts higher follow-up 
LL above and beyond the presence of baseline WM lesions. Edge density is denoted 
as the proportion of existing edges divided by the total possible number of edges 
reflecting thus the overall network connectivity (Kaiser, 2011). Our results indicated 
that the more connected the network is, the greater the lesion volume after two years 
becomes. This could mean that a more preserved connectivity at baseline indicates a 
higher biological cost which makes the network more vulnerable to additional 
pathology such as pathogenic processes including astrogliosis, oligodendrocyte loss 
and infiltration by macrophages/microglia (Bogdan et al., 2013), contributing to 
increased WM damage over a short period of time. The fact that this behaviour is not 
detected in progressive diseases suggests that edge density could serve as an early 
marker of future tissue damage.  
 Moreover, our findings demonstrated that in the primary progressive group 
alone lower baseline efficiency predicts higher lesion volume after adjusting for its 
baseline value. WM lesions are likely to affect the information transfer capacity within 
a network and this could explain the decreased overall brain efficiency as the lesion 
volume increases, as reported in our baseline analysis of this study and in previous 
work (Shu et al., 2011). Interestingly, our analysis indicates that the greater the 
baseline lesion volume is, the greater the reduction of network efficiency, which in turn 
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predicts higher lesion volume after two years above and beyond of baseline focal 
damage (i.e. lesions). Although the exact mechanism underlying this observation 
remains to be elucidated, we can hypothesise that network efficiency metrics are 
sensitive to microstructural changes in the normal appearing WM such as reduced 
cross-sectional area (Smith et al., 2015a) that will contribute to further tissue damage. 
A previous longitudinal MTR study demonstrated that anomalies detected in the 
normal appearing WM were predictive of tissue loss in visual and motor cortex, 
supporting partially the results presented here. To further elaborate on our findings, 
we could hypothesise that primary demyelination causes reductions in neuronal tract 
density, although the reverse could be possible, in turn reflecting reduced network 
efficiency. Future investigations considering myelin density and with longer 
longitudinal studies could validate or confute this hypothesis.  
Baseline network measures predict tissue loss 
Our findings show interesting results with respect to the DGM volume loss. Higher 
mean local efficiency is associated with smaller DGM volume at baseline. Given that 
DGM atrophy is more strongly associated with cognitive impairment as previously 
reported (Debernard et al., 2015) and in chapter 6 of this thesis, it is possible that the 
increase in local information flow reflects some potential mechanisms to compensate 
for the tissue loss. However, we speculate that these potentially ‘adaptive’ 
mechanisms over time may cause increased atrophy as we demonstrated that higher 
baseline global efficiency predicts greater atrophy in the DGM volume after two years 
when the baseline DGM volume value is considered. Although this is not the first time 
network reorganization has been reported in structural (Fleischer et al., 2017) or in 
functional (Rocca et al., 2016) connectivity studies, this is the first study that 
investigates the predictive nature of diffusion-derived network metrics in MS.  
  162 
 Furthermore, we demonstrate that primary progressive patients with lower 
network connectivity at baseline will have greater DGM atrophy after two years. Given 
that we also presented here that higher baseline connectivity predicts higher visible 
damage at follow-up, we believe that the temporal-related occurrence of inflammation 
and neurodegeneration are captured by our analyses. For example, a patient with MS 
and shorter disease duration may have high connectivity that predicts more lesion 
volume at follow-up, while longer disease duration suggests less connectivity due to 
the progressive loss of connections predicting neurodegeneration. In fact, lower 
connectivity predicts greater tissue loss in mild cognitive impairment patients (Nir et 
al., 2015) justifying in part our results; however, due to the small sample size in our 
study this explanation remains speculative. Hence, these findings need to be 
confirmed in other cohorts with longer follow-up data and if true they could 
demonstrate that edge density in particularly might serve as predictor for disease 
progression.  
Our baseline analysis also shows that lower mean clustering coefficient is 
associated with reduced brain tissue. Mean clustering coefficient is a topological 
metric and reduced values reflect reduced brain segregation (Rubinov and Sporns, 
2010). Interestingly, when we adjusted for LL in our analysis, we found that the 
association between clustering coefficient and brain tissue volume was no longer 
significant; neither the mean clustering coefficient nor the LL variables were 
associated with brain volume. This can be explained by the fact that the two predictors 
are highly correlated (r = 0.6), which means that they both “compete” with each other 
in explaining the variance in the data, therefore losing their significance. Reduced 
clustering coefficient is thought to reflect more random structural networks. Therefore, 
the fact that reduced mean clustering coefficient is associated with greater lesion 
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volume supports the disconnection mechanism hypothesis proposed elsewhere 
(Dineen et al., 2009). 
Further considerations of the present study 
We detected evidence of differential rates of change in edge density and mean 
clustering coefficient between MS subtypes. This could provide some useful insights 
in whole brain connectivity properties and longitudinal development of brain damage, 
that future investigations can be built upon: A) The two year-window might be a short 
period to capture significant network alterations. Therefore, longer interval scans might 
be desirable. B) Our cohort has a relatively long disease duration (mean ± SD; 17 ± 
11 years) which means that it is likely that any network changes might have occurred 
at earlier stages of the disease. In fact, Tur et al. (2016) demonstrated that optic 
radiations diffusion-derived metrics decreased over time in patients after optic neuritis 
after one-year follow-up. C) The findings from Tur et al. (2016) suggest that a more 
targeted subnetwork derived metrics might be more sensitive in capturing longitudinal 
changes. Taking into consideration a recent study demonstrating that a SDMT score 
is sensitive to cognitive changes after one year in MS (Lopez-Gongora et al., 2015), 
we could speculate that subnetwork-metrics that include for example areas from the 
DGM nuclei could be good candidate to validate this hypothesis.  
 This study has several limitations. The limitations associated with the pipeline 
itself have been addressed in chapters 5-7. In addition, we appreciate our small 
sample size, primarily in the primary progressive group (n=14). However, we inspected 
all regression models for outliers and influencers, with negative results. Additionally, 
we evaluated whether network metrics could predict tissue damage longitudinally. 
While this is important for disease stratification, it is also important to help evaluate 
whether those metrics can predict the conversion of prodromal or mild diseased types 
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into more progressive stages. A similar approach was adopted in a study of small 
vessel disease patients which demonstrated that subjects who converted to dementia 
had lower baseline global efficiency (Tuladhar et al., 2016). Early MS subjects should 
be studied to complement our current data to investigate whether the network metrics 
presented in the current study are predictive of MS type conversion. Finally, we used 
global network metrics to predict coarse anatomical volumetric changes. Steenwijk et 
al. (2016) recently demonstrated that cortical atrophy does not equally affect all brain 
regions which might indicate that neurodegeneration might have a predilection for 
particular areas. This in turn suggests that prediction of more regional changes would 
be of future interest for assessing its sensitivity to disease progression.  
8.5. Conclusion  
In conclusion, our study provides evidence of longitudinal damage that can be 
predicted by baseline network metrics and it is independent of the baseline visible 
damage and the extent of the baseline tissue loss. Here we show for the first time that 
that diffusion-based network measures can be novel predictors for MS progression.  
 The network metrics used in chapter 6 and 8 were derived from the brain as a 
whole. However, considering the findings published by Tur et al. (2016) and by 
Steenwijk et al. (2016) it becomes apparent that targeted subnetwork analysis might 
be more sensitive in capturing longitudinal network changes. Therefore, decomposing 
the network into subnetworks may well be a valuable strategy to obtain further insights 
into subnetwork organisation and how this is affected in pathology. The following 
chapter will cover a novel, data-driven decomposition approach and its application in 
MS.  
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BASELINE 
 HC (n=12) Whole MS (n=61) 
RRMS 
(n=27) 
PPMS 
(n=14) 
SPMS 
(n=20) 
Age, years 36 ± 13 47 ± 11 41 ± 11 50 ± 10 54 ± 07 
Gender (M/F) 06/06 21/41 05/22 08/06 08/12 
Interval from 
baseline, years 1.83 ± 0.55 1.84 ± 0.55 1.80 ± 0.52 2.24 ± 0.66 1.62 ± 0.33 
Disease 
duration, years - 17 ± 11 12 ± 9 13 ± 8 26 ± 10 
EDSS, median - 5.00 (1-6.5) 2.00 (1-6) 6.00 (3-6.5) 6.50 (4-8.5) 
      
NABV, cm3 1186 ± 107 1040 ± 127 1060 ± 144 1081 ± 99 984 ± 103 
GM, cm3 699 ± 60 626 ± 68 637 ± 76 645 ± 57 599 ± 58 
CGM, cm3 659 ± 56 592 ± 65 602 ± 73 609 ± 55 566 ± 55 
DGM, cm3 40 ± 3 34 ± 4 35 ± 5 36 ± 3 33 ± 4 
NAWM, cm3 487 ± 52 414 ± 62 423 ± 72 436 ± 46 386 ± 48 
LL, ml - 17.42 ± 17.98 
17.49 ± 
20.41 
15.86 ± 
17.65 
18.42 ± 
15.31 
      
Edge density, % 91.15 ± 
2.37 90.66 ± 3.62 90.76 ± 4.15 91.15 ± 3.29 90.18 ± 3.16 
Global 
efficiency 3955 ± 118 3894 ± 226 3952 ± 156 3880 ± 252 3827 ± 274 
Mean local 
efficiency 4071 ± 139 4000 ± 261 4061 ± 193 3979 ± 285 3934 ± 314 
Mean clustering 
coefficient 249 ± 10 230 ± 21 235 ± 19 231 ± 20 222 ± 21 
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Table 8.1. Baseline characteristics of the participants 
Abbreviations: HC = healthy controls; MS = multiple sclerosis; RRMS = relapsing-
remitting MS; PPMS = primary progressive MS; SPMS = secondary progressive MS; 
NABV = normal appearing brain volume; GM = grey matter; CGM = cortical grey 
matter; DGM = deep grey matter; NAWM = normal appearing white matter; LL = Lesion 
load  
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WHOLE MS GROUP 
Follow-up lesion load (ml) 
Main baseline 
predictors  
Regression 
Coefficient 95% CI P-value 
Edge density  0.18 0.02 – 0.35 0.033 
Global efficiency -0.00042 -0.0031 – 0.0022 0.749 
Local Efficiency -0.00061 -0.0029 – 0.0016 0.586 
Clustering coefficient 0.017 -0.018 – 0.053 0.289 
MS SUBTYPES 
Edge density     
     RRMS 0.40 0.035 – 0.76 0.032 
     PPMS  0.28 -0.085 – 0.64 0.130 
     SPMS  -0.12 -0.44 – 0.20 0.454 
Global efficiency    
     RRMS 0.0013 -0.0040 – 0.0065 0.624 
     PPMS  -0.0076 -0.012 – -0.0029 0.0019 
     SPMS  0.0022 -0.0015 – 0.0060 0.246 
Local Efficiency    
     RRMS -0.00019 -0.0044 – 0.0040 0.93 
     PPMS  -0.0068 -0.011 – -0.0027 0.0017 
     SPMS  0.0022 -0.0011 – 0.0055 0.18 
Clustering coefficient    
     RRMS 0.036 -0.014 – 0.087 0.158 
     PPMS  -0.034 -0.099 – 0.032 0.308 
     SPMS  0.017 -0.039 – 0.072 0.55 
Table 8.2. Linear regression of baseline associations between baseline metrics 
and follow-up lesion load in multiple sclerosis group and subtypes 
Models are adjusted for baseline age, baseline lesion load and gender  
Data reported as two significant figures  
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS; CI = 
confidence interval  
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WHOLE MS GROUP 
Follow-up deep grey matter volume (cm3) 
Main baseline 
predictors  
Regression 
Coefficient 95% CI P-value 
Edge density  -0.012 -0.050 – 0.024 0.487 
Global efficiency -0.00052 -0.00099 – -0.0000057 0.048 
Local Efficiency -0.00041 -0.00085 – -0.000025 0.064 
Clustering coefficient 0.0045 -0.010 – 0.0011 0.109 
MS SUBTYPES 
Edge density     
     RRMS -0.024 -0.072 – 0.022 0.297 
     PPMS  0.075 0.0019 – 0.15 0.044 
     SPMS  -0.040 -0.11 – 0.026 0.229 
Global efficiency    
     RRMS -0.000033 -0.0012 – 0.0011 0.953 
     PPMS  -0.00064 -0.0016 – 0.00037 0.212 
     SPMS  -0.00018 -0.00099 – 0.00064 0.666 
Local Efficiency    
     RRMS 0.000071 -0.00083 – 0.00098 0.875 
     PPMS  -0.00061 -0.0015 – 0.00028 0.172 
     SPMS  -0.00010 -0.00081 – 0.00061 0.774 
Clustering coefficient    
     RRMS -0.0015  -0.012 – 0.0085 0.753 
     PPMS  0.0036 -0.0092 – 0.017 0.576 
     SPMS  -0.0084 -0.019 – 0.0023 0.123 
Table 8.3. Linear regression of baseline associations between baseline metrics 
and follow-up deep grey matter volume in multiple sclerosis group and 
subtypes 
Models are adjusted for baseline age, baseline lesion load, baseline deep grey 
matter volume and gender 
Data reported as two significant figures  
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS; CI = 
confidence interval  
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Figure 8.1. Prediction of follow-up lesion load form baseline network metrics 
The graph demonstrates the prediction of follow-up lesion load from baseline edge 
density (A), global efficiency (B) and mean local efficiency (C).  The thick lines 
represent significant association. 
 
 
 
 
Figure 8.2. Prediction of follow-up deep grey matter volume from baseline 
edge density 
The thick line represents significant association. 
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Appendix B Supplemental results 
eTable 8.1: Linear regression of baseline associations between baseline metrics and 
baseline and baseline lesion load in multiple sclerosis group and subtypes.  
Models are adjusted for baseline age, baseline lesion load and gender   
Data reported as two significant figures 
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS; CI = 
confidence interval 
  
WHOLE MS GROUP 
Baseline lesion load (ml) 
Main predictors  Regression Coefficient 95% CI P-value 
Edge density  -2.130 -3.30 – -0.97 <0.001 
Global efficiency -0.025 -0.047 – -0.0040 0.037 
Local Efficiency -0.014 -0.03 – 0.0045 0.132 
Clustering coefficient -0.510 -0.70 – -0.33 <0.001 
MS SUBTYPES 
Edge density     
     RRMS -2.857 -4.45 – -1.31 <0.001 
     PPMS  0.1032 -2.77 – 2.98 0.94 
     SPMS  -2.431 -4.91 – 0.048 0.054 
Global efficiency    
     RRMS -0.029 -0.075 – 0.016 0.20 
     PPMS  -0.042 -0.082 – -0.0026 0.037 
     SPMS  -0.012 -0.045 – 0.021 0.47 
Mean local Efficiency    
     RRMS -0.0040 -0.042 – 0.034 0.83 
     PPMS  -0.035 -0.071 – 0.00051 0.053 
     SPMS  -0.0065 -0.036 – 0.023 0.66 
Mean clustering coefficient    
     RRMS -0.604 -0.91 – -0.30 <0.001 
     PPMS  -0.561 -0.98 – -0.14 0.0096 
     SPMS  -0.547 -0.89 – -0.21 0.0023 
  172 
WHOLE MS GROUP 
Baseline normal appearing brain volume (cm3) 
Main predictors  Regression Coefficient 95% CI P-value 
Edge density  10.84 3.49 – 18.18  0.005 
Global efficiency -0.039 -0.16 - 0.086 0.536 
Local Efficiency -0.052 -0.16 – 0.053 0.324 
Clustering coefficient a 2.35 1.09 – 3.62 <0.001 
MS SUBTYPES 
Edge density     
     RRMS 11.38 1.77 – 20.99  0.021 
     PPMS  2.86 -12.81 – 18.58 0.714 
     SPMS  11.00 -0.30 – 25.03 0.122 
Global efficiency    
     RRMS -0.0092 -0.25 – 0.23 0.943 
     PPMS  -0.070 0.29 – 0.14 0.522 
     SPMS  -0.074 -0.25 – 0.10 0.403 
Mean local Efficiency    
     RRMS -0.056 -0.25 – 0.14 0.565 
     PPMS  -0.053 -0.24 – 0.14 0.583 
     SPMS  -0.070 -0.22 – 0.084 0.367 
Mean clustering coefficient    
     RRMS 1.72 -0.48 – 3.93 0.122 
     PPMS  0.093 -2.74 – 2.92 0.947 
     SPMS  0.64 1.73 – 3.02 0.588 
eTable 8.2: Linear regression of baseline associations between baseline network 
metrics and baseline normal appearing brain volume in multiple sclerosis group and 
subtypes.  
Models are adjusted for baseline age, baseline lesion load and gender  
Data reported as two significant figures  
a after adjusting for baseline lesion load the association is no longer significant 
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS; CI = 
confidence interval 
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WHOLE MS GROUP 
Baseline grey matter volume (cm3) 
Main predictors  Regression Coefficient 95% CI P-value 
Edge density  6.79 3.19 – 10.40 <0.001 
Global efficiency -0.035 -0.10 – 0.032 0.295 
Local Efficiency -0.039 -0.096 – 0.017 0.169 
Clustering coefficient a 0.81 0.12 – 1.50 0.022 
MS SUBTYPES 
Edge density     
     RRMS 6.08 0.76 – 11.40 0.026 
     PPMS  1.27 -7.43 – 9.93 0.774 
     SPMS  6.57 -1.19 – 14.33 0.095 
Global efficiency    
     RRMS -0.019 -0.15 – 0.12 0.775 
     PPMS  -0.039 -0.016 – 0.082 0.523 
     SPMS  -0.058 -0.16 – 0.039 0.234 
Mean local Efficiency    
     RRMS -0.038 -0.15 – 0.07 0.453 
     PPMS  -0.029 -0.13 – 0.077 0.589 
     SPMS  -0.054 -0.13 – 0.031  0.205 
Mean clustering coefficient    
     RRMS 0.59 -0.064 – 1.83 0.339 
     PPMS  -0.19 -1.78 – 1.39 0.806 
     SPMS  -0.0055 -1.33 – 1.33 0.993 
eTable 8.3: Linear regression of baseline associations between baseline network 
metrics and baseline grey matter volume in multiple sclerosis group and subtypes.  
Models are adjusted for baseline age, baseline lesion load and gender  
Data reported as two significant figures  
a after adjusting for baseline lesion load the association is no longer significant 
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS; CI = 
confidence interval  
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WHOLE MS GROUP 
Baseline cortical grey matter volume (cm3) 
Main predictors  Regression Coefficient 95% CI P-value 
Edge density  6.21 2.78 – 9.63 <0.001 
Global efficiency -0.032 -0.0096 – 0.032 0.320 
Local Efficiency -0.035 -0.089 – 0.018 0.190 
Clustering coefficient a 0.73 0.082 – 1.39 0.028 
MS SUBTYPES 
Edge density     
     RRMS 5.65 0.58 – 10.72 0.029 
     PPMS  0.95 -7.33 – 9.23 0.819 
     SPMS  6.09 -1.31 – 13.49 0.105 
Global efficiency    
     RRMS -0.015 -0.14 – 0.11 0.806 
     PPMS  -0.034 -0.15 – 0.080 0.551 
     SPMS  -0.054 -0.15 – 0.039 0.247 
Mean local Efficiency    
     RRMS -0.035 -0.14 – 0.066 0.484 
     PPMS  -0.025 -0.12 – 0.076 0.623 
     SPMS  -0.050 -0.13 – 0.030 0.217 
Mean clustering coefficient    
     RRMS 0.55 -0.62 – 1.72 0.345 
     PPMS  -0.16 1.67 – 1.34 0.827 
     SPMS  -0.0097 -1.27 – 1.25 0.988 
eTable 8.4: Linear regression of baseline associations between baseline network 
metrics and baseline cortical grey matter volume in multiple sclerosis group and 
subtypes.  
Models are adjusted for baseline age, baseline lesion load and gender  
Data reported as two significant figures  
a after adjusting for baseline lesion load the association is no longer significant 
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS; CI = 
confidence interval  
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WHOLE MS GROUP 
Baseline deep grey matter volume (cm3) 
Main predictors  Regression Coefficient 95% CI P-value 
Edge density  0.45 0.21 – 0.69 <0.001 
Global efficiency -0.0035 -0.0077 – 0.00071 0.101 
Local Efficiency -0.0038 -0.0073 – -0.00024 0.036 
Clustering coefficient a 0.072 0.027 – 0.12 0.002 
MS SUBTYPES 
Edge density     
     RRMS 0.43 0.11 – 0.75 0.009 
     PPMS  0.30 -0.22 – 0.82 0.254 
     SPMS  0.48 0.013 – 0.94 0.044 
Global efficiency    
     RRMS -0.0035 -0.012 – 0.0047 0.394 
     PPMS  -0.0044 -0.012 – 0.0030 0.233 
     SPMS  -0.0043 -0.010 – 0.0015 0.145 
Mean local Efficiency    
     RRMS -0.0045 -0.011 – 0.0019 0.162 
     PPMS  -0.0038 -0.010 – 0.0026 0.233 
     SPMS  -0.0039 -0.0091 – 0.0011 0.134 
Mean clustering coefficient    
     RRMS 0.042 -0.033 – 0.112 0.277 
     PPMS  -0.029 -0.13 – 0.068 0.546 
     SPMS  0.0041 -0.078 – 0.086 0.913 
eTable 8.5: Linear regression of baseline associations between baseline metrics and 
baseline deep grey matter volume in multiple sclerosis group and subtypes.  
Models are adjusted for baseline age, baseline lesion load and gender  
Data reported as two significant figures  
a after adjusting for baseline lesion load the association is no longer significant 
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS; CI = 
confidence interval  
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WHOLE MS GROUP 
Follow-up normal appearing brain volume (cm3) 
Main baseline 
predictors  
Regression 
Coefficient 95% CI P-value 
Edge density  0.21 -0.43 – 0.84 0.524 
Global efficiency 0.00057 -0.0089 – 0.010 0.904 
Local Efficiency 0.00019 -0.0081 – 0.0085   0.962 
Clustering coefficient   0.026 -0.083 – 0.13 0.633 
MS SUBTYPES 
Edge density     
     RRMS 0.018    -0.92 – 0.96 0.969 
     PPMS    1.21 -0.25 – 2.68 0.103 
     SPMS  -0.37 -1.71 – 0.97 0.578 
Global efficiency    
     RRMS 0.00090 -0.021 – 0.023 0.935   
     PPMS  -0.0087 -0.028 – 0.011 0.382 
     SPMS  0.0065 -0.0095 – 0.022 0.421 
Local Efficiency    
     RRMS 0.00052 -0.017 – 0.018 0.953 
     PPMS  -0.0087 -0.026 – 0.0087 0.321 
     SPMS  0.0059 -0.0080 – 0.020 0.397 
Clustering coefficient    
     RRMS   0.0026 -0.20 – 0.21 0.979 
     PPMS  0.29 -0.12 – 0.39 0.293 
     SPMS  0.0049   -0.21 – 0.22 0.964 
eTable 8.7: Linear regression of baseline associations between baseline network 
metrics and follow-up normal appearing brain volume in multiple sclerosis group and 
subtypes.  
Models are adjusted for baseline normal appearing brain volume, baseline age, 
baseline lesion load and gender  
Data reported as two significant figures  
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS; CI = 
confidence interval 
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WHOLE MS GROUP 
Follow-up grey matter volume (cm3) 
Main baseline 
predictors  
Regression 
Coefficient 95% CI P-value 
Edge density  0.28 -0.22 – 0.80 0.262 
Global efficiency 0.00043 -0.0074 – 0.0083 0.912 
Local Efficiency -0.00015 -0.0070 – 0.0067 0.965 
Clustering coefficient   0.052 -0.034 – 0.13 0.232 
MS SUBTYPES 
Edge density     
     RRMS 0.17 -0.56 – 0.91 0.633 
     PPMS  0.87 -0.27 – 2.02 0.132 
     SPMS  -0.66 -1.71 – 0.39 0.214 
Global efficiency    
     RRMS 0.00075 -0.016 – 0.018 0.931 
     PPMS  -0.0063 -0.022 – 0.0092 0.415 
     SPMS  0.0077 -0.0049 – 0.020 0.227 
Local Efficiency    
     RRMS -0.00058 -0.014 – 0.013 0.934 
     PPMS  -0.0057 -0.019 – 0.0079 0.402 
     SPMS  0.0072 -0.0038 – 0.018 0.194 
Clustering coefficient    
     RRMS 0.064 -0.091 – 0.22 0.410 
     PPMS  0.18 -0.012 – 0.38 0.064 
     SPMS  0.015 -0.15 – 0.182 0.855 
eTable 8.6: Linear regression of baseline associations between baseline network 
metrics and follow-up grey matter volume in multiple sclerosis group and subtypes.  
Models are adjusted for baseline grey matter volume, baseline age, baseline lesion 
load and gender  
Data reported as two significant figures  
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS; CI = 
confidence interval 
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WHOLE MS GROUP 
Follow-up cortical grey matter volume (cm3) 
Main baseline 
predictors  
Regression 
Coefficient 95% CI P-value 
Edge density  0.30 -0.19 – 0.78 0.229 
Global efficiency 0.00090 -0.0067 – 0.0085 0.813   
Local Efficiency 0.00021 -0.0064 – 0.00684 0.950 
Clustering coefficient  0.057  -0.026 – 0.14 0.173 
MS SUBTYPES 
Edge density     
     RRMS 0.21    -0.51 – 0.92 0.563 
     PPMS  0.80 -0.31 – 1.91 0.154 
     SPMS  -0.61 -1.63 – 0.40 0.233 
Global efficiency    
     RRMS 0.00072 -0.016 – 0.017 0.932 
     PPMS  -0.0058 -0.021 – 0.0092 0.441 
     SPMS  0.0078 -0.0044 – 0.020 0.206 
Local Efficiency    
     RRMS -0.00073 -0.014 – 0.013 0.914 
     PPMS  -0.0052 -0.019 – 0.0080 0.432 
     SPMS  0.0073 -0.0034 – 0.018 0.177 
Clustering coefficient    
     RRMS 0.067 -0.084  0.21 0.379 
     PPMS  0.18 -0.0091 – 0.38 0.061 
     SPMS  0.024 -0.14 – 0.19 0.769 
eTable 8.8: Linear regression of baseline associations between baseline network 
metrics and follow-up cortical grey matter volume in multiple sclerosis group and 
subtypes.  
Models are adjusted for baseline cortical grey matter volume, baseline age, baseline 
lesion load and gender  
Data reported as two significant figures 
Abbreviations: MS = multiple sclerosis; RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS; CI = 
confidence interval  
  179 
 
eTable 8.9: Annualised changes of network metrics.  
Abbreviations: MS = multiple sclerosis RRMS = relapsing-remitting MS; PPMS = 
primary progressive multiple sclerosis MS; SPMS = secondary progressive MS;  
Data (mean ± SD) reported as two significant figures  
  
ANNUALISED CHANGES 
 HC (n=12) Whole MS (n=61) 
RRMS 
(n=27) 
PPMS 
(n=14) 
SPMS 
(n=20) 
Edge 
density, % -0.07 ± 1.18 -0.50 ± 1.22 -0.43 ± 1.05 -0.14 ± 0.92 
-0.86 ± 
1.50 
Global 
efficiency 
31.68 ± 
54.78 7.55 ± 53.23 7.25 ± 55.15 
20.27 ± 
29.75 
-0.95 ± 
63.12 
Mean 
local 
efficiency 
36.17 ± 
60.69 16.30 ± 59.55 
13.12 ± 
61.31 
24.02 ± 
38.91 
15.17 ± 
70.43 
Mean 
clustering 
coefficient 
-3.22 ± 6.21 -1.32 ± 4.22 -1.52 ± 4.90 -0.23 ± 1.92 -1.80 ± 4.75 
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Chapter 9 
9. Distinct patterns of principal network organisation in 
multiple sclerosis subtypes 
Summary 
In this chapter we sought to investigate principal network organization in healthy 
controls and multiple sclerosis patients. Structural brain networks were reconstructed 
from diffusion-weighted magnetic resonance images in 51 healthy controls and 122 
patients consisting of 58 relapsing-remitting, 28 primary progressive and 36 secondary 
progressive. We then calculated and compared the first and second principal networks 
from the derived mean connectivity matrix from healthy controls and for each of the 
MS phenotypes. We also estimated and compared the subject-wise brain regions that 
exhibited high connectivity (hubs) in each group. The results presented here show 
preserved hub organization in all multiple sclerosis subtypes. However, there was 
reduced strength in some hubs in multiple sclerosis and the number of affected regions 
increased in more severe phenotypes. In healthy controls, the first principal network 
consisted of 10 fully-connected hubs and this organization was preserved in relapsing-
remitting and primary progressive patients, while in secondary progressive group a 
loss of the right thalamo-cortical connections from this network was detected. The 
second principal network consisted of 10 hub regions with strong interhemispheric 
connections in healthy controls. In multiple sclerosis patients, this network did not 
include the right putamen compared to healthy controls, while secondary progressive 
patients had an additional reduction of the right thalamo-cortical connections. This 
exploratory analysis suggests that this technique may provide insights into the pattern 
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of progressive reduction of connectivity in more severe multiple sclerosis phenotypes 
and has potential utility as disease biomarkers. 
 
Scientific contribution 
The results presented in this chapter have been presented as a traditional poster: 
Differential topological organisation of brain networks in multiple sclerosis. 
OHBM (2018). Singapore. The manuscript is in preparation to be submitted in peer-
reviewed Multiple Sclerosis Journal. 
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9.1. Introduction 
As discussed in chapter 4, network-based approaches may offer new and useful 
insights into MS specific processes. For example, network studies have demonstrated 
the existence of a number regions that receive higher number of connections, known 
as network hubs, and that these are affected in MS (Shu et al., 2011). It has also been 
proposed that hub nodes have the tendency to be more densely connected with each 
other rather than with nodes that have lower number of connections (van den Heuvel 
and Sporns, 2011) and in fact such ‘rich-club’ organisation seems to be affected in 
PPMS (Stellmann et al., 2017). Recently, a data-driven framework has been proposed 
for network decomposition into stable, meaningful and reproducible subnetworks with 
strong internal connectivity (Clayden et al., 2013). Briefly, applying the principal 
components analysis-based technique, the full connectivity matrix is decomposed into 
partial connectivity matrices through a linear decomposition. Effectively, the full 
connectivity matrix is the sum of these component matrices, namely principal 
networks. Fig. 9.1. serves as an example of whole network decomposition to its 
principal networks. Although these principal networks are considered topological 
features depicting regions that are highly interconnected, their relevance to MS 
remains unknown. In this chapter, we aimed: 
1. to characterise the principal networks and investigate their relationship with the 
well-defined network hubs 
2. to explore whether principal network structures are sensitive to pathology in 
RRMS, PPMS and SPMS. 
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9.2. Methods 
In this study, we used the same cohort and pre-processing and post-processing 
pipeline as in chapter 5-6. Below, we briefly describe the main steps: 
9.2.1. Participants 
Fifty-one HC (25 male, mean age (± SD) 41 ± 13 years), 58 RRMS (18 male, mean 
age 42 ± 10 years), 28 PPMS (10 male, mean age 52 ± 9 years) and 36 SPMS (8 
male, mean age 57 ± 7 years) underwent MRI assessment. Demographics of the 
participants are summarised in Table 9.1. This work has been approved by the local 
institutional ethics committee and written consent was obtained from all the patients. 
9.2.2. MRI data acquisition  
MRI data were acquired on a Philips Achieva 3T MR scanner (Philips Healthcare, 
Best, Netherlands) with a 32-channel head coil using: (1) 3D sagittal T1-weighted 
scans with a fast-field echo scan, (2) whole brain HARDI scan with echo planar 
imaging consisted of a cardiac-gated SE sequence and (3) dual-echo proton 
density/T2-weighted axial oblique-scans.  
9.2.3. Structural imaging processing  
A non-rigid transformation was performed to register the subject’s non-filled T1-
weighted bias-field corrected image to the corresponding diffusion-weighting image 
(DWI) using BrainSuite v.15b (Bhushan et al., 2012). The target volume was the first 
b0 image after DWI pre-processing, resulting in a structural image of resolution 2x2x2 
mm3. T2-hyperintense lesions were manually delineated from the PD-T2-weighted 
scans using JIM (v6.0, Xinapse Systems, Aldwincle, UK), non-rigidly transformed to 
DWI space and then filled the T1-weighted images using a modality-agnostic patch-
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based method. The filled T1-weighted images were then segmented into different 
tissue types and parcellated according to Desikan–Killiany–Tourville atlas protocol 
using GIF (Cardoso et al., 2015).  
9.2.4. Diffusion-weighted imaging processing  
The 7 b0 images were rigid registered to the 61 DWI correcting for eddy current, head 
motion (Andersson and Sotiropoulos, 2016) and EPI distortions (Bhushan et al., 
2012). We generated 107 streamlines implementing the ACT framework (Smith et al., 
2012) followed by SIFT2 to modulate the contribution of each streamline to the 
relevant edge (Smith et al., 2015b).  
9.2.5. Network analysis  
For the brain network, we defined as nodes the cortical and subcortical regions, and 
as edges the sum of the weights of streamlines connecting a pair of nodes (Smith et 
al., 2015b). We generated one brain network per subject and defined hubs as regions 
that exhibited higher strength (≥ mean + SD) (van den Heuvel and Sporns, 2013). 
Strength is defined as the sum of all weights connected to the node.  
For principal network calculation, we first estimated the mean connectivity matrix 
for each group (HC, RRMS, PPMS, SPMS) and then derived the first and second 
principal networks in each group. The default loading threshold of 0.1 was applied. 
Loadings are the normalised eigenvectors of the association matrix (eigenvectors are 
special vectors that do not change directions when a linear transformation is applied 
to them). Their magnitude corresponds to the influence of each node to the principal 
network and the (relative) sign reflects their influence to the other nodes (i.e. nodes 
from the left or right hemisphere). Principal network decomposition method is fully 
supported in TractoR (http://www.tractor-mri.org.uk) (Clayden et al., 2011). 
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9.2.6. Statistical analysis  
Statistical analysis was performed using R software (https://www.r-project.org/ v3.3.0). 
Student t-test was used to compare nodal strengths between subjects with MS and 
HC. P-values < 0.05 were considered statistically significant. 
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9.3. Results  
Identification and comparison of network hubs between MS subtypes 
and healthy volunteers.  
Table 9.2 shows the identified network hubs for HC, RRMS, PPMS and SPMS. There 
were 18 network hubs in both the control and disease groups indicating preserved hub 
organisation across all groups under investigation. Interestingly, we detected 
significantly reduced strength in some hubs in MS subtypes while the number of 
regions with reduced strength increased in more severe phenotypes as the highlighted 
values show in Table 9.2. For instance, in RRMS, 7 hub regions show decreased 
strength when compared to HC whereas in SPMS 16 out of 18 regions exhibit 
statistically reduced strength. (Table 9.2; p < 0.05). Remarkably, deep nuclei are 
affected in all MS subtypes. 
 
Identification and comparison of the first principal network in healthy 
controls and MS subtypes 
Fig. 9.2A. and Table 9.3. demonstrate first principal networks identified in HC. We 
identified 10 brain regions that composed the first principal network. These regions 
are a subset of the previously defined network hubs Table 9.2. and they include 
regions from the frontal parietal and subcortical grey matter. Additionally, Fig 9.2A. 
shows that the connectivity of the first principal network comprises but is not limited to 
inter-hemispheric connections.  
 We used the same threshold to identify the first principal network in each MS 
group. In RRMS and PPMS, the first principal network is the same as in the control 
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group, whereas in SPMS a loss of the right thalamo-cortical connections from this 
network was detected that resulted in the right thalamus to be excluded as a principal 
network node (Fig. 9.2A. and Table 9.3.).  
 
Identification and comparison of the second principal network in healthy 
controls and MS subtypes 
Fig. 9.2B. and Table 9.4. show that the second principal network in healthy controls 
is comprised of 10 brain regions which are very similar to the first principal network 
with the exception of right Putamen while left Thalamus did not qualify as node in the 
second principal network. Of note, right Putamen is still identified as network hub 
(Table 9.2). In addition, the second principal network is comprised of regions with 
strong interhemispheric connections (Fig. 9.2B.).  
In all MS subtypes, this network did not include the right putamen compared to 
healthy controls, while in SPMS group there was an additional loss of the right 
thalamo-cortical connections (Fig. 9.2B).  
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9.4. Discussion 
Network hubs and principal network organisation have been recognised as important 
features of the brain networks (van den Heuvel and Sporns, 2013; Clayden et al., 
2013). In this study, we investigated for the first-time a) how principal network 
organisation relates to the well-established hub organisation and b) whether principal 
network organisation is sensitive in RRMS, PPMS and SPMS. Generally, we observed 
distinct patterns of connectivity which indicates progressive weakening of connections 
which matched the severity of the MS phenotypes. 
 Within the framework of network science, nodes that are found to have a central 
role in the network are generally referred to as network hubs. There are many different 
graph measures that can be used to derive a network hub, most of which express 
facets of nodal centrality (van den Heuvel and Sporns, 2013; Yeh et al., 2016). The 
most commonly used measure is strength (for weighted networks) or degree (for 
binary networks), which were defined either as the sum of the weights or number of 
the connections respectively that are linked to each node (van den Heuvel and Sporns, 
2011). In this study, we identified 18 hub nodes, including regions from frontal, 
temporal and parietal lobes and DGM structures. Despite methodological differences 
that exist between previous investigations and the present study (parcellation 
schemes and hub definitions) there was a great overlap of areas identified as hub 
nodes (Shu et al., 2016; Yeh et al., 2016; van den Heuvel and Sporns, 2013).  
The relevance of network hubs has been previously studied in MS pathology. 
In general, network hub distribution is mostly preserved in RRMS compared to the 
control group (Shu et al., 2016; Llufriu et al., 2017). Here, we report for the first time 
preserved hub organisation not only in RRMS but also in PPMS and SPMS. Hubs with 
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decreased strength were detected in all MS subtypes and the reduced strength 
showed a disease specific pattern. For instance, in RRMS, a condition with little or no 
tissue loss (Frischer et al., 2009), reduced strength was detected in a subset of hubs 
when compared to controls whereas in SPMS, which is the condition with the highest 
neurogenerative component (Calabrese et al., 2015) reduced strength was exhibited 
in the majority of hubs. Interestingly, deep nuclei atrophy which is known to be the first 
areas affected in pathology and to drive disability in MS (Eshaghi et al., 2018) showed 
reduced strength in all MS subtypes. 
Principal networks decomposition is a novel technique that allowed us to 
disentangle the different subnetworks based on brain’s internal connectivity (Clayden 
et al., 2013). Applying this technique to our control data we identified a structural 
organisation of hub nodes forming the first principal network. Of note, the first principal 
network includes inter-hemispheric connections whereas the second principal network 
includes only intra-hemispheric connection while there is a great overlap of nodes in 
both networks. Functional neuroanatomy studies have demonstrated that one brain 
region can participate in more than one network. For instance, thalamus acts as a 
relay area for both motor and limbic circuit (Lapidus et al., 2014). This non-mutually 
exclusive participation of brain regions in networks can be detected by our technique 
constituting principal networks decomposition method a biologically relevant 
approach. 
The number of nodes of the first principal network was the same in RRMS and 
PPMS but less in SPMS. As the exact same criteria were applied to identify principal 
networks in each of the MS subtypes, the smaller number of nodes in SPMS indicate 
reduced internal connectivity within that group. Notably, the node that was not included 
in SPMS was the right thalamus, indicating reduced thalamocortical connections, 
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which they are known to be affected in pathology especially in more progressive 
stages (Tovar-Moll et al., 2009).  
For the second principal network, the number of nodes was reduced in all MS 
subtypes compared to controls while in SPMS there was an additional loss of a node 
from this network. Similar to the first principal network, weaker connections between 
deep nuclei with cortex in all MS subtypes resulted in the absence of right putamen as 
a principal network node compared to controls. In the principal network of the most 
progressive group, there were no deep nuclei nodes due to possibly the weakening of 
all cortical-subcortical connections (Tovar-Moll et al., 2009; Kipp et al., 2015). In fact, 
it is hypothesised that thalamic connections are affected due to and through their 
extensive connections with other brain regions (Kipp et al., 2015; Chard and Trip, 
2017), a phenomenon that our technique can capture. 
Reduced connection strength in hub nodes and altered principal network 
organisation in particular suggests widespread brain disconnection. This is consistent 
with previous studies that showed reduced network efficiencies in MS (Shu et al., 
2016; Shu et al., 2011; Rocca et al., 2016; He et al., 2009) and that network disruption 
is associated with cognitive impairment (Llufriu et al., 2017). Pathological features of 
disconnection include neuroaxonal damage, inflammation and neurodegeneration 
(Ciccarelli et al., 2014) while recently GM damage has also been recognised as a 
pathological feature of MS, although the relationship between GM and WM damage 
remains to be elucidated (Calabrese et al., 2015). 
Our principal network analysis captures the progressive weakening of 
connections in a layer specific manner. For instance, the first principal network 
corresponds to the most highly interconnected network and we only identified network 
changes in the most severe MS subtype. For the second most interconnected network, 
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we were able to detect connectivity changes between MS and controls. Thus, using 
our analysis framework we could highlight that disconnection occurs at different layers 
from the least to the most interconnected network. Based on our findings, we could 
hypothesise that the higher the severity of the disease, the higher layer of connectivity 
is affected. Although these findings should be validated to a bigger cohort, we could 
speculate that principal network analysis holds the potential to provide a connectivity 
fingerprint for each clinical phenotype. 
Another brain organisation feature that has been studied in neurological 
disorders including MS is the rich-club organisation, that is the tendency of hub nodes 
to be more interconnected among themselves (van den Heuvel and Sporns, 2011). 
Disrupted rich-club organisation was reported in Alzheimer’s disease (Lee et al., 2018) 
while decreased strength within rich-club was reported in CIS (Shu et al., 2018) and 
in PPMS (Stellmann et al., 2017). Recently, it has been demonstrated that there are 
nodes common to principal networks and to rich-club organisation (Powell et al., 
2018), highlighting that there is a subset of nodes with specific role in the network 
independent of the choice of the decomposition method. Mapping out structural 
linkages of hub nodes and how these are affected in pathology could serve as a 
framework to identify disease progression.  
Our findings are more of explorative nature and need further validation. There 
are several measures that can be used to define hubs each of which might influence 
the results (Rubinov and Sporns, 2010). In our analysis, we used strength as a metric 
to characterise hubs which is the most commonly used metric although other centrality 
metrics could be potentially used. Additionally, the nodes of the principal networks do 
not correspond to the previously reported work (Clayden et al., 2013). This could be 
accounted to differences in the methodological approach during network 
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reconstruction. For instance, Clayden et al. (2013) did not include DGM as nodes, 
which is possible to alter the distribution of streamlines to some nodes. Additionally, 
in our approach we reweighted the streamlines of the network using SIFT2 (Smith et 
al., 2015b) which could alter the internal connectivity as the decomposition depends 
on the applied weighting method. The effect of SIFT2 and other network reconstruction 
methods on principal network organisation was beyond the scope of this study. 
Furthermore, tractography method used to reconstruct the brain network shares some 
inherent limitations (Sotiropoulos and Zalesky, 2017). Especially, WM lesions are 
known to hamper connectivity and potentially influence the analysis. However, in this 
study, we used methods that aim to minimise tracking biases (Smith et al., 2012; Smith 
et al., 2015b), while we made sure that no streamlines were terminated incorrectly into 
the WM due to the lesions (chapter 5; Fig. 5.8.). However, we cannot exclude the 
possibility that lesions may alter the streamline distribution influencing in part our study 
outcomes.  
The findings presented here could form the basis for future work. Future 
longitudinal studies could investigate how the patterns of connectivity change over 
time and if it changes in the same way in all MS subtypes. Moreover, it is hypothesised 
that hubs and their connections might be particularly vulnerable to pathogenic factors 
due their central role in the network (Crossley et al., 2014). Thus, future studies could 
investigate whether there is a higher probability of lesions being present in principal 
networks and/or whether the presence of lesions in the principal network is more 
detrimental for accumulation of disability.  
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9.5. Conclusion  
Using a data-driven approach, we demonstrated that network hubs form principal 
networks that are sensitive to pathology. Importantly, we identified differential patterns 
of connectivity in MS compared to controls, while the weakening of cortico-subcortical 
connections was reasonably consistent across the MS spectrum. This technique, 
which considers multiple “layers” of connectivity separately, provides insights into the 
progressive reduction of connectivity which matches the severity of the MS 
phenotypes. Although these are preliminary findings and further is work is needed, we 
highlight the potential utility of the presented approach as imaging biomarkers for 
disease progression or treatment effects. 
  
  196 
 
 
 
Figure 9.1. Example of a whole network and its decomposed subnetworks 
Linear decomposition of the full network (A) results in two main subnetworks (B) and 
(C) such that the sum of these two subnetworks result in the full network (A). The 
decomposition occurs based on their internal connectivity (Figure taken from Clayden 
et al. (2013)). 
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Table 9.1. Demographics of the study participants 
Abbreviations: HC = Healthy controls; MS = multiple sclerosis; RRMS = relapsing 
remitting MS; PPMS = primary progressive MS; SPMS = secondary progressive MS 
 
 
  
  HC 
(n = 51) 
MS 
patients  
(n = 122) 
RRMS  
(n = 58) 
PPMS 
(n = 28) 
SPMS  
(n = 36) 
Age, years 41 ± 13 48 ± 11 49 ±cl 12 46 ± 9 52 ± 9 
Gender (M/F) 25/26 36/86 18/40 10/18 8/28 
Disease 
duration, years 
- 15 ± 10 11 ± 8 14 ± 7 22 ± 10 
EDSS, median - 5.5 (0-8.5) 2 (0-7) 6 (3-8) 6.5 (4-8.5) 
LL (mL) - 14.37 ± 
15.92 
12.78 ± 
15.72 
16.56 ± 
19.83 
15.23 ± 12.73 
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Table 9.2. Network hubs in healthy controls and multiple sclerosis subtypes 
Average values and standard deviations (SD) of region-specific strength  
Bold and highlighted values represent regions that exhibit significant decrease in nodal 
strength against healthy controls. The highlighted and underlined regions indicate 
regions that are belong to the first and second principal network in healthy controls 
respectively 
Abbreviations: HC = healthy controls; RRMS = relapsing-remitting MS; PPMS = 
primary progressive MS; SPMS = secondary progressive MS  
Brain region HC (x105) RRMS (x105) PPMS (x105) SPMS (x105) 
Frontal lobe 
Right precentral gyrus 3.39 (0.21) 3.34 (0.27) 3.27 (0.24) 3.23 (0.23) 
Left precentral gyrus 3.53 (0.23) 3.38 (0.28) 3.36 (0.30) 3.34 (0.32) 
Right superior frontal gyrus 3.37 (0.18) 3.22 (0.23) 3.11 (0.26) 3.09 (0.25) 
Left superior frontal gyrus 3.28 (0.17) 3.20 (0.26) 3.10 (0.03) 3.13 (0.24) 
Right middle frontal gyrus 2.88 (0.20) 2.78 (0.25) 2.75 (0.23) 2.58 (0.22) 
Left middle frontal gyrus 3.04 (0.19) 2.92 (0.27) 2.77 (0.23) 2.76 (0.22) 
Parietal lobe 
Right postcentral gyrus 2.25 (0.10) 2.28 (0.16) 2.20 (0.16) 2.16 (0.18) 
Left postcentral gyrus 2.32 (0.12) 2.27 (0.14) 2.31 (0.19) 2.32 (0.18) 
Right superior parietal lobule 2.26 (0.10) 2.21 (0.13) 2.09 (0.16) 2.08 (0.15) 
Left superior parietal lobule 2.01 (0.10) 1.96 (0.12) 1.93 (0.13) 1.85 (0.11) 
Right precuneus 2.20 (0.10) 2.14 (0.13) 2.10 (0.16) 1.98 (0.13) 
Left precuneus 2.01 (0.10) 1.95 (0.12) 1.94 (0.13) 1.85 (0.12) 
Temporal lobe 
Right middle temporal gyrus 2.06 (0.10) 1.96 (0.13) 1.89 (0.12) 1.88 (0.12) 
Left middle temporal gyrus 1.85 (0.09) 1.78 (0.12) 1.73 (0.10) 1.74 (0.11) 
Subcortical grey matter 
Right thalamus  2.67 (0.15) 2.32 (0.02) 2.27 (0.19) 2.08 (0.15) 
Left thalamus  2.53 (0.15) 2.22 (0.13) 2.23 (0.17) 2.06 (0.14) 
Right putamen 2.34 (0.13) 2.13 (0.12) 2.11 (0.02) 2.03 (0.13) 
Left putamen 2.20 (0.09) 2.03 (0.11) 2.04 (0.15) 1.94 (0.13) 
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Figure 9.2. The first and second principal network in healthy controls and 
multiple sclerosis subtypes  
(A) There is a loss of the right thalamo-cortical connections in the first principal network 
in SPMS.  
(B) For the second principal network, there is a loss of the right putamen connections 
in all MS subtypes, and an additional loss of the right thalamo-cortical network in 
SPMS. Intensity of the edges’ colour denotes the strength of the connection.  
Abbreviations: HC = healthy controls; RRMS = relapsing-remitting MS; PPMS = 
primary progressive MS; SPMS = secondary progressive MS 
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1st principal network nodes 
HC RRMS PPMS SPMS 
Frontal lobe 
Right precentral 
gyrus 
Right precentral 
gyrus 
Right precentral 
gyrus 
Right precentral 
gyrus 
Left precentral 
gyrus 
Left precentral 
gyrus 
Left precentral 
gyrus 
Left precentral 
gyrus 
Right superior 
frontal gyrus 
Right superior 
frontal gyrus 
Right superior 
frontal gyrus 
Right superior 
frontal gyrus 
Left superior 
frontal gyrus 
Left superior 
frontal gyrus 
Left superior 
frontal gyrus 
Left superior 
frontal gyrus 
Right middle 
frontal gyrus 
Right middle 
frontal gyrus 
Right middle 
frontal gyrus 
Right middle 
frontal gyrus 
Left middle frontal 
gyrus 
Left middle frontal 
gyrus 
Left middle frontal 
gyrus 
Left middle frontal 
gyrus 
Parietal lobe 
Right postcentral 
gyrus 
Right postcentral 
gyrus 
Right postcentral 
gyrus 
Right postcentral 
gyrus 
Left postcentral 
gyrus 
Left postcentral 
gyrus 
Left postcentral 
gyrus 
Left postcentral 
gyrus 
Subcortical grey matter 
Right Thalamus 
Proper 
Right Thalamus 
Proper 
Right Thalamus 
Proper 
 
Left Thalamus 
Proper 
Left Thalamus 
Proper 
Left Thalamus 
Proper 
Left Thalamus 
Proper 
Table 9.3. First principal network nodes in healthy controls and multiple 
sclerosis subtypes 
Abbreviations: HC = healthy controls; RRMS = relapsing-remitting MS; PPMS = 
primary progressive MS; SPMS = secondary progressive MS 
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2nd principal network nodes 
HC RRMS PPMS SPMS 
Frontal lobe 
Right precentral 
gyrus 
Right precentral 
gyrus 
Right precentral 
gyrus 
Right precentral 
gyrus 
Left precentral 
gyrus 
Left precentral 
gyrus 
Left precentral 
gyrus 
Left precentral 
gyrus 
Right superior 
frontal gyrus 
Right superior 
frontal gyrus 
Right superior 
frontal gyrus 
Right superior 
frontal gyrus 
Left superior 
frontal gyrus 
Left superior 
frontal gyrus 
Left superior 
frontal gyrus 
Left superior 
frontal gyrus 
Right middle 
frontal gyrus 
Right middle 
frontal gyrus 
Right middle 
frontal gyrus 
Right middle 
frontal gyrus 
Left middle frontal 
gyrus 
Left middle frontal 
gyrus 
Left middle frontal 
gyrus 
Left middle frontal 
gyrus 
Parietal lobe 
Right postcentral 
gyrus 
Right postcentral 
gyrus 
Right postcentral 
gyrus 
Right postcentral 
gyrus 
Left postcentral 
gyrus 
Left postcentral 
gyrus 
Left postcentral 
gyrus 
Left postcentral 
gyrus 
Subcortical grey matter 
Right Thalamus 
Proper 
Right Thalamus 
Proper 
Right Thalamus 
Proper 
 
Right Putamen    
Table 9.4. Second principal network nodes in healthy controls and multiple 
sclerosis subtypes 
Abbreviations: HC = Healthy controls; RRMS = relapsing-remitting MS; PPMS = 
primary progressive MS; SPMS = secondary progressive MS 
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Chapter 10 
10. Conclusions and future directions 
The overarching aim of this work was to investigate structural network disruption in 
MS (taking into consideration the different disease subtypes), evaluating the potential 
of brain network analyses as new biomarkers in MS pathology. This is part of the more 
general goal of bridging the gap between MRI measures and clinical outcomes 
providing insights into underlying mechanisms and targeting treatments.  
The major contributions of the thesis are summarised below: 
Mapping connectomes with diffusion MRI is challenging. In this thesis, we developed 
and optimised a network reconstruction pipeline applying the latest methodological 
developments at the time which aimed to reduce some of the reconstruction biases 
discussed in earlier chapters. One of the limitations addressed in our optimised 
pipeline, was the improvement of the density of the reconstructed network pathways 
such that these pathways are more reflective of underlying biological white matter 
connectivity. This allowed more biologically relevant measures to be obtained. Despite 
the fact that network quantification is an active area of research and better techniques 
will be developed, our optimised pipeline was the first to apply these cutting-edge 
techniques in MS. 
A few studies have investigated network disruption in pathology and MS 
specifically, but none explored the importance of network analysis in predicting 
disability over the conventional imaging metrics. In this thesis, we showed for the first 
time that network metrics explain disability better than non-network metrics such as 
lesion volume and tissue atrophy over and above. More specifically, the best model 
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for EDSS score showed that reduced network density and global network efficiency 
and older individuals were associated with increased clinical disability. Additionally, 
the best model for SDMT score showed that smaller deep grey matter volume, 
reduced global network efficiency and male gender were associated with worse 
information processing speed. These promising results highlight the clinical 
importance of network analysis and the potential of network metrics as biomarkers for 
disease diagnosis or for assessing treatment effects.  
There have been very few longitudinal structural studies of brain networks and 
none in MS. From a network reconstruction perspective, specific techniques are 
required that take advantage of the longitudinal design without introducing any 
potential biases. In this thesis we proposed and validated a longitudinal network 
analysis pipeline that enables longitudinal studies on structural networks without 
affecting the derived metrics. Additionally, this pipeline appears sufficiently robust 
even in the presence of substantial brain abnormalities such as WM lesions. With the 
increasing need for longitudinal studies, we anticipate that this framework is 
transferable and will have a wide range of application not only in MS but also in many 
neurological conditions with imaging data. 
Our longitudinal analysis demonstrated that network metrics can predict future 
tissue damage either at the macroscopic level (increased lesion volume), or at the 
microscopic level causing deep grey matter volume loss (atrophy). These results 
highlight the fact that network studies have the potential to be used as predictive 
markers for disease progression.  
Finally, the last chapter demonstrated distinct patterns of connectivity which are 
indicative of connections weakening linked to the severity of the MS phenotypes. The 
main strength of this study is the data-driven nature of the network decomposition 
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method that allows automatic selection of brain regions with high internal connectivity. 
The results reported in this chapter suggest that connectivity fingerprinting for each 
phenotype might be possible with potential future application to disease prognosis and 
diagnosis.  
 
Future directions 
The results presented in this thesis form a robust framework that future investigations 
could build upon. One of the things that could be addressed that is directly related to 
this thesis is whether subnetwork-specific metrics can relate to disability even more, 
compared with whole-brain global network metrics and imaging measures. 
Additionally, for the longitudinal studies, future investigations could study whether 
subnetwork-specific metrics serve as predictors not only of whole-brain loss but also 
of more regional tissue atrophy. Finally, it would be of particular importance to study 
whether the identified principal networks change differently over time in different 
subtypes. The above investigations would shed light into the clinical importance of 
network approaches and help to appreciate brain network dynamics over time. 
One outstanding question in MS pathology, is why not all MS patients progress 
at the same rate or convert at the time into the progressive phenotypes. Perhaps future 
network-based analyses could address this. For instance, longitudinal studies with 
long follow-up time, could investigate if specific network patterns exist such that 
disruption of these (due to lesions, neurodegeneration) predispose certain individuals 
to worsen at a faster rate or convert to more severe phenotypes. These network 
analyses would help not only to gain insights into the disease processes in order to 
help develop neuroprotective strategies for the affected individual.  
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 From a methodological perspective, current approaches could be further 
improved. Algorithms for modelling tissue microstructure, whole brain tractography 
and brain parcellation belong to some of the research themes that are very active at 
the moment. Therefore, we anticipate more techniques to be developed that could 
address some of the limitations discussed in this thesis. In addition, connectivity 
studies could be validated histologically with post-mortem tissue as this could provide 
the gold standard for our in vivo investigations. Moreover, the application of multimodal 
approaches is essential to appreciate the pathological substrates of changes in 
network topology and function. For instance, magnetisation transfer techniques to 
measure myelin content, sodium imaging to estimate sodium concentration or fMRI to 
study brain activation either at rest or during task are some of the MRI modalities that 
could offer complementary information with respect to brain networks and better 
understand how these are affected in MS.  
 
Final thoughts  
Human brain integrity is crucial for normal functioning and human brain pathology 
can result in a wide range of disorders including MS. Despite its importance, 
understating brain structure and function has been limited due to the current in vivo 
imaging tools. The efforts in this thesis aim to explore further approaches that could 
help address clinically relevant questions. We demonstrated that our methods may 
provide additional information with respect to pathology highlighting the importance 
of expanding the analyses methods available. We hope that the work here may 
provide a framework for future work to finally bridge the gap between imaging and 
symptomatology. 
